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ABSTRACT OF DISSERTATION

COMPUTER SIMULATION OF A HOLLOW-FIBER BIOREACTOR:
HEPARAN REGULATED GROWTH FACTORS-RECEPTORS BINDING
AND DISSOCIATION ANALYSIS

This thesis demonstrates the use of numerical simulation in predicting the behavior
of proteins in a ﬂow environment.
A novel convection-diﬀusion-reaction computational model is ﬁrst introduced to
simulate ﬁbroblast growth factor (FGF-2) binding to its receptor (FGFR) on cell surfaces and regulated by heparan sulfate proteoglycan (HSPG) under ﬂow in a bioreactor. The model includes three parts: (1) the ﬂow of medium using incompressible
Navier-Stokes equations; (2) the mass transport of FGF-2 using convection-diﬀusion
equations; and (3) the cell surface binding using chemical kinetics. The model consists of a set of coupled nonlinear partial diﬀerential equations (PDEs) for ﬂow and
mass transport, and a set of coupled nonlinear ordinary diﬀerential equations (ODEs)
for binding kinetics. To handle pulsatile ﬂow, several assumptions are made including neglecting the entrance eﬀects and an approximate analytical solution for axial
velocity within the ﬁbers is obtained. To solve the time-dependent mass transport
PDEs, the second order implicit Euler method by ﬁnite volume discretization is used.
The binding kinetics ODEs are stiﬀ and solved by an ODE solver (CVODE) using
Newton’s backward diﬀerencing formula. To obtain a reasonable accuracy of the biochemical reactions on cell surfaces, a uniform mesh is used. This basic model can be
used to simulate any growth factor-receptor binding on cell surfaces on the wall of
ﬁbers in a bioreactor, simply by replacing binding kinetics ODEs.
Circulation is an important delivery method for natural and synthetic molecules,
but microenvironment interactions, regulated by endothelial cells and critical to the
molecule’s fate, are diﬃcult to interpret using traditional approaches. Growth factor
capture under ﬂow is analyzed and predicted using computer modeling mentioned
above and a three-dimensional experimental approach that includes pertinent circulation characteristics such as pulsatile ﬂow, competing binding interactions, and
limited bioavailability. An understanding of the controlling features of this process is
desired. The experimental module consists of a bioreactor with synthetic endotheliallined hollow ﬁbers under ﬂow. The physical design of the system is incorporated into
the model parameters. FGF-2 is used for both the experiments and simulations. The

computational model is based on the ﬂow and reactions within a single hollow ﬁber
and is scaled linearly by the total number of ﬁbers for comparison with experimental
results. The model predicts, and experiments conﬁrm, that removal of heparan sulfate (HS) from the system will result in a dramatic loss of binding by heparin-binding
proteins, but not by proteins that do not bind heparin. The model further predicts
a signiﬁcant loss of bound protein at ﬂow rates only slightly higher than average
capillary ﬂow rates, corroborated experimentally, suggesting that the probability of
capture in a single pass at high ﬂow rates is extremely low. Several other key parameters are investigated with the coupling between receptors and proteoglycans shown
to have a critical impact on successful capture. The combined system oﬀers opportunities to examine circulation capture in a straightforward quantitative manner that
should prove advantageous for biological or drug delivery investigations.
For some complicated binding systems, where there are more growth factors or
proteins with competing binding among them moving through hollow ﬁbers of a
bioreactor coupled with biochemical reactions on cell surfaces on the wall of ﬁbers,
a complex model is deduced from the basic model mentioned above. The ﬂuid ﬂow
is also modeled by incompressible Navier-Stokes equations as mentioned in the basic
model, the biochemical reactions in the ﬂuid and on the cell surfaces are modeled
by two distinctive sets of coupled nonlinear ordinary diﬀerential equations, and the
mass transports of diﬀerent growth factors or complexes are modeled separately by
diﬀerent sets of coupled nonlinear partial diﬀerential equations. To solve this computationally intensive system, parallel algorithms are devised, in which all the numerical
computations are solved in parallel, including the discretization of mass transport
equations and the linear system solver Stone’s Implicit Procedure (SIP). A parallel
SIP solver is designed, in which pipeline technique is used for LU factorization and an
overlapped Jacobi iteration technique is chosen for forward and backward substitutions. For solving binding equations ODEs in the ﬂuid and on cell surfaces, a parallel
scheme combined with a sequential CVODE solver is used. The simulation results are
obtained to demonstrate the computational eﬃciency of the algorithms and further
experiments need to be conducted to verify the predictions.

KEYWORDS: Numerical simulation, laminar convection diﬀusion ﬂow, mass transport, ﬁbroblast growth factor and receptor binding, parallel computing

Changjiang Zhang
September 15, 2011

COMPUTER SIMULATION OF A HOLLOW-FIBER BIOREACTOR:
HEPARAN REGULATED GROWTH FACTORS-RECEPTORS BINDING
AND DISSOCIATION ANALYSIS

By
Changjiang Zhang

Jun Zhang, Ph.D.
Director of Dissertation
Raphael Finkel, Ph.D.
Director of Graduate Studies
September 15, 2011
Date

RULES FOR THE USE OF DISSERTATIONS
Unpublished dissertations submitted for the Doctor’s degree and deposited in the
University of Kentucky Library are as a rule open for inspection, but are to be used
only with due regard to the rights of the authors. Bibliographical references may
be noted, but quotations or summaries of parts may be published only with the
permission of the author, and with the usual scholarly acknowledgements.
Extensive copying or publication of the dissertation in whole or in part also requires
the consent of the Dean of the Graduate School of the University of Kentucky.
A library that borrows this dissertation for use by its patrons is expected to secure
the signature of each user.
Name

Date

DISSERTATION

Changjiang Zhang

The Graduate School
University of Kentucky
2011

COMPUTER SIMULATION OF A HOLLOW-FIBER BIOREACTOR:
HEPARAN REGULATED GROWTH FACTORS-RECEPTORS BINDING
AND DISSOCIATION ANALYSIS

DISSERTATION
A dissertation submitted in partial fulﬁllment of the
requirements for the degree of Doctor of Philosophy in the
College of Engineering
at the University of Kentucky

By
Changjiang Zhang
Lexington, Kentucky
Director: Jun Zhang, Ph.D., Professor of Computer Science
Lexington, Kentucky
2011
c Changjiang Zhang 2011
Copyright ⃝

ACKNOWLEDGEMENTS
It took ﬁve years for me to ﬁnish this dissertation. During these ﬁve years of study
at the University of Kentucky, I encountered many diﬃculties in my academic study.
Thanks to all kinds of support, help, and encouragement from my advisor, collaborators, and friends around me, I managed to ﬁnish this dissertation.
First, I would like to thank my academic advisor, Dr. Jun Zhang, who has inspired
and encouraged me to conduct research in computer modeling and simulation, and
led me to the area of bioinformatics and computational biology, a totally new area to
me. Dr. Zhang has been a great mentor on every account, and his broad knowledge
and constructive suggestions to this dissertation are sincerely appreciated.
Second, I would like to thank other faculty members of my Advisory Committee: Dr. Zongming Fei (Department of Computer Science), Dr. Jerzy W. Jaromczyk
(Department of Computer Science), and Dr. Fuqian Yang (Department of Chemical
and Materials Engineering), for their insightful comments and invaluable suggestions
on this work. I would also like to thank the outside examiner Dr. Daniel Lau (Department of Electrical and Computer Engineering) for taking the time to review this
document and his helpful comments on this dissertation.
Third, I would like to express my appreciation to my research collaborators, Dr.
Wensheng Shen, Department of Computational Science, SUNY Brockport, for his outstanding work for the modeling of this research and initial basic program, Dr. Michael
Fannon, Department of Ophthalmology and Visual Sciences, University of Kentucky,
for his invaluable comments on this dissertation and interesting introduction in biology, Dr. Kimberly Forsten-Williams, Department of Chemical Engineering, Virginia
Polytechnic Institute and State University, for her great mentor on building binding
kinetics models, invaluable comments and suggestions on conducting the simulations,
and Dr. Bing Zhao, Department of Ophthalmology and Visual Sciences, University
of Kentucky, for her collaboration in providing all the experimental data and veriﬁiii

cations.
Fourth, I would like to thank all members during my study in the Laboratory
for High Performance Scientiﬁc Computing & Computer Simulation, Dr. Yin Wang,
Dr. Jie Wang, Dr. Xuwei Liang, Mr. Ning Cao, Mr. Dianwei Han, Mr. Qi Zhuang,
Mr. Lian Liu, Mr. Pengpeng Lin, Ms. Ruxin Dai, Mr. Nirmal Thapa, and Mr.
Xiwei Wang, for creating a friendly working environment together and their helpful
discussions and suggestions.
Finally, I would like to thank my family members. I thank my parents for their
long lasting support of my education. Most importantly, I thank my dear wife, Mou
Zhou, and my two lovely sons, Jeﬀrey Zhang and Eric Zhang, for their endless love,
ever-lasting support, and great patience during my graduate study at Lexington, KY
toward my Ph.D. degree in Computer Science.
The research work with this dissertation was fully supported by:
• U.S. National Institutes of Health (NIH-HL086644).
I would like to express my gratitude to this funding agency that has provided the
ﬁnancial support.

iv

Table of Contents

Acknowledgements

iii

List of Tables

viii

List of Figures
List of Files . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

ix
xiv

1 Introduction
1.1 Motivation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1.2 Modeling Procedure . . . . . . . . . . . . . . . . . . . . . . . . . . .
1.3 Numerical Methods for PDEs . . . . . . . . . . . . . . . . . . . . . .

1
2
3
6

2 Iterative Methods and Preconditioners
2.1 Direct Methods . . . . . . . . . . . . . . . . . . . . .
2.1.1 Gaussian Elimination . . . . . . . . . . . . . .
2.2 Stationary Iterative Methods . . . . . . . . . . . . . .
2.2.1 Jacobian Iteration . . . . . . . . . . . . . . .
2.2.2 Gauss-Seidel Iteration . . . . . . . . . . . . .
2.2.3 Successive Overrelaxation Iteration . . . . . .
2.2.4 Symmetric Successive Overrelaxation Iteration
2.3 Krylov Subspace Based Iterative Methods . . . . . .
2.3.1 Conjugate Gradient . . . . . . . . . . . . . . .
2.3.2 Bi-Conjugate Gradient Stabilized (BiCGStab)
2.3.3 General Minimum Residual (GMRES) . . . .
2.4 Preconditioners . . . . . . . . . . . . . . . . . . . . .
2.4.1 Jacobi, GS, SOR, and SSOR Preconditioners .
2.4.2 ILU(0) Preconditioner . . . . . . . . . . . . .
2.4.3 ILU(p) Preconditioner . . . . . . . . . . . . .
2.4.4 ILUT Preconditioner . . . . . . . . . . . . . .
2.5 Stone’s SIP Method . . . . . . . . . . . . . . . . . . .

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

3 A Numerical Study of Pulsatile Flow Through a Hollow Fiber Cartridge: Growth Factor-Receptor Binding and Dissociation Analysis
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3.2 Simulation Environment . . . . . . . . . . . . . . . . . . . . . . . . .
3.3 Modeling Process . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3.3.1 Medium Flow Equations . . . . . . . . . . . . . . . . . . . . .
3.3.2 Mass Transport Equations . . . . . . . . . . . . . . . . . . . .
3.3.3 Binding Kinetics Equations . . . . . . . . . . . . . . . . . . .
3.4 Numerical Algorithm . . . . . . . . . . . . . . . . . . . . . . . . . . .
3.5 Some Implementation Details . . . . . . . . . . . . . . . . . . . . . .
3.5.1 Mesh Size Selection . . . . . . . . . . . . . . . . . . . . . . . .
3.5.2 The Concentration of Growth Factor at Inlet . . . . . . . . . .
3.5.3 The Mass of Growth Factor Bound . . . . . . . . . . . . . . .
v

9
9
9
10
11
11
12
13
13
13
15
15
16
17
17
18
18
19
23
23
24
24
25
29
34
35
38
38
40
41

3.5.4 The Mass of Growth Factor Flowing Into or Out of the Fibers
3.5.5 Some Considerations for the Simulation . . . . . . . . . . . . .
3.6 Simulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3.6.1 Flow Rate Impact on Growth Factor Binding . . . . . . . . .
3.6.2 Diﬀusivity Impact on Growth Factor Binding . . . . . . . . .
3.7 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4 Endothelial Cell Capture of Heparin-Binding Growth Factors under
Flow
4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4.2 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . .
4.2.1 Preparation of Bovine Aortic Endothelial Cells (BAECs) . . .
4.2.2 Preparation and Maintenance of Endothelial Cartridges . . . .
4.2.3 Growth Factor Flow Studies . . . . . . . . . . . . . . . . . . .
4.2.4 Viscosity Measurements . . . . . . . . . . . . . . . . . . . . .
4.2.5 Enzymatic Treatment . . . . . . . . . . . . . . . . . . . . . . .
4.2.6 Determination of Non-speciﬁc Binding . . . . . . . . . . . . .
4.2.7 Determination of Growth Factor Concentration in Outﬂow . .
4.3 Model Development . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4.3.1 Criteria for Comparison Between Simulation and Experiment .
4.4 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4.4.1 Endothelial Cells Form a Uniform and Conﬂuent Monolayer in
Cartridge Capillaries . . . . . . . . . . . . . . . . . . . . . . .
4.4.2 There is Signiﬁcant Capture of FGF-2 Under Low Flow Rates
4.4.3 Heparinase Treatment Signiﬁcantly Increases the FGF-2 Outﬂow
4.4.4 VEGF but not EGF is Impacted by Heparinase Treatment . .
4.4.5 Simulations Capture Critical Properties of Process . . . . . . .
4.4.6 Pulsatile and Steady Flow Results Are Similar at Low Flow Rates
4.4.7 Simulations Predict Peak FGF-2 Binding at Entrance to the
Cell-lined Hollow Fibers . . . . . . . . . . . . . . . . . . . . .
4.4.8 Flow Rate Impacts FGF-2 Binding . . . . . . . . . . . . . . .
4.4.9 Changes in FGF-2 Aﬃnity for HSPG Are Predicted to Have a
Larger Impact on Retention Than Similar Changes in Aﬃnity
for FGFR at Physiological Cell Densities . . . . . . . . . . . .
4.4.10 Simulations Predict Binding Site Density is Critical for FGF-2
Retention . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4.4.11 Simulations Predict Coupling is Key to Eﬀective Capture of
FGF-2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4.5 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4.6 Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5 Parallel Simulation of Multiple Proteins Through a Bioreactor Coupled with Biochemical Reactions
5.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5.2 Modeling Process . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5.2.1 Medium Flow Equations . . . . . . . . . . . . . . . . . . . . .

vi

43
44
45
45
46
47
51
51
53
53
54
54
55
55
56
56
57
58
60
60
60
62
63
64
66
66
67

68
69
70
72
77
90
90
90
91

5.3

5.4

5.5

5.6

5.2.2 Mass Transport Equations . . . . . . . . . . . . . . . . . . . .
5.2.3 Binding Kinetics Equations . . . . . . . . . . . . . . . . . . .
Parallel Design and Implementation . . . . . . . . . . . . . . . . . . .
5.3.1 Parallel Discretization . . . . . . . . . . . . . . . . . . . . . .
5.3.2 Parallel SIP solver . . . . . . . . . . . . . . . . . . . . . . . .
5.3.3 Parallel Algorithm . . . . . . . . . . . . . . . . . . . . . . . .
5.3.4 Time Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . .
Some Implementation Details . . . . . . . . . . . . . . . . . . . . . .
5.4.1 The Concentration of Proteins at Entrance . . . . . . . . . . .
5.4.2 The Mass of Proteins Bound . . . . . . . . . . . . . . . . . . .
Simulations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5.5.1 Eﬀect of Heparin on FGF-2 Capture . . . . . . . . . . . . . .
5.5.2 Eﬀect of HB-EGF on FGF-2 Capture . . . . . . . . . . . . . .
5.5.3 HB-EGF Has Only a Minor Impact on Heparin Regulation of
FGF-2 Binding . . . . . . . . . . . . . . . . . . . . . . . . . .
5.5.4 Multi-pass Simulation . . . . . . . . . . . . . . . . . . . . . .
5.5.5 Eﬀect of Time on FGF-2 Capture Under Multi-pass . . . . . .
5.5.6 Eﬀect of Diﬀerent Radiuses of Fibers on FGF-2 Capture . . .
Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

6 Parallel Stone’s Strongly Implicit Procedure Solver
6.1 Introduction . . . . . . . . . . . . . . . . . . . . . . .
6.2 Analysis of Sequential Strongly Implicit Procedure . .
6.2.1 LU Factorization . . . . . . . . . . . . . . . .
6.2.2 Forward Substitution . . . . . . . . . . . . . .
6.2.3 Backward Substitution and Correction . . . .
6.3 Parallel SIP Algorithms . . . . . . . . . . . . . . . .
6.3.1 Pipeline Algorithm . . . . . . . . . . . . . . .
6.3.2 Overlapped Jacobi Iteration Algorithm . . . .
6.4 Results . . . . . . . . . . . . . . . . . . . . . . . . . .
6.5 Summary . . . . . . . . . . . . . . . . . . . . . . . .
7 Conclusion, Contribution and
7.1 Conclusion . . . . . . . . . .
7.2 Contribution . . . . . . . . .
7.3 Future Work . . . . . . . . .

.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.

.
.
.
.
.
.
.
.
.
.

92
94
99
99
100
104
106
106
106
108
109
109
110
110
111
113
113
115
117
117
118
118
119
119
120
120
121
122
122

Future Work
124
. . . . . . . . . . . . . . . . . . . . . . . 124
. . . . . . . . . . . . . . . . . . . . . . . 126
. . . . . . . . . . . . . . . . . . . . . . . 127

Appendix
129
7.4 A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
Bibliography

130

Vita

138

vii

List of Tables
3.1
3.2
3.3
3.4

Equations describing the binding reactions in the model.
Parameter values used in simulation. . . . . . . . . . . .
The relationship between ﬂow rate and binding. . . . . .
The relationship between diﬀusivity and binding. . . . .

4.1
4.2
4.3
4.4
4.5

Parameter values used in simulation. . . . . . . . . . . . . . . . . . .
Heparinase and chondroitinase but not keratanase impact FGF-2 output.
VEGF but not EGF retention is impacted by heparinase (experimental).
Increased ﬂow rate eliminates FGF-2 binding (experimental). . . . . .
Simulations predict eﬀect of entrance HSPG zone on FGF-2 capture
at 5 min. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

5.1
5.2
5.3
5.4
5.5
5.6
5.7

.
.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

.
.
.
.

36
36
46
47
58
63
64
68
72

Model reactions on cell surfaces. . . . . . . . . . . . . . . . . . . . . . 95
Model reactions in the ﬂuid. . . . . . . . . . . . . . . . . . . . . . . . 96
Binding equations in the ﬂuid. . . . . . . . . . . . . . . . . . . . . . . 96
Binding equations on cell surfaces in the non-receptor-coupling model. 96
Binding equations on cell surfaces in the receptor-coupling model. . . 97
Parameter values used in simulation. . . . . . . . . . . . . . . . . . . 98
Some values used in simulations of diﬀerent radiuses. . . . . . . . . . 114

viii

List of Figures
3.1 Hollow ﬁber cartridge system from FiberCellr . . . . . . . . . . . . . .
3.2 The diagram of modeling process. . . . . . . . . . . . . . . . . . . . .
3.3 The ﬁnite volume notation of control volumes in axisymmetric coordinates, (A) the control volume, (B) the north boundary control volume.
3.4 The diagram of binding kinetic pathway. . . . . . . . . . . . . . . . .
3.5 The cross section of a ﬁber and the mesh schematic diagram. . . . . .
3.6 The diagram of inlet reservoir. . . . . . . . . . . . . . . . . . . . . . .
3.7 Comparison of the growth factor (FGF-2) exited in diﬀerent mesh sizes.
3.8 The relationship between ﬂow rate and the amount of FGF-2 binding.
(A) Cell-bound FGF-2 is shown after 5 min of simulation for various
amount of FGF-2 injected and various ﬂow rates. (B) Cell-bound FGF2 is shown along the ﬁber. 1ng FGF-2 was injected at time 0 under
diﬀerent ﬂow rates. Each cell expressed 104 FGFRs and 5×105 HSPGs
initially. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3.9 Plot of FGF-2 bound to FGFR and HSPG versus time at the entrance
, middle and exit of the ﬁber when FGF-2(1ng) is introduced into the
ﬁber under pulsatile ﬂow at 0.67ml/min with FGF-2 having a diﬀusivity of 1.67 × 10−10 m2 /s (black) or 1.67 × 10−9 m2 /s(red). . . . . . . .

25
26
31
35
39
40
44

49

50

4.1 Brightﬁeld and DAPI stained images of endothelial cells from the unit
showing the continuous vessel-type architecture. . . . . . . . . . . . . 61
4.2 Signiﬁcant retention of FGF-2 occurs under ﬂow). (A) FGF-2 (5.0±0.4
ng) was injected into the inlet reservoir, pumped through the cartridge at 0.65±0.01 mL/min (1.3 mm/sec), and measured in the output
stream samples from three independent runs on three separate cartridges. The average retention of FGF-2 within the cell-lined cartridge
was 40±0.5of the three runs shown) with a speciﬁc binding of 9±2.5%
(B) FGF-2 ((•) 0.92 ng , (◦) 6.9 ng, (×) 12 ng, and () 18 ng FGF-2)
was injected into the initial reservoir, run through the system at 0.64
mL/min, and the FGF-2 in the output stream measured using ELISA.
Results are from individual runs with 9 independent cartridges. (C)
FGF-2 (ng) retained within the cell-lined cartridge versus the FGF-2
(ng) injected into the system is shown. The ﬂow rate for this study
varied between 0.60 and 0.67 mL/min (1.2 and 1.34 mm/sec respectively). 79
4.3 EGF and VEGF are retained under ﬂow. (A) EGF (1.49 ng) was
injected into the input reservoir, pumped through the system at 0.61
mL/min (1.22 mm/sec), and EGF quantiﬁed in the output ﬂow by
ELISA. Data shown are from the same cartridge either untreated (◦)
or enzyme-treated (•). FGF-2 (1.01ng - ×) is shown for comparison.
(B) VEGF was injected into the input reservoir of untreated (0.95ng ◦) or heparinase-treated (0.98ng - •) cartridges, run through the system
at 0.66 mL/min (1.32 mm/sec), and VEGF quantiﬁed in the output
ﬂow by ELISA. Data are representative of at least three runs quantiﬁed
in Table 4.3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80

ix

4.4 Simulations agree well with FGF-2 outﬂow measurements. (A) FGF2(0.92 ng) was injected into the cartridge reservoir and then ﬂowed
through the cell-lined hollow ﬁbers at 0.63 mL/min (1.26 mm/sec),
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FGF-2 amount injected at the same ﬂow rate (◦) are also shown. (B)
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ng) addition for heparinase-treated (experimental - •) and simulation
results with out HSPG (simulations - ◦). Simulations were run with
cells expressing 1×104 FGFR/cell and 30% loss in the entrance reservoir.
4.5 Simulation and experimental comparison between pulsatile and steady
ﬂow. (A) Simulation results of FGF-2 in the outﬂow as a function
of time for pulsatile (◦) or steady (•) ﬂow, (B) Simulation results of
FGF-2 bound along the endothelial-lined hollow ﬁber as a function of
distance at 44 sec (pulsatile (◦), steady (pink circle) ﬂow) and at 88
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(C) Experimental comparison of FGF-2 in outﬂow using pulsatile (◦)
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4.8 Simulations show reduced binding with increased ﬂow rate. (A) Simulations for control (•), and HSPG-deﬁcient cells (◦), were run modeling
injection of FGF-2 (1 ng) into the system and run at varied ﬂow rate.
30% non-speciﬁc loss of FGF-2 in the reservoir was incorporated. (B)
Cell-bound+internalized FGF-2 as a function of injection concentration at 5 min as a function of ﬂow rate is shown. Simulations performed at 0.63 (•), 1.8 (◦), and 3.0 () mL/min pulsatile ﬂow(1.26,
3.6, and 6 mm/sec, respectively). Each cell on the cell-lined hollow
ﬁber expressed 1 × 104 FGFR/cell and 2.5 × 105 HSPG/cell. . . . . .
4.9 Simulations predict binding aﬃnity of FGF-2 for HSPG impacts FGF2 capture more than aﬃnity for FGFR. (A) The aﬃnity of FGF-2
for HSPG was varied in simulations by changing the association rate
constant (•) or the dissociation rate constant (◦). (B) The aﬃnity of
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Introduction

The purpose of this chapter is to state the motivation of the proposed dissertation
research and give an introduction to computer modeling and simulation in the areas
of ﬂuid dynamics, mass transfer, chemical reaction, cellular and molecular biochemistry. Simulation models are usually described by coupled nonlinear partial diﬀerential equations (PDEs) for ﬂuid dynamics and mass transfer, and ordinary diﬀerential
equations (ODEs) for chemical reaction and cellular and molecular biochemistry.
By Moore’s law, the number of transistors that can be placed inexpensively on an
integrated circuit doubles approximately every two years. This trend has continued
for more than half a century, and it is expected to continue until 2015 or 2020 or
later [42, 51]. Today, computer capacity (processing speed, memory capacity, etc.) is
growing much more rapidly. High performance desktop computers, even laptops with
multi-core processors and graphics processing unit (GPU) technology, are commonly
used in homes, oﬃces and research laboratories. These computers have more powerful
computational capacity than most middle-sized mainframe computers from the 1970’s
and 80’s. Problems that take a few minutes or even seconds of CPU time using
today’s computers would have taken years to complete using computers available two
decades ago [1]. In the meantime, computational cost has been reduced constantly
and substantially. According to current investigation, expenses for a given task have
been reduced by a factor of ten every eight years [8].
A direct consequence of this trend is that the modeling and simulation of complex
phenomena, such as multi-dimensional molecular binding that couples ﬂuid ﬂow and
chemical reactions, is made possible in practice. Most costly computer simulations
and visualizations running on high performance computers (cluster machines or even
personal computers) have become a reality. Technological advancement in computer
science had led to the rapid development of bioinformatics and computational system
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biology.
1.1

Motivation

Traditionally, research on ﬂuid dynamics, mass transfer, chemical reaction, cellular
and molecular biochemistry has depended heavily on experimental and theoretical
approaches. The advantages of these two approaches are that the experimental approach produces more realistic results and the theoretical approach gives a clean
solution in formula form. However, both of these have some drawbacks. For the
experimental approach, test equipment is required and expensive in some cases. For
example, measurement in wind tunnel experiments is diﬃcult and costly. Sometimes,
it is even impractical to perform experiments or measurements, like in vivo diagnostics related to human beings or drug delivery research in human blood vessels or
capillaries. Instead, in vitro experiments and/or numerical simulations are used as
alternatives. The theoretical approach is usually restricted to simple geometries and
linear problems, and therefore it is not possible to obtain a theoretical solution for
most complicated geometries and nonlinear problems.
The numerical method, however, can overcome many of the drawbacks related to
experimental and theoretical approaches. It can cut the cost of experiments, apply
it to complicated nonlinear problems, and obtain a transient solution. Although it
may have some drawbacks, such as modeling issues, numerical errors, convergence
and stability issues, boundary conditions, etc. [1], these issues are easily recognized
and can be avoided in most cases.
One of the most important topics of this dissertation is the numerical simulation
of laminar convection-diﬀusion-reaction pulsatile ﬂow in a bioreactor, an in vitro
experimental apparatus for cellular study. Since the ﬂow in human blood vessels or
capillaries has similar properties, it can be used as a complementary tool to simulate
biochemical reactions in vitro. Examples of the applications include drug delivery and
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tumor therapy research in human blood vessels or capillaries, which are beneﬁcial to
the health care of human beings.
Though there are several commercial software packages on the market that could
be used for similar research purposes, such as COMSOLr , these packages are either
too costly or too general, and can not be used for speciﬁc needs. In this research work,
we develop a software package to complement experiments, in order to study biochemical processes, such as growth factors-receptors binding and dissociation analysis in a
bioreactor ﬂow environment.
1.2

Modeling Procedure

The procedures involved in modeling and simulation usually include four steps [74]:
(1) set up a mathematical model;
(2) rewrite the mathematical model for computer simulation;
(3) develop a computer program;
(4) verify simulation results.
Generally, computer simulation often incurs a very low cost, though an initial cost
is required to develop a simulation program or purchase commercial simulation software. It should be recognized that once a simulation program is created, the cost
in subsequent studies is usually negligible. Also, it is easy to modify the simulation
program to handle diﬀerent situations.
This research focuses on the modeling and simulation of physical, biochemical and
cellular binding kinetics processes in ﬂow conditions, which are governed by partial
diﬀerential equations (PDEs) and ordinary diﬀerential equations (ODEs). So, the
ﬁrst step in the modeling procedure is to derive a set of PDEs or ODEs as the
mathematical model.
For ﬂow dynamics and mass transport equations, they are usually deﬁned by
a set of second-order partial diﬀerential equations. A general second-order partial
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diﬀerential equation in a standard form in a 2D Cartesian coordinate system can be
written as [1]:
a(x, y)uxx + b(x, y)uxy + c(x, y)uyy + d(x, y)ux + e(x, y)uy + f (x, y)u = g(x, y) (1.1)
where a(x, y), b(x, y), c(x, y), d(x, y), e(x, y), and f (x, y) are functions of (x, y).
Eq. (1.1) can be classiﬁed as hyperbolic, parabolic and elliptic, based on the
values of a, b and c. The PDE is hyperbolic if b2 − 4ac > 0, parabolic if b2 − 4ac = 0
and elliptic if b2 − 4ac < 0. Hyperbolic or parabolic PDEs govern initial value or
initial boundary value problems, which are frequently called marching or propagation
problems. Elliptic PDEs govern boundary value problems, or equilibrium problems,
which include steady-state temperature distributions, incompressible inviscid ﬂow,
and equilibrium stress distributions in solids.
The mathematical model of PDEs is not suitable for direct computer simulation.
The PDEs in the continuous domain must be discretized, so that the dependent
variables exist only at discrete points. Frequently-used discretization techniques in
numerical simulation include ﬁnite diﬀerence, ﬁnite element and ﬁnite volume methods. The ﬁnite diﬀerence method is easy to apply to discretizing diﬀerential equations
directly, easy to obtain higher order accuracy by using higher order diﬀerence, and
the coeﬃcient matrix of the linear system obtained from implicit discretization is easy
to solve, but diﬃcult to apply it to irregular domains. For ﬁnite volume and ﬁnite
element methods, the diﬀerential equations have to be written in integral form. The
major advantage of ﬁnite volume and ﬁnite element methods is their application in
irregular domains and use of fully unstructured grids composed of triangles and/or
quadrilaterals [4]. The ﬁnite volume method has an inherent ﬂux conservation, which
is a desired feature in numerical simulation of ﬂuid ﬂow and mass transfer. This
explains why the ﬁnite volume method is so popular in applications of computational
ﬂuid dynamics (CFD). However, both ﬁnite volume and ﬁnite element methods have
the drawback of higher computational cost in implicit discretization, due to a denser
4

coeﬃcient matrix. The selection of a discretization method depends on actual applications. For simple geometry, the ﬁnite diﬀerence method can be used for simplicity.
In the case of complex geometry with irregular boundaries, the ﬁnite volume or the
ﬁnite element method can be applied.
Biochemical reaction and cellular binding kinetics equations are usually deﬁned
by a set of nonlinear ordinary diﬀerential equations. A general nonlinear ordinary
diﬀerential equation can be expressed in vector form as:
d⃗y
= f (⃗y , t)
dt

(1.2)

Eq. (1.2) can be solved by the ﬁnite diﬀerence method by using backward diﬀerencing formulation.
⃗y n = ⃗y n−1 + ∆tf (⃗y n )

(1.3)

Newton’s method is used to solve Eq. (1.3) and the solution is
⃗y n = ⃗y n−1 + ∆t(I − ∆tJ)−1 ⃗y n−1

(1.4)

where J = ∂f /∂y is the Jacobian matrix. This nonlinear system can be solved by a
ODE solver. For example, The CVODE solver [6] can be used with a user-supplied
Jacobian matrix.
Normally, the whole simulation system is a complicated one, with coupled PDEs
and ODEs, which should be calculated in a planned order. For example, in order
to calculate mass transport equations for growth factors competitive binding to their
receptors in capillaries or ﬁbers of a bioreactor, two steps are needed. First, ﬂow velocities and binding kinetics equations are calculated separately; second, mass transport
equations are calculated by using velocities obtained in the ﬁrst step. The solution
of binding kinetics in the ﬁrst step is used as an initial solution for mass transport
equations, if binding kinetics occur in the whole domain, or as boundary conditions,
if binding kinetics only occur on cell surfaces lined on the walls of ﬁbers.
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1.3

Numerical Methods for PDEs

Numerical schemes, which are employed to convert governing PDEs to discrete algebraic expressions, are very important for the solution of equations in terms of accuracy,
stability and eﬃciency, and are usually problem dependent. Hyperbolic equations
can be solved very eﬃciently using explicit methods, in which only one unknown appears in each equation. High resolution schemes have been developed using explicit
discretization and ﬂux limiters [81], such as the second order total variation diminishing (TVD) scheme [62], second order Monotone Upstream-centered Schemes for
Conservation Laws (MUSCL) type TVD scheme [86], third order piecewise parabolic
method (PPM) [9], Runge-Kutta methods, and higher order weighted essentially nonoscillatory (WENO) scheme [72]. For these explicit schemes, there exists a common
drawback. They are not unconditionally stable. The stability of explicit numerical
schemes is conﬁned by the Courant−Friedrichs−Lewy (CFL) condition [11].
For problems governed by elliptic PDEs, such as the steady-state heat conduction
equation, simultaneous equations have to be solved, which involves inversion of the
coeﬃcient matrix. Such a matrix is usually sparse, and its detailed structure depends
on the dimensions of the problem and the discretization strategy. For parabolic equations, such as the transient heat conduction equation, the simple explicit method is
highly dissipative. The commonly used method is the implicit treatment of temporal
terms, and again, simultaneous algebraic equations have to be solved.
For one dimensional applications in ﬂuid dynamics, such as 1D diﬀusion problems,
the coeﬃcient matrix of the discrete algebraic equations is frequently tridiagonal
or block tridiagonal. A very eﬃcient numerical algorithm, the tridiagonal matrix
algorithm (TDMA), also known as the Thomas algorithm (named after Llewellyn
Thomas), exists, running in linear time. It is a simpliﬁed form of the Gaussian
elimination method that can be used to solve tridiagonal systems of equations [10].
For multidimensional cases, however, the coeﬃcient matrix is very diﬃcult to invert
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directly. Due to the attractive features of the Thomas algorithm, a multi-dimensional
problem is frequently solved with multi-steps, such that a tridiagonal matrix is formed
for each step. Algorithms related to this technique include the alternating-directionimplicit (ADI) method and fractional-step methods.
The ADI method is a ﬁnite diﬀerence method for solving parabolic and elliptic
PDEs, and most notably, it is used to solve the problem of heat conduction, or solve
diﬀusion equations, in two or more dimensions [1]. The advantage of the ADI method
is that the equations in every iteration have a simpler structure and are thus easier
to solve than traditional methods, such as the Crank-Nicolson method. The disadvantage is that the splitting techniques of the ADI method and the fractional-step
method do not work well in situations that are highly nonlinear, such as the strongly
coupled chemical reactions in ﬂow conditions. Therefore, this research is focused on
the Krylov subspace iterative methods and incomplete LU factorization methods to
solve linear systems in simulation of various physical and biological phenomena which
are modeled by PDEs in a ﬂow environment.
This dissertation is organized as follows. Chapter 2 gives a brief review of some
diﬀerent methods of solving linear systems related to PDEs in computational ﬂuid
dynamics and mass transfer, which are very important parts of this research. Iterative
Methods and Preconditioners are also discussed. Chapter 3 describes basic models
and numerical methods for performing simulations of pulsatile ﬂow moving through
a hollow ﬁber cartridge, as well as methods used to analyze growth factor-receptor
binding and dissociation processes. Chapter 4 describes in detail how to combine
experiments and simulations, in order to study the endothelial cell capture of heparinbinding growth factors under ﬂow condition. Chapter 5 presents a parallel system
to simulate multiple proteins moving through a bioreactor coupled with competitive
binding in the ﬂuid and on cell surfaces, in order to mimic complex bioreactions
in human blood vessels or capillaries. A novel parallel, Stone’s strongly implicit
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procedure solver, is introduced in Chapter 6. Conclusions, contributions and future
work are presented in Chapter 7.

c Changjiang Zhang 2011
Copyright ⃝
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2

Iterative Methods and Preconditioners

The purpose of this chapter is to give a brief review of some diﬀerent methods for
solving linear systems related to solving PDEs in computational ﬂuid dynamics and
mass transfer, which are very important parts of this research. It will review direct
methods, stationary iterative methods, Krylov subspace-based iterative methods, preconditioners, and Stone’s strongly implicit procedure (SIP) [80].
2.1

Direct Methods

2.1.1

Gaussian Elimination

The Gaussian elimination method is used for solving general linear systems of algebraic equations, Ax = b, where A is a square

a11 a12
 a21 a22
A=
 ··· ···
an1 an2

matrix and has the following form:

· · · a1n
· · · a2n 

··· ··· 
· · · ann

The algorithm of Gaussian elimination has two parts, forward elimination and backward substitution. Forward elimination reduces a given system to either triangular
or echelon form, or results in a degenerate equation with no solution, indicating the
system has no solution. This is accomplished through the use of elementary row
operations. Backward substitution ﬁnds the solution of the linear system above.
For a linear system of n equations for n unknowns, the number of arithmetic
operations required by Gaussian elimination is on the order of O(n3 ). The Gaussian
elimination method is numerically stable for diagonally dominant or positive-deﬁnite
matrices. For general matrices, Gaussian elimination is usually considered to be stable
in practice if partial pivoting is used, even though some unstable examples exist [30].
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2.2

Stationary Iterative Methods

Stationary iterative methods are methods for solving a linear system of equations
Ax = b
where A is a given matrix and b is a given vector.
Stationary iterative methods are based on the relaxation of coordinates. Beginning with an initial approximate solution, these methods modify the components of
approximation, one or a few at a time and in a certain order, until convergence is
reached and the criteria of relative errors are met. Each of these modiﬁcations, called
relaxation steps, is aimed at eliminating one or a few components of the residual
vector [66].
Stationary iterative methods can be expressed in the simple form:
xk = Bxk−1 + C
where neither B nor C depends upon the iteration count k [43].
Four main stationary methods are the Jacobi method, the Gauss-Seidel (GS)
method, the successive overrelaxation (SOR) method, and the symmetric successive
overrelaxation (SSOR) method.
The Jacobi method is based on solving for every variable locally, with respect to
the other variables. One iteration corresponds to solving for every variable once. It
is easy to understand and implement, but convergence is slow. The GS method is
similar to the Jacobi method, except that it uses updated values as soon as they are
available. The GS method generally converges faster than the Jacobi method, but
it is still relatively slow. The SOR method can be derived from the GS method by
introducing an extrapolation parameter. This method can converge faster than the
GS method by an order of magnitude. The SSOR method is useful as a preconditioner
for nonstationary methods. However, it has no advantage over the SOR method as a
stand-alone iterative method.
10

2.2.1

Jacobian Iteration

Let xki denote the ith component of the kth iteration; therefore the Jacobi iteration
can be expressed as:
(
)
xk+1
= a−1
bi − Σj̸=i aij xkj
i
ii
This is a component-wise form of the Jacobi iteration. The Jacobi iteration uses
splitting in the following way:
A = D + (L + U )
where D is the diagonal component of A. L and U are the strictly lower and upper
triangular components of A.
The Jacobi iteration can be rewritten in vector form as:
xk+1 = −D−1 (L + U )xk + D−1 b
The Jacobi iteration matrix is:
MJ = −D−1 (L + U )
Note that D is diagonal and hence trivial to invert.
2.2.2

Gauss-Seidel Iteration

Similarly, the GS iteration overwrites the approximate solution with the new value
as soon as it is computed. For forward GS iteration, the new value can be expressed
as:
(
)
xk+1
= a−1
bi − Σj<i aij xk+1
− Σj>i aij xkj
i
ii
j
The forward GS iteration uses the following splitting:
A = (D + L) + U
Note that D + L is a lower triangular, hence (D + L)−1 is easy to compute. The
forward GS iteration can be rewritten in a vector form as:
xk+1 = −(D + L)−1 U xk + (D + L)−1 b
11

The forward GS iteration matrix is:
MF GS = −(D + L)−1 U
The backward GS iteration begins the update of x with the nth coordinate, rather
than the 1st, resulting in the splitting:
A = (D + U ) + L
D + U is an upper triangular, and its inverse is also easy to compute. The backward
GS iteration can be rewritten in matrix form as:
xk+1 = −(D + U )−1 Lxk + (D + U )−1 b
The backward GS iteration matrix is:
MBGS = −(D + U )−1 L
A symmetric GS iteration is a forward GS iteration followed by a backward GS
iteration. This leads to the iteration matrix:
MSGS = MBGS MF GS = (D + U )−1 L(D + L)−1 U.
When A is symmetric, or U = LT , we have:
MSGS = (D + U )−1 L(D + L)−1 U = (D + LT )−1 L(D + L)−1 LT .
2.2.3

Successive Overrelaxation Iteration

The SOR iteration modiﬁes the GS iteration by adding a relaxation factor ω to the
linear system [66, 93]. The system of linear equations is rewritten as:
(D + ωL)x = ωb + ((1 − ω)D − ωU )x
where ω > 1 is a constant. The iteration matrix of SOR is:
MSOR = (D + ωL)−1 ((1 − ω)D − ωU ).
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The performance can be dramatically improved with ideal values of ω, but it still
can not compete with the Krylov methods. Another disadvantage of the SOR is that
it is often diﬃcult to make the choice of relaxation factor ω, which depends on the
properties of the coeﬃcient matrix A.
2.2.4

Symmetric Successive Overrelaxation Iteration

If the coeﬃcient matrix A is symmetric, the SSOR method can produce an iteration
matrix similar to a symmetric matrix. The SSOR includes a forward SOR sweep and
a backward SOR sweep. This method is usually used as a preconditioner to other
iterative methods for symmetric matrices. The iteration matrix of the SSOR is:
MSSOR = (D + ωU )−1 ((1 − ω)D − ωL)(D + ωL)−1 ((1 − ω)D − ωU ).
2.3

Krylov Subspace Based Iterative Methods

Krylov subspace iteration methods are considered to be the most useful iterative
techniques available for solving large linear systems. These techniques are based on
projections, both orthogonal and oblique, onto Krylov subspaces, which are subspaces
spanned by vectors of the form p(A)v, where p is a polynomial. In short, these
techniques approximate A−1 b by p(A)b, where p is a ”good” polynomial [66].
2.3.1

Conjugate Gradient

The Conjugate Gradient (CG) method is intended to solve symmetric positive deﬁnite
(SPD) linear systems. A matrix A is symmetric if A = AT and positive deﬁnite if
its eigenvalues are all positive, i.e., xT Ax > 0 for all x ̸= 0. For a positive deﬁnite
matrix, solving the system of equations Ax = b is equivalent to ﬁnding the minimum
of the following equation, with respect to all the xi [19].
∑
1 ∑∑
1
ϕ(x) = xT Ax − xT b =
aij xi xj −
xi bi
2
2 j=1 i=1
i=1
n
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n

n

Note that if ϕ(x) is the minimal value of Rn then
∇ϕ(x̃) = Ax̃ − b = 0
and hence x̃ = x.
One of the conjugate gradient algorithms is presented in Algorithm 1 [66].
Algorithm 1 Conjugate Gradient Algorithm
1: Initialization: r0 = b − Ax0 , p0 = r0
2: for j = 0, · · · , until convergence or j < jmax do
αj = (rj , rj )/(Apj , pj )
3:
4:
xj+1 = xj + αj pj
5:
rj+1 = rj − αj Apj
6:
if rj+1 is suﬃciently small then exit for loop
7:
βj = (rj+1 , rj+1 )/(rj , rj )
8:
pj+1 = rj+1 + βj pj
9: end for
10: the result is xk+1
This is the most commonly used algorithm. In Algorithm 1, only four vectors
need to be stored, x, p, r, and Ap. There are several alternative formulations [43, 66],
such as the Preconditioned Conjugate Gradient (PCG) and the Split Preconditioned
Conjugate Gradient (SPCG) algorithms.
The conjugate gradient method can be applied to an arbitrary n-by-m matrix by
applying it to normal equations AT A and right-hand side vector AT b, since AT A is a
symmetric positive-semideﬁnite matrix for any A. The result is a conjugate gradient
on the normal equations (CGNR):
AT Ax = AT b
As an iterative method, it is not necessary to form AT A explicitly in memory but only
to perform the matrix-vector and transposed matrix-vector multiplications. Therefore
CGNR is particularly useful when A is a sparse matrix, since these operations are
usually extremely eﬃcient. However, the drawback is that the condition number
κ(AT A) = κ2 (A), so the rate of convergence of CGNR may be slow and the quality
of the approximate solution may be sensitive to roundoﬀ errors.
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2.3.2

Bi-Conjugate Gradient Stabilized (BiCGStab)

The BiCGStab method was proposed by van der Vorst [85], with the purpose of
extending the CG algorithm to solve nonsymmetric linear systems. It is a variant of
the biconjugate gradient (BiCG) method, and it has faster and smoother convergence
than the original BiCG, as well as other variants such as the conjugate gradient
squared (CGS) method . The BiCGStab algorithm is summarized in Algorithm 2
[43].
Algorithm 2 Unpreconditioned BiCGStab
1: r0 = b − Ax0
2: Choose an arbitrary vector r̂0 = r0
3: ρ0 = α = ω0 = 1
4: v0 = p0 = 0
5: for j = 0, · · · , until convergence or j < jmax do
6:
ρj = (r̂0 , rj−1 )
7:
β = (ρj /ρj−1 )(α/ωj−1 )
8:
pj = rj−1 + β(pj−1 − ωj−1 vj−1 )
9:
vj = Apj
10:
α = ρj /(r̂0 , vj )
11:
s = rj−1 − αvj
t = As
12:
13:
ωj = (t, s)/(t, t)
14:
xj = xj−1 + αpj + ωj s
15:
rj = s − ωj t
16: end for
In Algorithm 2, seven vectors need to be stored, x, b, r, r̂0 , p, v and t. Four
matrix-vector products are required in each iteration of the algorithm.
2.3.3

General Minimum Residual (GMRES)

The GMRES method is a projection method that minimizes the residual norm over
all vectors in x0 + Kk , where x0 is the initial value and Kk is the k-th Krylov subspace
with v1 = r0 /∥r0 ∥2 [66]. The k-th Krylov subspace is:
Kk (A, r0 ) = span(r0 , Ar0 , · · · , Ak−1 r0 )
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where r0 = b − Ax0 .
This method seeks an approximate solution xk from the aﬃne subspace x0 + Kk of
dimension k by imposing the Galerkin condition:
b − Axm ⊥Kk
The kth GMRES iteration is equivalent to the least squares problem:
minimizex∈x0 +Kk ∥b − Ax∥2 .
One implementation of the GMRES can be written as Algorithm 3 [66].
Algorithm 3 GMRES
1: Compute r0 = b − Ax0 , β = ∥r0 ∥2 , and v1 = r0 /β
2: Deﬁne the (m + 1) × m matrix H¯m = hi,j (1 ≤ i ≤ m + 1, 1 ≤ j ≤ m)
3: Set H¯m = 0
4: for j = 1, · · · , m do
5:
Compute wj = Avj
6:
for i = 1, · · · , j do
7:
hi,j = (wj , vi )
8:
wj = wj − hi,j vi
end for
9:
10:
hj+1,j = ∥wj ∥2
11:
If hj+i,j = 0 set m = j and goto 14
12:
vj+1 = wj /hj+1,j
13: end for
14: Compute ym , the minimizer of ∥βe1 − H¯m y∥2
15: Compute xm = x0 + Vm ym

2.4

Preconditioners

A preconditioner to a given linear system can be any form of explicit or implicit
modiﬁcations of the original system that makes it easier and faster to solve by an
iterative method [66]. For the original system Ax = b, a preconditioned system
M −1 Ax = M −1 b can be formed, where the preconditioning matrix M −1 can be inexpensively applied to a matrix-vector product. The construction of M −1 can be
performed in diﬀerent ways depending on a variety of applications.
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2.4.1

Jacobi, GS, SOR, and SSOR Preconditioners

A ﬁxed-point iteration for the linear system Ax = b has the form [66]:
xk+1 = M −1 N xk + M −1 b = Gxk + f
where A = M − N , M and N are the splitting of A,f = M −1 b, and G = M −1 N =
I − M −1 A.
For the Jacobian iteration, the preconditioning matrix is M = D, where D is the
diagonal of A.
For the GS iteration, the preconditioning matrix is M = (D + L) for a forward
sweep and M = D + U for a backward sweep, where L and U are the strict lower and
upper parts of A, respectively.
For the SOR iteration, the preconditioning matrix is in the form of M = (D + ωL)
or M = (D + ωU ).
The preconditioning matrix for the SSOR iteration is M = (D+ωL)D−1 (D+ωU ).
2.4.2

ILU(0) Preconditioner

The ILU(0) Preconditioner is an incomplete LU factorization of A with no ﬁll-in, i.e.,
the zero pattern of matrix M = LU is precisely the same as that of matrix A. For
a 2D Laplace’ equation, the coeﬃcient matrix A is ﬁve-diagonal, but matrix M is
seven-diagonal. The entries in these extra diagonals are called ﬁll-in elements. The
ILU(0) factorization can be stated as any pairs of matrices L (unit lower triangular)
and U (upper triangular), such that the elements of A − LU are zero in locations
where the elements of A are not zero. For any arbitrary matrix A, let N Z(A) denote
any nonzero elements in A, i.e., the set of pairs (i, j), such that ai,j ̸= 0, where
1 ≤ i, j ≤ n. The algorithm of ILU(0) factorization can be written as Algorithm 4
[66].
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Algorithm 4 ILU(0)
1: for i = 2, · · · , n do
2:
for k = 1, · · · , i − 1 do
3:
if (i, k) ∈ N Z(A) then
4:
Compute ai,k = ai,k /ak,k
5:
for j = k + 1, · · · , n do
if (i, j) ∈ N Z(A) then
6:
7:
Compute ai,j = ai,j − ai,k ak,j
8:
end if
9:
end for
10:
end if
11:
end for
12: end for
2.4.3

ILU(p) Preconditioner

The accuracy of the ILU(0) incomplete LU factorization may be insuﬃcient to yield
an adequate rate of convergence. More accurate Incomplete LU factorizations are
often more eﬃcient, as well as more reliable. These more accurate factorizations will
diﬀer from ILU(0) in that they allow some ﬁll-ins [66].
The ILU(p) Preconditioner allows some ﬁll-ins to increase the accuracy and improve the rate of convergence, where p is the level of ﬁll.
In an ILU(p), all ﬁll-in elements with a level of ﬁll less than p are kept. The higher
the level, the smaller the elements. The initial level of ﬁll of an element ai,j of a sparse
matrix A is deﬁned by levi,j = 0 if ai,j ̸= 0 or i = j, and levi,j = ∞ otherwise. During
the construction, the level of ﬁll is updated by levi,j = min(levi,j , levi,k + levk,j + 1).
Let ai,∗ indicate the ith row of A, and let ai,j indicate the entry of A. The algorithm
for ILU(p) factorization can be written as Algorithm 5 [66].
2.4.4

ILUT Preconditioner

Incomplete factorizations, which rely on the levels of ﬁll, are blind to numerical values
because elements that are dropped depend only on the structure of A. This can cause
some diﬃculties for realistic problems. A few alternative methods are available which
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Algorithm 5 ILU(p)
1: Initialization
2: for ai,j ̸= 0 do
3:
lev(ai,j ) = 0
4: end for
5: for i = 2, · · · , n do
for k = 1, · · · , i − 1 do
6:
7:
if lev(ai,k ) ≤ p then
8:
Compute ai,k = ai,k /ak,k
9:
Compute ai,∗ = ai,∗ − ai,k ak,∗
10:
levi,j = min(levi,j , levi,k + levk,j + 1)
11:
end if
12:
end for
13:
for each ai,j in row i do
14:
if lev(ai,j ) > p then
15:
ai,j = 0
16:
end if
17:
end for
18: end for
are based on dropping elements in the Gaussian elimination process, according to
their magnitude rather than their locations. The ILUT Preconditioner algorithm has
two dropping steps with two parameters, p and τ . The ﬁrst step is to drop any
element wk such that wk < τi , where w is a full length working row and wk is the k-th
entry of this row. τi is relative tolerance, obtained by multiplying τ by the 2-norm of
the i-th row. The second step is to drop any element in the row that is less than the
relative tolerance τi , keeping only the p largest elements in the L part, and p largest
elements in the U part of the row, in addition to the diagonal element. Therefore,
p can be viewed as a parameter that helps control memory usage, while τ helps to
reduce computational cost. An algorithm of ILUT factorization can be written as
Algorithm 6 [66].
2.5

Stone’s SIP Method

LU decomposition is an excellent general purpose linear equation solver. The biggest
disadvantage is that it fails to take advantage of coeﬃcient matrix A as a sparse
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Algorithm 6 ILUT
1: Initialization
2: for i = 1, · · · , n do
3:
w = ai,∗
4:
for k = 1, · · · , i − 1 do
5:
if wk ̸= 0 then
6:
wk = wk /ak,k
7:
if wk < τ ∥w∥2 then
8:
wk = 0
9:
end if
if wk ̸= 0 then
10:
11:
w = w − wk uk,∗
12:
end if
13:
end if
14:
end for
15:
Apply dropping rule to row w
16:
for j = 1, · · · , i − 1 do
17:
li,j = wj
18:
end for
19:
for j = i, · · · , n do
20:
ui,j = wj
21:
end for
22:
w=0
23: end for
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matrix. The LU decomposition of a sparse matrix is usually not sparse; thus, for
large system of equations, LU decomposition may require a prohibitive amount of
memory and arithmetical operations.
In preconditioned iterative methods, if the preconditioner matrix M is a good
approximation of coeﬃcient matrix A, then the convergence is faster. Thus, it may
be a good idea to use approximate factorization LU of A as iteration matrix M .
Stone proposed a version of an incomplete lower-upper decomposition method for
solving such a sparse linear system of equations in 1968, also known as the strongly
implicit procedure (SIP) [80]. The method uses an incomplete LU decomposition,
which approximates the exact LU decomposition, in order to generate an iterative
solution. This method is designed for an equation system arising from the discretization of partial diﬀerential equations, and it was ﬁrst used as a pentadiagonal system
obtained while solving an elliptic partial diﬀerential equation in a two dimensional
space by a ﬁnite diﬀerence method. This method does not apply to a general system of equations, but it does apply to a sparse linear system of equations arising in
computational ﬂuid dynamic problems.
An algorithm of SIP can be written as Algorithm 7 [19, 80].

c Changjiang Zhang 2011
Copyright ⃝
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Algorithm 7 Ston’s Strongly Implicit Procedure(SIP)
1: For the sparse linear system Ax = b
2: calculate Incomplete LU factorization of matrix A
3: Ax = (M − N )x = (LU − N )x = b
4: M xk+1 = N xk + b , with ∥M ∥ ≫ ∥N ∥
5: M xk+1 = LU xk+1 = ck
6: LU xk = L(U xk+1 ) = Ly k = ck
7: set a guess
8: k = 0, xk
9: r k = b − Axk
10: while ∥r k ∥2 > ϵ do
11:
evaluate new right hand side
12:
ck = N x k + b
13:
solve Ly k = ck by forward substitution
14:
y k = L−1 ck
15:
solve U xk+1 = y k by back substitution
16:
xk+1 = U −1 y k
17: end while
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3 A Numerical Study of Pulsatile Flow Through a Hollow Fiber
Cartridge: Growth Factor-Receptor Binding and Dissociation Analysis
3.1

Introduction

The binding of ﬁbroblast growth factor-2 (FGF-2) to its cell surface receptor (FGFR)
and the role of heparan sulfate proteoglycans (HSPG) in regulating the process for
endothelial cells has been of interest for many years because of their roles in cell
signaling and cellular proliferation, processes which are important for angiogenesis.
Certainly control of these cells which line blood vessels is likely to be important in
being able to control tumor growth and wound healing. In the past two decades,
with the development of high performance computers, several computational models
of FGF-2 binding to its receptor FGFR and regulated by HSPG have been proposed
[13, 17, 20, 26, 27, 38, 48, 55]. Nugent and Edelman were among the earliest researchers, developing a simple model, involving these three species, FGF-2, FGFR
and HSPG. They measured kinetic binding rate constants experimentally and their
results provided a foundation for investigating the complexity of FGF-2 binding. Nugent, Forsten-Williams and coworkers introduced more complexity into their models
with dimerization and formation of higher order species. Filion and Popel proposed a
model of FGF-2 interactions with cell surface receptors including diﬀusive transport
within the culture dish [20]. Ibrahimi and coworkers proposed a simple model for
the stepwise assembly of a ternary FGF-2-FGFR-HSPG complex [38]. Not like the
previous models for the kinetic assembly of a ternary complex in which binary FGF2-FGFR or FGFR-HSPG complexes are intermediates, they claimed that FGFR and
HSPG are unbound in the absence of FGF-2 ligand, and the availability of FGF2 results in formation of initial FGF-2-HSPG complexes, which promotes the rapid
binding of FGFR and creates ternary complexes capable of undergoing dimerization
and subsequent FGFR activation. Forsten-Williams and coworkers took their model
a step further by linking their model to experimental activation of ERK 1/2, an
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important intracellular signaling pathway component [27]. These previous modeling
systems are based on culture environment.
This chapter addresses the competitive binding of some basic models, in which only
one growth factor (such as FGF-2) binds to its receptors (such as FGFR, HSPG, etc.)
in a ﬂow environment to mimic kinetics occur on cell surfaces in blood capillaries.
No competitive binding occurs in the solution. The whole model consists of three
coupled parts [71, 96]: (1) the medium ﬂow part uses the incompressible NavierStoke equations; (2) the convective and diﬀusive mass transport of a growth factor
in the ﬂow uses transport equations; (3) the binding kinetics on cell surfaces uses a
set of ordinary diﬀerential equations.
3.2

Simulation Environment

In order to investigate the quantitative properties of the growth factor (FGF-2) binding, one-pass experiments (i.e., no recycling of the ﬂuid through the cartridge) and
simulations have been set up. Fig. 3.1 is a diagram of the hollow ﬁber cartridge system used in the experiments [50]. The growth factor (FGF-2) is injected into the left
sampling port and the pump is turned on. The ﬂuid is pumped into the cartridge
and the growth factor (FGF-2) enters into twenty hollow-ﬁber capillaries, which are
coated with endothelial cells on the wall. Fluid from the capillaries is pooled in the
right outlet reservoir and collected in tubes approximately every ten seconds during
one-pass experiments.
3.3

Modeling Process

The geometric model is based on the experimental one and illustrated in Fig. 3.2.
The ﬂow is pulsatile. So, the simulation cost can be greatly reduced by ﬁnding some
analytical solution to the velocity, instead of calculating it numerically. The walls of
the hollow-ﬁber capillaries are assumed to be rigid and nonporous. In addition, the
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Figure 3.1: Hollow ﬁber cartridge system from FiberCellr .

following assumptions are made: (1) All of the twenty hollow-ﬁber capillaries have
the same dimensions, ﬂow, and cell densities; (2) The ﬂow is steady, axisymmetric
and laminar, for simplicity, entrance eﬀects are ignored [35]; (3) The ﬂuid is incompressible, Newtonian, viscous and isothermal; (4) The endothelial cells are distributed
evenly on the wall of the hollow-ﬁber capillaries and tightly packed.
The model consists of three coupled parts: (1) the medium ﬂow equations; (2) the
convective and diﬀusive mass transport equations of the growth factor (FGF-2) in
the ﬂow; (3) the competitive binding kinetics equations [71, 96]. The binding kinetics
of the simulation is based on Forsten-Williams et al. 2005 model [27].
3.3.1

Medium Flow Equations

Because of the axis-symmetry of the hollow-ﬁber capillaries, the model can be simpliﬁed from 3D to 2D. Based on the above assumptions, the governing equations of
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Figure 3.2: The diagram of modeling process.

the model are given by [19, 71, 94]:
The mass conservation equation:
∂u v ∂v
+ +
=0
∂x r ∂r

(3.1)

The radial momentum equation:
ρ(

∂v
∂v
∂v
∂p
1 ∂v ∂ 2 v ∂ 2 v
v
+u
+v )+
= µ(
+ 2 + 2 − 2)
∂t
∂x
∂r
∂r
r ∂r ∂x
∂r
r

(3.2)

The axial momentum equation:
ρ(

∂u
∂u
∂p
1 ∂u ∂ 2 u ∂ 2 u
∂u
+u
+v )+
= µ(
+
+
)
∂t
∂x
∂r
∂x
r ∂r ∂x2 ∂r2

(3.3)

where ρ is the density, µ is the viscosity of the medium and it is a constant due
to Newtonian incompressible ﬂow, p is the dynamic pressure, u is the axial velocity,
and v is the radial velocity.
The above PDEs can be computed numerically, as described in [71]. They can
also be calculated theoretically in some special cases, such as described below.
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If these equations are restricted to only fully developed region of the ﬂow, Eq. (3.1)
reduces to:
v
r

+

∂v
∂r

= 0, so v ≡ 0, and

≡0

∂p
∂r

Eq. (3.2) can be eliminated. Eq. (3.3) reduces to:
ρ

∂u ∂p
1 ∂u ∂ 2 u
+
= µ(
+ 2)
∂t
∂x
r ∂r
∂r

(3.4)

Eq. (3.4) is the simpliﬁed form on which the classical solution for fully developed,
steady, and pulsatile ﬂow is based.
If the ﬁber is assumed to be rigid, the velocity of u is a function of r and t only,
and pressure p is a function of x and t only, that is, u=u(r,t),p=p(x,t). For oscillatory
ﬂow, if the steady and oscillatory parts of velocity and pressure are identiﬁed by
subscripts ”s” and ”ϕ”, respectively, to isolate the oscillatory ﬂow problem, we write
u(r, t) = us (r) + uϕ (r, t) and p(x, t) = ps (x) + pϕ (x, t)
Substituting these into Eq. (3.4), we obtain:
∂ps
1 ∂us ∂ 2 us
∂uϕ ∂pϕ
1 ∂uϕ ∂ 2 uϕ
− µ(
+
)
+
ρ
+
−
µ(
+
)=0
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r ∂r
∂r2
∂t
∂x
r ∂r
∂r2
Suppose pressure gradient is

∂p
∂t

(3.5)

= ks + kϕ (t). Eq. (3.5) can be separated into the

steady and oscillatory parts.
For steady part equation:
∂ps
1 ∂us ∂ 2 us
− µ(
+
)=0
∂x
r ∂r
∂r2
The solution is us =

ks
(r2
4µ

− R2 ).

The volumetric ﬂow rate qs = Nf
us =

2qs
(R2
Nf πR4

− r2 ) =

2qs
(1
Nf πR2

−

∫

us 2πrdr = −

ks Nf πR4
,
8µ

(3.6)

8µ
or ks = − NqfsπR
4 , thus,

r2
),
R2

where Nf (= 20) is the number of ﬁbers in the cartridge.
For oscillatory part equation:
µ(

1 ∂uϕ ∂ 2 uϕ
∂uϕ
+
)−ρ
= kϕ (t)
2
r ∂r
∂r
∂t
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(3.7)

Let kϕ (t) = ks ejωt = ks (cosωt + isinωt) = kϕR + ikϕI and uϕ (r, t) = Uϕ (r)eiωt ,
Eq. (3.7) becomes:

where α =

√

1 dUϕ d2 Uϕ
iα
ks
+
−
U
=
ϕ
r dr
dr2
R2
µ

(3.8)

ρω
R.
µ

Combining boundary conditions Uϕ (R) = 0 and |Uϕ (0)| < ∞, the solution is
Uϕ (r) =

(ζ)
iks R2
(1 − JJ00(Λ)
)
µα2

√ )α, ζ = Λ r , and J0 (Z) is the Bessel functions
where Λ = ( i−1
R
2

of the ﬁrst kind of order zero.
Therefore,
uϕ (r, t) =

iks R2
J0 (ζ) iωt
(1 −
)e
2
µα
J0 (Λ)

(3.9)

or
−ks R2
r2
iα2
4r2
r4 iωt
uϕ (r, t) =
((1 − 2 ) −
(3 − 2 + 4 ))e
4µ
R
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(3.10)

When oscillatory ﬂow is at low frequency, that is α < 1.0, the second part in Eq. (3.10)
can be ignored and it becomes:
uϕ (r, t) =

−ks R2
r2
(1 − 2 )eiωt
4µ
R

(3.11)

Let kϕ (t) = kϕR , then:
u(r, t) = us (r) + uϕ (r, t) =

2qs
r2
(1
−
)(1 + cosωt)
Nf πR2
R2

(3.12)

The distance downstream from the ﬁber entrance to where ﬂow becomes fully
developed is called the entrance length, symbolized Le . The entrance length required
for a fully developed velocity proﬁle to form in laminar ﬂow has been expressed by
Langhaar according to [89]:
Le = 0.0575 × Re × D = 0.0575 ×

ρD2 V
µ

(3.13)

where D represents the inside diameter of the ﬁber, Re is the Reynolds number, ρ is
the density of the ﬂuid, µ is the viscosity of the ﬂuid, and V is the mean ﬂuid velocity.
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When the average volumetric ﬂow rate q is 0.67 ml/min for the whole cartridge,
the mean ﬂuid velocity for one ﬁber V will be 0.001451 m/s. In the current study,
ρ = 1000kg/m3 , and µ = 0.001P a · s, Le is around 0.004 cm, which is much less than
one percent of the length of the ﬁber (12 cm). Even for some higher ﬂow rates, such
as q=6.7 ml/min, Le ≈ 0.04 cm, it is still less than one percent of the length of the
ﬁber. Thus, the ﬂow in the whole ﬁber is treated as fully developed, and the entrance
eﬀects are ignored.
Eq. (3.12) is used as an approximate analytical solution of u during the simulation,
and Eq. (3.10) can be used as a general solution to a pulsatile pressure gradient
function.
3.3.2

Mass Transport Equations

The mass transport equation for the growth factor (FGF-2) consists of two mechanisms: convection and dissipation. Convection describes the transport of local
components along the streamlines of the ﬂow. Dissipation describes the diﬀusive
transport of components due to concentration gradient. The mass must be conserved.
Generally, the mass transport equation can be expressed as [71]:
∂ρϕ
+ ∇ · (ρ⃗uϕ) = ∇ · (Kd ∇ϕ) + S(ϕ)
∂t
where ϕ is the concentration, Kd is the diﬀusion coeﬃcient,

∂ρϕ
∂t

(3.14)
is the transient term,

∇ · (ρ⃗uϕ) is the convection term, ∇ · (Kd ∇ϕ) is the diﬀusion term, and S(ϕ) is the
source term.
In the model, the density ρ is constant due to incompressible ﬂow. The mass
transport of the growth factor (FGF-2) in a circular hollow-ﬁber can be described by
the following equation [71]:
∂ϕ 1 ∂(rvϕ) ∂(uϕ)
1 ∂
∂ϕ
∂
∂ϕ
+
+
=
(rKd ) +
(Kd ) + F (ϕ, t, x)
∂t
r ∂r
∂x
r ∂r
∂x
∂x
∂x

(3.15)

where ϕ is the concentration of the growth factor (FGF-2), u and v are the axial
and the radial velocities, respectively, Kd is the molecular diﬀusion coeﬃcient and
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treated as a constant in both radial and axial directions, and F (ϕ, t, x) is the rate of
change due to the kinetic transformation of the growth factor (FGF-2) binding to its
receptors on cell surfaces.
If the ﬂow in the ﬁber is assumed to be fully developed, Eq. (3.15) can be simpliﬁed
as:
∂ϕ ∂(uϕ)
1 ∂
∂ϕ
∂
∂ϕ
+
=
(rKd ) +
(Kd ) + F (ϕ, t, x)
∂t
∂x
r ∂r
∂x
∂x
∂x

(3.16)

The boundary conditions of Eq. (3.16) are:
(1)

∂ϕ
∂r

= 0 at r = 0, reﬂecting symmetry of the ﬂow along the ﬁber centerline.

(2)

∂ϕ
∂r

= F (ϕ, t, x) at r = R, reﬂecting binding rate of the growth factor (FGF-2)

on cell surfaces on the wall of the ﬁber.
(3) ϕ(t) = ϕent (t) at x = 0, assuming well mixed entrance ﬂow, with uniform
concentration along the ﬁber radius.
The Mass Transport Equation Discretization
The mass transport equation is the most critical part of the whole computational
model. It is preferable to solve it with a reasonable accuracy. In the current study, the
second order accuracy is enough considering the accuracy of the experimental results.
To achieve the second order time accuracy, a quadratic backward approximation
for the time derivative term is used. To maintain numerical stability as well as to
achieve second order spatial accuracy, a deferred correction numerical strategy is used
[19, 71]. This is a combination of the ﬁrst order upwind diﬀerencing and the second
order central diﬀerencing, as shown in the following formula:
F = F L + λ(F H − F L )old

(3.17)

where F is the approximation of surface integrals or the net ﬂux through the control
volume boundary, F L stands for the approximation by some lower-order scheme, such
as the ﬁrst order upwind diﬀerencing scheme (UDS) in this research, F H is the higherorder approximation, such as the second order central diﬀerencing scheme (CDS), and
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Figure 3.3: The ﬁnite volume notation of control volumes in axisymmetric coordinates, (A) the control volume, (B) the north boundary control volume.
λ is the blending factor (0 ≤ λ ≤ 1). The term in brackets is evaluated using values
from the previous iteration, as indicated by the superscript ’old’ [19]. The diﬀusive
terms are discretized by the central diﬀerence method. Overall, the second order
accuracy is achieved for time and space.
The detailed discretization is illustrated as follows.
By using the ﬁnite volume method, Eq. (3.16) could be written as:
3(ρϕ)n+1
− 4(ρϕ)nP + (ρϕ)n−1
P
P
+ (Je − Jw ) + (Jn − Js ) = Sc + SP ϕP
2δt

(3.18)

where Sc and SP are the results of source term linearization, Je = Fe − De , Jw =
Fw − Dw , Jn = Fn − Dn , Js = Fs − Ds are the convection-diﬀusion ﬂuxes at each of
the four interfaces of the control volume P.
The notations of spatial discretization in Eq. (3.18) is illustrated in Fig. 3.3 (A),
where the uppercase letters indicate the center of the control volumes, and the lowercase letters indicate the interfaces between neighboring control volumes. Using
deferred correction [19], the convection ﬂux can be written as a mixture of upwind
and central diﬀerence schemes. The convection ﬂux in the axial direction could be
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written as:
(Fe − Fw )n = (Feu − Fwu )n + λ((Fec − Fwc ) − (Feu − Fwu ))n−1
in which
Feu = max ((ρu)e δrj , 0)ϕP + min((ρu)e δrj , 0)ϕE
Fwu = max((ρu)w δrj , 0)ϕW + min((ρu)w δrj , 0)ϕP
Fec = (ρu)e δrj (1 − αe )ϕP + (ρu)e δrj αe ϕE
Fwc = (ρu)w δrj (1 − αw )ϕW + (ρu)w δrj αw ϕP
where λ = (0 ∼ 1) is a parameter, and the superscripts

n

and

n−1

indicate taking

the value from the current and previous iterations, respectively, αe and αw are the
interpolation factors, and are deﬁned as: αe =

xe −xP
xE −xP

, αw =

xP −xw
xP −xW

. For uniform

mesh, αe = αw = 1/2.
Thus, we have:
Fec = (ρu)e δrj (ϕP + ϕE )
Fwc = (ρu)w δrj (ϕW + ϕP )
The convection ﬂux in the radial direction could be applied in a similar way. In
this research, the velocity in the radial direction v is totally ignored, therefore, no
convection ﬂux is considered.
The diﬀusion ﬂuxes are deﬁned as:
De = D

rj (ϕE −ϕP )
,
xE −xP

Dw = D

rj (ϕP −ϕW )
,
xP −xW

N −ϕP )
P −ϕS )
Dn = D ri (ϕ
, Ds = D ri (ϕ
.
rN −rP
rP −rS

where D is the diﬀusion coeﬃcient, and is treated as a constant.
Substituting everything into Eq. (3.18), a set of algebraic equations are obtained
in the following form:
AS ϕS + AW ϕW + AP ϕP + AE ϕE + AN ϕN = b
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(3.19)

The coeﬃcients of Eq. (3.19) consist of a pentadiagonal matrix, and are given by:
δxi rn
rN − rP
δxi rs
AS = −D
rP − rS
AN = −D

δrj rP
xE − xP
δrj rP
AW = − max((ρu)w δrj , 0) − D
xP − xW
3ρrP δxi δrj
AP =
− (AW + AS + AE + AN )
2δt
AE = min((ρu)e δrj , 0) − D

The right hand side vector is given by:
2ρϕnP
ρϕn−1
b = (Sc + SP )rP δxi δrj + (
− P )rP δxi δrj − λ(Fec − Feu − Fwc + Fwu )
δt
2δt
The matrix of the equations can be solved by Stone’s SIP [80] solver, or some other
suitable solver, such as BiCGStab solver. Stone’s SIP solver is preferred due to its
faster convergence and simpler implementation.
The North Boundary Condition Discretization
The north boundary condition discretization is worth mentioning, because the binding
kinetics occurs on the north boundary or cell surfaces of the wall. Fig. 3.3 (B) shows
the north boundary control volume.
Based on Fick’s ﬁrst law, diﬀusive ﬂux in one dimension is expressed as J = Kd ∂ϕ
,
∂r
where Kd is the diﬀusive coeﬃcient or diﬀusivity of the growth factor (FGF-2) in the
solution, and regarded as a constant here. The north boundary condition is:
q
∂ϕ
=f =
∂r
Kd

(3.20)

where q is the boundary ﬂux.
By using one-side diﬀerence, then:
(

∂ϕ
ϕN − ϕP
ϕP − ϕS
)n = β
+ (1 − β)
∂r
rN − rP
rP − rS
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(3.21)

where β =

α+2
,
α+1

and α =

rP −rS
rN −rP

= 2, so β = 43 . By using ﬁnite volume method [19],

Eq. (3.20) can be discretized as:
4 ϕN − ϕP
1 ϕP − ϕS
qN
−
=
3 rN − rP
3 rP − rS
Kd
or
ϕN = (1 +

1 rN − rP
1 rN − rP
3 rN − rP
)ϕP −
ϕS +
qN
4 rP − rS
4 rP − rS
4 Kd

Therefore:
1 rN − rP
3 rN − rP
1 rN − rP
)ϕP − AN
ϕS + A N
qN
4 rP − rS
4 rP − rS
4 Kd
1 rN − rP
AP = AP + AN (1 +
)
4 rP − rS
1 rN − rP
AS = AS − AN
4 rP − rS
3 rN − rP
qN
b = AN
4 Kd
AN ϕN = AN (1 +

where, subscripts N, P, S indicate the northern interface, the cell center, and the
southern interface of a control volume, respectively.
To solve the mass transport equations correctly, the unit of the growth factor
(FGF-2) should be appropriate. In binding kinetics equations described in the next
section, the unit of growth factor is mol/L, which is a very small value, even less
than the stopping criteria. Obviously, this unit is inappropriate. Instead, to solve the
equations, the unit of ng/ml is used, which is much larger than the stopping criteria.
Thus, a unit conversion is required between calculating mass transport equations
PDEs and binding kinetics equations ODEs.
A transient solution is pursued. The linear system is solved by using Stone’s SIP
method [80].
3.3.3

Binding Kinetics Equations

The binding kinetics model is adopted from Forsten-Williams et al. [27], as shown
in Fig. 3.4. It involves a series of molecular activities, including the growth factor
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Figure 3.4: The diagram of binding kinetic pathway.

(FGF-2) binding to its receptors (FGFR and HSPG), some intermediate complexes
and dimers are created, and internalization of those complexes and dimers. Nine
chemical reactions and species are involved [27, 71]. The computational model is
expressed as a set of ODEs shown in Table 3.1 and in Appendix A [20, 27]. Some key
parameters used in simulation are listed in Table 3.2.
These coupled nonlinear ODEs can be solved by the CVODE solver with usersupplied Jacobian matrix [6]. Readers are referred to Chapter 1 for details.
3.4

Numerical Algorithm

In order to solve those coupling equations (PDEs and ODEs), a numerical algorithm
for simulation has been designed. A schematic algorithm is given in Algorithm 8.
Inside the while loop, ﬁrst, it computes the velocity u in each grid for the whole
mesh by calling Eq. (3.12); then, solves the binding kinetics ODEs on the north
boundary grids by calling the CVODE solver since the boundary conditions of mass
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Table 3.1: Equations describing the binding reactions in the model.
No
1
2
3
4
5
6
7
8
9

Binding Equations
dR
dt = −konF R F R + kof f F R C + Kof f F HR T − kc RG − kint R + kint R0
dC
2
dt = konF R F R − kof f F R C − kc CH − kc C + 2kuc C2 − kint C
dC2
2
dt = 0.5kc C − kuc C2 − kintD C2
dT
2
dt = kc RG + kc CH − kof f F HR T − kc T + 2kuc T2 − kint T
dT2
2
dt = 0.5kc T − kuc T2 + kintD T2
dH
dt = −konF H F H + kof f F H G + kof f F HR T − kc CH − kint H + kint H0
dG
2
dt = konF H F H − kof f F H G − kc RG − kc G + 2kuc G2 − kint G
dG2
2
dt = 0.5kc G − kuc G2 − kintD G2
V dF
dt = −konF R F R + kof f F R C + kof f F HR T − konF H F H + kof f F H G

Cells line the walls of the hollow ﬁber tube in the model and growth factor can bind
to both receptors FGFR (R) or HSPG (H) to form complexes (C or G, respectively).
These complexes can dimerize (C2 or G2 ,) or form heterodimers (T) that can then
form higher order complexes (T2 ). The equations that describe the binding reactions
are listed as well as the parameters (Table 3.2) and initial conditions used for the
simulations. The initial condition for the FGF-2 concentration (F) was based on the
amount of FGF-2 injected. The concentration is assumed to be uniform across the
entrance. The receptor FGFR and HSPG densities were the initial conditions for R
and H respectively. All other variables had an initial value of zero.
Table 3.2: Parameter values used in simulation.
Parameter
konF R
kof f F R
konF H
kof f F H
kof f F HR
kc
kuc
kint
kintD
R0
H0
Kd
µ
ρ

Value
4.2 × 108 M −1 min−1
0.79min−1
1.2 × 108 M −1 min−1
1.37min−1
0.038min−1
0.001(#/cell)−1 min−1
1.0min−1
0.005min−1
0.078min−1
104 #/cell
106 #/cell
1.57 × 10−10 m2 /sA
0.001P a · sB
1000kg/m3

Meaning(Ref.)
ARC for FGF-2 and FGFR [77]
DRC for FGF-2 and FGFR [77]
ARC for FGF-2 and HSPG [77]
DRC for FGF-2 and HSPG [20]
DRC for FGF-2 and HSPG and FGFR [77]
coupling rate constant [33]
uncoupling rate constant [33]
IRC for complexes [77]
IRC for dimers [77]
initial FGFR density [17, 20, 40]
initial HSPG density [17, 20, 40]
FGF-2 diﬀusivity at 37◦ C [20]
viscosity of aqueous solution
density of aqueous solution

A

Filion & popel (2004), but aqueous solution this study used has diﬀerent viscosity
. The relationship between viscosity and diﬀusivity can be expressed by StokeskT
Einstein-Sutherland equation, that is,Kd = 6πµa
, where Kd is the diﬀusion coeﬃcient, k is the Boltzmann’s constant, T is absolute temperature, µ is viscosity, and
a is molecular radius. ARC = association rate constant, DRC = dissociation rate
constant, IRC = internalization rate constant.
B
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Algorithm 8 Numerical algorithm for simulation system
Initialization
t=0
while t ≤ tend do:
Compute velocities by solving medium ﬂow equations
Solve binding kinetics equations by using CVODE solver
Solve mass transport equation by using ﬁnite volume method
Compute growth factor binding(captured, exited, etc.) if user needs
Output results for analysis and visualization if needed
t = t + ∆t
end while
transport equations depend on those ODEs; at last, solves the mass transport equations in the whole mesh domain by calling SIP or BiCGStab solver, an inner iterative
loop. At this point, it computes the binding information (bound, internalized, exited,
etc.) and outputs those results for analysis and visualization if user needs. At the
end, it moves forward to the next time step and loops again until the target simulation
time is reached.
Since the unit of the growth factor (FGF-2) should be in the unit of mol/L during
the calculation of kinetics binding equations, a very small value. For example, 2.54
ng/ml of the growth factor (FGF-2) equals to 1.411 × 10−10 mol/L. It is too small
to be used to solve mass transport equations. Instead, the unit of ng/ml is used for
the precision of calculation.
In the algorithm above, the coupled equations of three parts actually can be solved
separately, which means diﬀerent parts can be calculated independently in a given
order. That is why diﬀerent binding kinetics models can be easily implemented into
the system with trivial eﬀorts. Also, it is possible to make it support more complicated
binding kinetics models, for example, more growth factors and receptors involved.
Due to its intensive computation, it is desirable to make the simulation system
running quickly and eﬃciently. The current system is implemented with Open MultiProcessing (OpenMP) and multi-threading techniques to take advantage of multicore processors of computers. If the binding occurs in the whole ﬁber (i.e., there are
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competitive bindings in the ﬂuid and on cell surfaces as well), some kind of parallel
algorithm needs to be implemented by using OpenMP or message passing interface
(MPI) techniques.
3.5

Some Implementation Details

In order to achieve accurate simulation results compared to those obtained from
experiments, several issues have to be addressed, such as: (1) What type of mesh
should be used? uniform or non-uniform? and how large the mesh size is appropriate?
(2) What is the concentration of the growth factor (FGF-2) ﬂowing into the ﬁbers at
a speciﬁc time? Obviously, it is a function of time and related to the amount of the
growth factor (FGF-2) injected at inlet reservoir, but what the concentration function
should be with respect to time? (3) How to measure the amount of the growth factor
(FGF-2) or other molecules (bound, internalized, or remained within the ﬁbers) ? (4)
How to calculate the amount of the growth factor (FGF-2) exited?
3.5.1

Mesh Size Selection

Because the binding reactions occur only on the cell surfaces on the wall of the ﬁbers,
a thin layer of the growth factor (FGF-2) near the surface of the hollow-ﬁbers binds
to its receptors (FGFR and HSPG, etc.) on cell surfaces. This cross sectional area is
illustrated in Fig. 3.5 and can be estimated as:
δv = π(R2 − rn2 )δx = πδr(2R − δr)δx

(3.22)

where δv is the volume of this area, δx is the length in the axial direction, rn is the
radius of the nth grid and δr is the grid size in the radial direction, respectively.
Supposing the cells are distributed evenly on the surface of the wall and packed
tightly, and the cell shape is round with the radius of rc , the total number of cells in
each ﬁber can be estimated as:
Ncell ≈

2πRL
πrc2

38

(3.23)

Figure 3.5: The cross section of a ﬁber and the mesh schematic diagram.
where R = 0.035cm is the radius of the ﬁber, and L = 12cm is the length of the ﬁber.
If a cell size is around 10um in radius, or rc = 10um, then, Ncell ≈ 8.4 × 105 . Let
Ncell = 8×105 , which is the same as the estimation of the experiment. Thus, the total
number of cells in the cartridge is about 16 millions. If δx = 20um is used, the number
of grids in the axial direction N = L/δx, which is around 6000. The number of grids
in the radial direction is set to be 24, that is M = 24 or δr = R/M ≈ 0.001458cm.
The major interest of this study is calculating the mass of proteins (such as FGF-2)
captured. It is appropriate to calculate those values on cell-by-cell basis. Therefore,
a uniform mesh is a better choice, and the mesh could be 6000 × 24 if the mesh size is
equivalent to the size of cells in the axial direction. So, δv = πδr(2R−δr)δx ≈ 6.279×
10−10 L. There are about 133.33 cells in each δv. Let v = δv/133.33 ≈ 4.721 × 10−12
Lcell−1 . (v is the volume of space corresponding to one cell.) The parameter V in
Eq. 9 of Table 3.1 can be calculated by the formula:
V = v × N a ≈ 2.835 × 1012 #Lcell−1 mol−1

(3.24)

where N a is the Avagodro’s number.
It is worth mentioning that the unit of the growth factor (FGF-2) concentration
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Figure 3.6: The diagram of inlet reservoir.
in Table 3.1 should be in mol/L, but it is normally given in the unit of ng/ml (also
preferred in solving mass transport equations). The unit conversion is necessary, and
we simply multiply it by a constant (For FGF-2, it is 5.556 × 10−11 ).
Other possible meshes could be 3000×24, 1500×24, etc. V is kept as a constant.
Another variable Kgf is used as a grid factor. Kgf is equal to the number of cells per
ﬁber divided by the number of grids in the axial direction.
3.5.2

The Concentration of Growth Factor at Inlet

To more closely link the simulations to the experimental model system, several additional assumptions were made. For simplicity, all the 20 ﬁbers are assumed to
have the same concentration function of growth factor at entrance or inlet. In the
experimental system, the growth factor (FGF-2) is injected into the inlet reservoir,
as shown in Fig. 3.6.
It is assumed that the initial concentration of the growth factor (FGF-2) in the
whole reservoir is uniform, and then distributed into the individual hollow-ﬁber capillaries by the pump. The concentration of the growth factor (FGF-2) in the reservoir
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is assumed to decrease gradually at each time step as:
ϕnent = ϕn−1
ent ×

v − δv
v

(3.25)

where v is the volume of the inlet reservoir, which is around 0.393 ml (refer to
Fig. 3.6), δv is the volume of ﬂuid ﬂowing into the ﬁbers at each time step, ϕn−1
ent is
the previous and ϕnent is the current concentration of the growth factor (FGF-2) in
the reservoir, and ϕ0ent =

F0
,
v

in which F0 is the amount of the growth factor (FGF-2)

injected in the unit of ng.
3.5.3

The Mass of Growth Factor Bound

The kinetics binding is assumed to occur on the cell surfaces only, and the amount of
the growth factor (FGF-2) bound to its receptors (FGFR and HSPG) within the ﬁbers
includes two parts: bound on cell surfaces and internalized. Let Mn be the amount
of the growth factor (FGF-2) bound, Mnint be the internalized part, and Mnsurf ace be
the bound on cell surfaces at the nth time step, we have:
Mn = Mnint + Mnsurf ace

(3.26)

First, the number of molecules of the growth factor (FGF-2) bound is determined,
then we multiply it by a constant to obtain the amount of the growth factor (FGF-2)
bound.
Based on deterministic approach and uniform mesh, the number of molecules of
the growth factor (FGF-2) bound at the nth time step Fn can be determined by the
following formulas:
Fn = Fnint + Fnsurf ace
Fnint

=

int
Fn−1

(3.27)

N
∑
n
n
+ Nf Kgf dt
(kint (Cin + Tin + Gni ) + 2kintD (C2,i
+ T2,i
+ Gn2,i )) (3.28)
i=1

Fnsurf ace

= Nf Kgf

N
∑

n
n
(kint (Cin + Tin + Gni ) + 2(C2,i
+ T2,i
+ Gn2,i ))

i=1
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(3.29)

n
where Cin , Tin , Gni are the number of the growth factor (FGF-2) complexes, and C2,i
,
n
T2,i
, Gn2,i are the number of the growth factor (FGF-2) dimers at the ith grid in the

axial direction (see Fig. 3.4), kint is the internalization rate constant of complexes,
kintD is the internalization rate constant of dimers, Superscript n means the nth time
step, Nf is the number of ﬁbers in the cartridge, and Kgf is the grid factor.
Supposing the cell density is 800,000 cells per ﬁber, or 16 millions cells per cartridge, if the mesh of 1500 grids in the axial direction is selected, there are about 533
cells in each grid cross sectional area of each ﬁber. This number is the grid factor,
i.e., Kgf ≈ 533.
Since the molecular weight of the growth factor is w kDa, once the above molecular
number is obtained, to convert the number of molecules to its weight in the unit of
ng, just multiply it by a constant (K = w × 1012 /6.022 × 1023 ), that is:
Mn = Fn × K(ng)

(3.30)

Based on the deterministic approach, the mass of any kind of molecule in biochemical reactions can be calculated in a similar way. Generally, the method can be
illustrated as follows:
Supposing two kinds of molecules A and B can be associated to C with the association rate constant kon and dissociation rate constant kof f , in the meantime, C may
be internalized with rate constant kint , the kinetics equation can be expressed as:
dC
= kon AB − kof f AB − kint C
dt

(3.31)

In a 2D case, if the uniform mesh is used and the mesh size is N × M , and the
binding reaction occurs in all 2D domain, the number of molecules of A bound to B
can be calculated by the formula:
An = k ×

M ∑
N
∑
j=1 i=1
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n
+ Aint
Ci,j
n

(3.32)

and
Aint
n

=

Aint
n−1

+k×

N
M ∑
∑

n
(∆t × kint × Ci,j
)

(3.33)

j=1 i=1

where An is the number of molecules of A bound to B in the nth time step, ∆t
n
is the time step of numerical simulation, Ci,j
is the number of molecules of C in grid

(i,j) at the nth time step, N and M are the mesh sizes in the axial and the radial
int
directions, respectively, k is the number of cells in each grid, Aint
n and An−1 are the

internalized components at the nth and the (n − 1)th time step, respectively.
Again, internalized component is accumulated at each time step.
To calculate the mass of A, we just multiply it by a constant if its molecular
weight is known. To the best of the author’s knowledge, there is no such formula in
the literature before.
3.5.4

The Mass of Growth Factor Flowing Into or Out of the Fibers

In order to control the amount of the growth factor (FGF-2) ﬂowing into the ﬁbers
or calculate the amount of the growth factor (FGF-2) exited, or calculate the total
amount of the growth factor (FGF-2) inside the ﬁbers, it is necessary to ﬁgure out
how to calculate the amount of the growth factor (FGF-2) ﬂowing through a cross
section of a ﬁber at a given time span.
The mass of the growth factor (FGF-2) moving through a ﬁber at location x in the
axial direction in δt can be integrated by the following formula:
∫

δt

∫

R

MF GF −2 (x) = 2 × π

u(r, t)ϕ(r, x, t)rdrdt
0

(3.34)

0

Numerically, it can be estimated in a similar way by:
MF GF −2 (xi ) ≈ π ×

M
∑

2
)uj (xi )ϕj (xi )δt
(rj2 − rj−1

(3.35)

j=1

where δt is the time step, uj (xi ) is the axial velocity, ϕj (xi ) is the concentration of
the growth factor (FGF-2) on the jth grid in the radial direction and at location xi
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Figure 3.7: Comparison of the growth factor (FGF-2) exited in diﬀerent mesh sizes.

in the axial direction, and M is the number of grids in the radial direction of the
current mesh.
Eq. (3.35) can be used to estimate the mass of the growth factor (FGF-2) ﬂowing
into or out of a ﬁber. To calculate the mass of the growth factor (FGF-2) inside one
ﬁber, the following formula is used:
Minside ≈

N
∑

Mgf (xi )

(3.36)

i=1

To obtain the mass of the growth factor (FGF-2) inside the whole cartridge, Minside
is multiplied by Nf (=20), the total number of ﬁbers in the cartridge.
3.5.5

Some Considerations for the Simulation

Choose an Appropriate Mesh Size for the Simulation
Generally speaking, larger mesh sizes mean less computational costs. It is desirable to
ﬁnd larger mesh size without sacriﬁcing accuracy. Three diﬀerent meshes 1500×24,
3000×24, and 6000×24 were evaluated. Fig. 3.7 is the comparison of the growth
factor (FGF-2) exited using diﬀerent mesh sizes. There are only slight diﬀerences
between these three cases. Other binding parameters, such as the amount of bound,
internalized, and inside the ﬁbers are also quite close between these three mesh sizes.

44

Conclusion: The coarsest grid 1500×24 is appropriate for the simulation and is
selected for all the subsequent simulations to save computational costs.
Choose an Appropriate Time Step for the Simulation
Generally, a smaller time step usually leads to more accurate results but longer simulation time, and a larger time step may sacriﬁce accuracy, but could save simulation
time. It is a trade oﬀ. For the current simulations, it is desirable for the ﬂuid to
move forward no more than one grid point within a time step since the simulation is
working on a cell by cell basis. The cells however are only localized on the wall of the
ﬁbers where the velocity in the axial direction u approaches zero. A relatively larger
time step therefore could possibly be used without sacriﬁcing the binding accuracy.
However, large time steps may inﬂuence the accuracy of calculating the amount of
the growth factor (FGF-2) ﬂowing into and out of the ﬁbers or the mass transport
equations.
For example, with a ﬂow rate of 0.67 ml/min, or 0.145 cm/s on average, if a
time step of 0.05 second is selected, the ﬂuid would only move forward 0.00725 cm
on average per time step. This is close to the value of one grid size (0.008 cm) in the
axial direction when a 1500×24 uniform mesh is used. Therefore, time step = 0.05
second is appropriate in this case. Even doubling the time step to 0.1 second, there
is no signiﬁcant impact on the simulation results. Therefore, 0.1 or 0.05 second is
considered an acceptable time step for slower ﬂow rates, such as 0.67 ml/min. For
higher ﬂow rates, time steps should be smaller accordingly. If the time step is too
big, it will cause computational stability issue for higher ﬂow rates.
3.6
3.6.1

Simulation
Flow Rate Impact on Growth Factor Binding

By intuition, people may think that higher ﬂow rates would result in less binding
due to lower residence time in the cell environment. Table 3.3 shows the quantitative
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Table 3.3: The relationship between ﬂow rate and binding.
Flow rate(ml/min)
0.6
0.7
0.8
0.9

FGF-2 exit(ng)
3.96
4.12
4.26
4.37

FGF-2 bound(ng)
0.016
0.0012
0.0009
0.0007

Initial FGF-2 injected 5.47ng, diﬀusivity 1.57 × 10−10 m2/s, heparinase treated cells,
total simulation time 643 seconds.
relationship between ﬂow rate and the growth factor (FGF-2) binding. Identical
simulation parameters except the ﬂow rate were used. Fig. 3.8 shows the relationship
between ﬂow rate and the amount of binding. The simulation results show that
the higher ﬂow rate, more growth factor exited, less growth factor bound, and more
growth factor bound at the entrance part of the ﬁber than at other parts.
3.6.2

Diﬀusivity Impact on Growth Factor Binding

Generally, larger diﬀusivity or smaller viscosity values will lead to more molecules of
the growth factor (FGF-2) dissipating toward the wall, where cells are located. More
binding will likely occur resulting in less growth factor exiting. Several simulations
were conducted with the same parameters except the diﬀusivity or viscosity to ﬁnd
out the quantitative relationship between the two, as shown in Table 3.4.
Diﬀusivity aﬀects the distribution of the growth factor (FGF-2) bound along the
ﬁber, as shown in Fig. 3.9. Larger diﬀusivity will cause more bound in the middle of
the ﬁber, but a slightly more bound at the entrance or exit of the ﬁber. Thus, diﬀusivity aﬀects the amount of the growth factor (FGF-2) bound and larger diﬀusivity
values will lead to more growth factor (FGF-2) bound to its receptors (FGFR and
HSPG).
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Table 3.4: The relationship between diﬀusivity and binding.
Diﬀusivity(cm2 /s)
5.22 × 10−7
1.57 × 10−6
1.75 × 10−6
2.18 × 10−6

Viscosity(cP)
3A
1B
0.89C
0.72D

FGF-2 exited(ng)
0.72
0.55
0.53
0.48

FGF-2 bound(ng)
0.13
0.22
0.23
0.25

Initial FGF-2 injected 0.92ng, ﬂow rate 0.63 ml/min, total simulation time 715 seconds. A blood at 25◦ C, B The solution this research used, C water at 25◦ C, D Filion &
Popel(2004) [20].
3.7

Summary

This chapter presents a numerical solution to describe growth factor-receptor binding
under ﬂow through hollow ﬁbers of a bioreactor. The ﬂuid ﬂow, the kinetics of the
growth factor (FGF-2) binding to its receptors (FGFR and HSPG) and the growth
factor mass transport is modeled by a set of coupled nonlinear partial diﬀerential
equations (PDEs) and coupled nonlinear ordinary diﬀerential equations (ODEs). A
ﬁnite volume method is used to discretize the PDEs. The ODEs are solved by a
stiﬀ ODE solver, the CVODE solver. Overall, second order accuracy in time and
space is achieved with the second order implicit Euler scheme. In order to obtain
a reasonable accuracy of the binding and dissociation from cells, a uniform mesh is
used. To handle pulsatile ﬂow, several assumptions are made including neglecting
any entrance eﬀects, and an analytical approximate solution for axial velocity within
the ﬁbers is obtained.
A computer simulation program has been developed for the simulation of a growth
factor binding to its receptors within the FiberCell Bioreactor Systems, an in vitro
ﬂow cell culture system. Some simulation results have been obtained based on the
basic model [27], such as (1) the current coarsest gird (1500×24) is appropriate for
the simulation; (2) the amount of binding of FGF-2 is proportional to the diﬀusivity
of the solution and roughly linear proportional to the ﬂow rate; (3) diﬀerent ﬂow rates
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or diﬀusion coeﬃcients will aﬀect the proﬁle of the growth factor (FGF-2) outﬂow
and the distribution of the growth factor (FGF-2) bound on the wall along the ﬁber
at diﬀerent time.
The simulation package can be used for any kinetics binding analysis in a similar
ﬂow environment, as long as only one growth factor is injected in the ﬂow. Next,
this simulation package is used to investigate growth factor-receptor binding and
compared with the experiments.

c Changjiang Zhang 2011
Copyright ⃝
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Figure 3.8: The relationship between ﬂow rate and the amount of FGF-2 binding.
(A) Cell-bound FGF-2 is shown after 5 min of simulation for various amount of FGF2 injected and various ﬂow rates. (B) Cell-bound FGF-2 is shown along the ﬁber.
1ng FGF-2 was injected at time 0 under diﬀerent ﬂow rates. Each cell expressed 104
FGFRs and 5 × 105 HSPGs initially.
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Figure 3.9: Plot of FGF-2 bound to FGFR and HSPG versus time at the entrance
, middle and exit of the ﬁber when FGF-2(1ng) is introduced into the ﬁber under
pulsatile ﬂow at 0.67ml/min with FGF-2 having a diﬀusivity of 1.67 × 10−10 m2 /s
(black) or 1.67 × 10−9 m2 /s(red).
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4 Endothelial Cell Capture of Heparin-Binding Growth Factors under
Flow
4.1

Introduction

The bioavailability of molecules as they circulate through the bloodstream is a crucial
factor in their signaling capability. Halﬂife in circulation can determine the eﬀectiveness of a drug simply by regulating the opportunities a molecule has to interact with
the vessel wall. Although in vivo measurements are routinely made by researchers
to monitor serum levels of molecules and to determine half-lives, interactions in the
microenvironment are not easily measured or observed. While some molecules may
have a long circulation life, many may have only a single opportunity to interact with
the blood vessel walls before being ﬁltered through the liver or kidneys. In addition,
even molecules with a long circulation life may still face impediments to direct interaction with the endothelium. This, for example, is the case with vascular endothelial
growth factor (VEGF) when bound to bevacizumab, a monoclonal antibody to VEGF
[37, 45]. Bevacizumab has been shown to increase the circulating concentration of
VEGF in cancer patients when compared to patients not undergoing therapy because
of the increased half-life of the growth factor-antibody complex; however the complex
is unable to bind to VEGF receptors [31] making delivery of the VEGF questionable. In order to better understand the vessel microenvironment and to accurately
monitor drug interactions in the context of that microenvironment, better tools are
needed to provide meaningful measurements that can predict the fate of molecules
in circulation. Many important measurements have and continue to be made using
in vitro mammalian tissue culture methods but there are obvious limitations to the
traditional two-dimensional culture approach. In circulation, the inﬂuence of ﬂow on
whether a molecule remains in the ﬂuid phase or binds to the vessel wall can be a
dominant factor. This inﬂuence cannot be ascertained in static tissue culture studies.
For example, the velocity of blood in the aorta is 400 mm/sec while at the capillary
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level it is less than 1 mm/sec [83]. This reduction in velocity allows the exchange
processes at the capillary level to take place more eﬃciently [83] and it likely also
aﬀects the activity of molecules in circulation that rely on cell surface binding in
order to fulﬁll their roles. While direct measurement of this binding process is difﬁcult, the computer model of this study makes use of a commercial bioreactor with
endothelial-lined hollow tubes operating under pulsatile ﬂow to mimic the vascular
environment architecture and to directly measure the loss of molecules as they pass
through these hollow ﬁbers. A single pass method is used to allow better assessment
of the eﬀect of ﬂow in either retaining molecules in the circulation or permitting their
interaction with vessels. This approach also makes use of a bolus administration,
since this is a typical way in which drugs would be delivered in a clinical setting. The
binding of ﬁbroblast growth factor-2 (FGF-2) to its cell surface receptor (FGFR) and
the role of heparan sulfate proteoglycans (HSPG) in regulating the process have been
of research interest for many years because of their role in angiogenesis, the growth
of new blood vessels from existing vessels. Knowledge of how these processes work
could aid in the development of new therapeutics to control tumor growth and assist
clinically in the treatment of chronic wounds. In order to understand the mechanism
of FGF-2-mediated cell proliferation, a multitude of experimental studies have been
undertaken [3] and, in the past two decades, several computational models of FGF-2
binding to its receptor FGFR and HSPG have been proposed [17, 20, 27, 38, 48, 55].
Insight can be gained through experiment-coupled modeling that could not otherwise
be readily obtained. Nugent and Edelman [55] were among the earliest researchers
to develop a simple model that includes three species, FGF-2, FGFR and HSPG.
They measured kinetic binding rate constants experimentally and used their model
to analyze the data thereby providing a foundation for investigating the complexity
of FGF-2 binding. A similar approach was used by Ibrahimi et al. [38] to investigate stepwise assembly of a ternary FGF-2-FGFR-HSPG complex in conjunction with
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their surface plasmon resonance measurements. Forstern-Williams et al. introduced
more complexity into the FGF-2 binding model with the inclusion of heparin binding
[26], receptor dimerization [27], and formation of alternative HSPG-FGFR species
[28]. Recent models have moved towards including intracellular signaling [29]. With
the exception of work by Filion and Popel [20, 21], which included diﬀusive transport, previous simulation work has been based on a static tissue culture environment
that may be quite diﬀerent from the dynamic in vivo environment of blood vessels.
A computational model based on a ﬂow environment was introduced, in which the
competitive binding of FGF-2, FGFR, and HSPG in a pulsatile ﬂow environment was
addressed to mimic blood vessel-like hollow ﬁbers [71, 96].
In this chapter, the model is used to explore how speciﬁc parameters such as ﬂow
rate impact FGF-2 capture and receptor binding, and compare simulation results with
experimental studies. Insights with regard to the importance of surface coupling and
ligand depletion zones within the ﬂuid phase were found. The described simulation
package provides a new and valuable way to investigate growth factor capture and
can be easily extended to other biologically relevant molecules and drugs.
4.2
4.2.1

Materials and Methods
Preparation of Bovine Aortic Endothelial Cells (BAECs)

BAECs (passage 10), cryopreserved in liquid nitrogen, were cultured in Dulbecco’s
modiﬁed Eagle’s medium (DMEM-low glucose, phenol red-free, Invitrogen Corporation, Grand Island, NY), supplemented with penicillin (100U/mL, Invitrogen Corporation, Grand Island, NY), streptomycin (100mg/mL, Invitrogen Corporation, Grand
Island, NY), glutamine (2mM, Invitrogen Corporation, Grand Island, NY), and 5%
newborn calf serum (Invitrogen Corporation, Grand Island, NY). When a suﬃcient
number of cells were grown (passage 11,13), they were transferred to the hollow ﬁber
cartridge.
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4.2.2

Preparation and Maintenance of Endothelial Cartridges

The FiberCell polysulfone plus endothelial cartridges (C2025, FiberCell Systems Inc.,
Frederick, MD), also called hollow ﬁber bioreactors, contain 20 capillaries which are
12 cm long, 700 mm I.D., 300 mm wall, 0.1 mm pore size, 53 cm2 lumen surface
area (Fig. 3.1). They were activated with 70% ethanol (Fisher Scientiﬁc, Houston,
TX), followed by multiple washes with sterile distilled water. The cartridges were
then coated using 5 mg/mL ﬁbronectin (Sigma Aldrich, St. Louis, MO) in phosphate
buﬀered saline (PBS, Invitrogen Corporation, Grand Island, NY). BAECs (passage
11,13) were inoculated into the cartridges (0.7 − 1 × 107 cells/cartridge) 24 hours after
the coating and placed in an incubator for 4 hours (rotated 180◦ after 2 hours) without
ﬂow in order to promote cell attachment. The BAEC culture cartridges were then
linked to the FiberCell pump system (FiberCell Systems Inc., Frederick, MD) and
medium circulated through the system at ,2.6 mL/minute (5.2 mm/sec). The ﬂow
system was maintained in the incubator (37o C,5% CO2) at all times except during
the experiment periods. Cell growth and viability was monitored by measurement of
the cell glucose consumption from the medium once a day with OneTouch UltraSmart
blood glucose monitoring system (Lifescan, Inc., Milpitas, CA).
4.2.3

Growth Factor Flow Studies

The ﬂow system and cell-lined cartridges were removed from the incubator, gently
washed once with warmed (37o C) PBS (60 mL), and then maintained in circulating
125 mL serum-free medium (DMEM-low glucose, phenol red-free, supplemented with
0.05% gelatin in PBS) in a sterile room-temperature tissue culture hood (Thermo Scientiﬁc, Waltham, MA). After establishing ﬂow at the desired rate (low rate: 0.60,0.68
mL/min (1.2-1.36 mm/sec); high rate: 1.6-1.8 mL/min (3.2-3.6 mm/sec) or 2.9-3.0
mL/min (5.8- 6.0 mm/sec)) with a CellMax Quad pump (Spectrum Laboratories,
Inc.) for about 2 minutes, ﬂow was stopped to allow the growth factor of interest
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(FGF-2 (Sigma Aldrich, St. Louis,MO), EGF (R&D Systems Inc., Minneapolis, MN)
and VEGF (R&D Systems Inc., Minneapolis, MN)) (0.11 mL) to be injected into
the inlet. After the injection, the ﬂow was resumed and the ﬂow medium collected
(two drops/fraction) for the desired time period. The ﬂow pattern was assumed to be
sigmoidal based on previous studies [7, 14]. The cartridges were then gently washed
with warmed PBS supplemented with 0.3 MNaCl (10 mL) followed by one wash with
10 mL PBS and a wash of the whole ﬂow system with PBS (60 mL). The system was
returned to the same culture medium and ﬂow rates as described under Preparation
of BAECs, allowing at least 24 hours before the next experiment. The medium fractions collected during the binding experiments were stored at 4o C and analyzed with
ELISA kits (R&D Systems Inc., Minneapolis, MN) within the next 24,48 hours.
4.2.4

Viscosity Measurements

Dynamic viscosity of the test cell culture medium was measured using a DV-II++
Pro Programmable cone-plate viscometer (cone #CPE-40; Brookﬁeld Engineering
Laboratories; Boston, MA) according to the manufacturers instructions. Viscosity
measurements were made for a range (375 to 750 sec−1 ) of shear rates (to conﬁrm
Newtonian ﬂuid behavior) at room (i.e., 25o C) and physiologic (i.e., 37o C) temperatures.
4.2.5

Enzymatic Treatment

Heparan sulfate expression was measured in static tissue culture dishes and in the
ﬂow cartridge by heparinase treatment of cells, collection of the cleaved glycosaminoglycans, and quantitation using a dimethylene blue colorimetric assay [5, 18]. Cells in
static culture contained 4.3±0.31×10−6 µg of heparan sulfate/cell and cells in cartridge
hollow ﬁbers contained 1.1±0.09×10−6 µg of heparan sulfate/cell, reﬂecting an 75%
reduction in cell surface heparan sulfate under ﬂow (0.63 mL/min (1.26 mm/sec)).
Heparinase III (0.01 unit/0.11mL, Seikagaku Corp., Japan; 0.2unit/0.11mL, Sigma
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Aldrich, St. Louis, MO), chondroitinase ABC (0.2 unit/0.11mL, Seikagaku Corp.,
Japan) and keratanase (0.33unit/0.11mL, Sigma Aldrich, St. Louis, MO) were utilized to observe their eﬀect on growth factor ﬂow and binding. In some experiments,
the enzymes (heparinase III, chondroitinase ABC and keratanase) were mixed together as an enzymatic cocktail solution at the above concentrations. Cartridges
were treated for 20 minutes at 37o C,washed with warmed PBS (10 mL), and growth
factor studies performed as described above.
4.2.6

Determination of Non-speciﬁc Binding

In addition to binding to receptors of interest, growth factors (such as FGF-2) may
also bind to other sites, such as plastic wall of a ﬁber. Binding to the receptors of
interest is called speciﬁc binding, while binding to the other sites is called nonspeciﬁc
binding. Non-speciﬁc binding of FGF-2 in the system was determined to be primarily
due to the inlet reservoir. The reservoir chamber was removed from the cartridge,
growth factors were injected into the inlet of the cartridges with a syringe, and ﬂow
was initiated. Fractions were collected as they exited the reservoir. Growth factors
were measured before injection and compared to the sum of the collected fractions.
The diﬀerence between the input amount and the amount collected constituted the
nonspeciﬁc binding in the experiments. For FGF-2 (1.0±0.1 ng), the amount retained
in the reservoir was 29±2.8% of the FGF-2 added (SD, n= 3). Additional nonspeciﬁc
binding within the hollow ﬁbers was assumed to be minimal.
4.2.7

Determination of Growth Factor Concentration in Outﬂow

The concentrations of FGF-2, EGF, and VEGF in the collected fractions were measured by ELISA. The ﬂow rate of each experimental run was determined from the
total volume collected divided by the total ﬂow time.

56

4.3

Model Development

The computational model is based on the physical dimensions of the bioreactor although the system is scalable to other desired dimensions. The domain of the simulation is the hollow-ﬁber portion of the cartridge (Fig. 3.1). The computational model
has three coupled parts: (1) the medium ﬂow equations; (2) the convective mass
transport equations of growth factor in the ﬂow; (3) the binding kinetics equations
on the wall of the ﬁbers [27, 71]. In order to solve the coupled equations numerically and eﬃciently, the following assumptions are made: (1) the walls of the hollow
ﬁbers are rigid and nonporous; (2) the ﬂow is axisymmetric and laminar; (3) the ﬂuid
is incompressible, Newtonian and isothermal; (4) all of the hollow-ﬁber capillaries
within the cartridge have the same dimensions, ﬂow rate, cell densities and entrance
conditions; and (5) the cells are packed tightly and distributed evenly on the wall
of the hollow-ﬁber capillaries. Entrance eﬀects of the ﬂow are ignored [35, 89] and,
consequently, the ﬂow within the ﬁbers is treated as fully developed ﬂow in which
the radial velocity is neglected. A uniform mesh is used. The kinetic pathways are
shown in Fig. 3.4 and the equations and parameter values are included in Table 3.1
and Table 4.1, respectively.
In the experimental system, FGF-2 is injected into the inlet reservoir where it is
assumed to quickly reach a uniform concentration. The concentration of FGF-2 in
the reservoir is assumed to decrease gradually as ﬂuid is pumped into the reservoir
prior to distribution into the capillaries with each time step as:
ϕnent = ϕn−1
ent ×

v − ∆v
v

(4.1)

where, v is the volume of the reservoir, ∆v is the volume of ﬂuid ﬂowing into the ﬁbers
at each time step and is time dependent due to pulsatile ﬂow, ϕnent is the current and
0
ϕn−1
ent is the previous concentration of FGF-2 in the reservoir. ϕent =

the amount of FGF-2 injected.
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F0
,
v

where, F0 is

Table 4.1: Parameter values used in simulation.
Parameter
konF R
kof f F R
konF H
kof f F H
kof f F HR
kc
kuc
kint
kintD
R0
H0
D
µ
ρ
ρcell

Value
3.2 × 108 M −1 min−1∗
0.28min−1∗
1.2 × 108 M −1 min−1∗
0.56min−1&
0.018min−1&
0.0024(#/cell)−1 min−1⋆
0.6min−1⋆
0.005min−1∗
0.078min−1∗
104 #cell−1&
2.5 × 105 #cell−1%
1.67 × 10−10 m2 /s&
0.00094P a · s%
1000kg/m3
800, 000#f iber−1%

∗

[78] but scaled to 25o C except for kint and kintD .
for R0 . ⋆ [49]. % measured.

&

[20] but scaled to 25o C except

The pump pulse cycle was measured experimentally and determined to be 36
strokes/min at a ﬂow rate of 1.4 mm/sec. Pulsatile ﬂow is treated in the following
manner. A pulse of ﬂuid volume enters the pre-pump inlet reservoir (0.4 mL volume),
from which a continuous ﬂow of ﬂuid having an axial velocity greater than or equal to
zero enters the cell-lined ﬁbers in the cartridge. The axial velocity is oscillatory but
with only positive terms. Entrance eﬀects are considered negligible [89]. The velocity
of the ﬂuid in the axial direction is determined with the following formula [96]:
u(r, t) ≈

r2
2qs
(1
−
)(1 + cosωt)
Nf πR2
R2

(4.2)

where qs is the average volumetric ﬂow rate, Nf is the number of ﬁbers inside
the cartridge, R is the radius of a ﬁber, ω = 2π/T is the angular frequency of the
pulsatile ﬂow, and T is the pump pulse cycle.
4.3.1

Criteria for Comparison Between Simulation and Experiment

Good agreement between the simulation and experimental results was determined
based on two criteria: an amount criterion and a curve-matching criterion.
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Amount Criterion
The amount criterion is deﬁned as:
|Mexp − Msim |
< 1%
M

(4.3)

where Mexp is the outﬂow amount of protein determined experimentally, Msim is the
outﬂow amount determined within the simulations and M is the amount of FGF-2
entering the capillary.
Curve-matching Criterion
The FGF-2 exit proﬁle curve is not a continuous curve but is a series of discrete values
at diﬀerent time intervals. This makes use of traditional curve matching algorithms
diﬃcult. The curve-matching criterion is calculated in the following way: (1) Align
the initial exit times for the simulations and experiments; (2) Calculates the distance
between points on the two outﬂow curves using the following formula:
√
∑N
2
i=1 (ai − bi )
D=
N

(4.4)

where N is the total number of time intervals. ai and bi is the amount of FGF-2
exited at the ith time interval in experiment and simulation, respectively. (3) The
curve-matching criterion is deﬁned as:
D
< 2%
M

(4.5)

Considering possible errors when recording the time during the experiment and
the second order accuracy of the numerical simulation, it is appropriate to set 2% for
the curve matching and 1% for the amount criteria.
In the simulations, there are 800,000 cells/ﬁber or 16,000,000cells/cartridge, a
value which was obtained from the experimental system. The tolerance for solving
the mass transport PDEs was set at 10−12 . The relative tolerance for solving the
kinetic ODEs was set at 10−8 and the absolute tolerance was set at 10−12 .
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4.4
4.4.1

Results
Endothelial Cells Form a Uniform and Conﬂuent Monolayer in Cartridge Capillaries

Endothelial cells line blood vessels and are the initial entry point for access of bloodborne proteins to the underlying tissue. The investigations of this study focused on
ﬂow and the impact it has on endothelial cell capture of growth factors, which are
important regulators of cell and tissue activity. To better approximate the microenvironment of a blood vessel, this research seeded bovine aortic endothelial cells into the
FiberCell cartridge system and cultured the cells under ﬂow (Fig. 3.1). Cell viability
was conﬁrmed for up to eight weeks and cell density was around 0.3×106 #/cm2 . The
geometry is clearly more similar to in vivo than typical cell culture dishes but it was
important to obtain a uniform and conﬂuent monolayer of cells within the cartridge
system to correctly perform and analyze experiments. To conﬁrm this, cartridges
were treated with a high salt wash to extrude the cell-based vessel and the cells were
ﬁxed and imaged (Fig. 4.1). An incision was made at one end to expose the lumen
and demonstrate the continuity of the cell layer.
4.4.2

There is Signiﬁcant Capture of FGF-2 Under Low Flow Rates

The average ﬂuid velocity in human capillaries is 1 mm/sec [83]. This research hypothesized that capture of regulatory growth factors from solution would be signiﬁcant at these ﬂow rates thereby facilitating growth factor activity. Using the lowest
velocity setting with the standard pulsatile pump included with the Cellmax system (1.3 mm/sec, 0.65 mL/min), FGF-2 (5.0±0.4 ng) was injected into the cartridge
inlet reservoir and ﬂow was commenced. As shown in Figure 3, there is a delay
in FGF-2 appearance in the outﬂow corresponding to the time for FGF-2 to travel
through the cartridge and exit the system. The majority of FGF-2 added exited the
cartridge as a large peak approximately 1 mL (or 1.5 min at this ﬂow rate) after
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Figure 4.1: Brightﬁeld and DAPI stained images of endothelial cells from the unit
showing the continuous vessel-type architecture.

ﬂow was initiated. Nonspeciﬁc binding within the injection cartridge reservoir was
measured directly (31±2.5%). Speciﬁc binding within the celllined hollow ﬁbers accounted for 9±2.5% of total FGF-2 added to the cartridge at this concentration and
13% of the FGF-2 entering the cell-lined ﬁbers, after taking into account non-speciﬁc
binding (Fig. 4.2). The results shown in Fig. 4.2(A) are from three independent experiments conducted using three diﬀerent cartridges illustrating the reproducibility of
the system. Repeated runs conducted using the same cartridge as well as runs using
radiolabeled FGF-2 instead of unlabeled FGF-2 both produced similar results. The
peak appearance time or volume in the outﬂow from the cartridge was insensitive to
FGF-2 injection concentration in the range studied. However, the size of the FGF-2
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peak correlated with the injection concentration with the highest peak corresponding
to the highest concentration of FGF-2 added (Fig. 4.2(B)). The accuracy of the measurements took into consideration speciﬁc losses that occurred with injection (i.e.,
tube, syringe, needle, and reservoir). Rather than averaging datasets with variable
FGF-2 reservoir values, they are presented as discrete results. A plot of total FGF2 retained at these discrete concentration points shows a dose responsive binding
curve, reﬂecting the linear portion of the binding curve expected at subsaturation
ligand concentrations (Fig. 4.2(C)).
4.4.3

Heparinase Treatment Signiﬁcantly Increases the FGF-2 Outﬂow

Heparan sulfate proteoglycans (HSPG) are ubiquitous molecules found on virtually
all cells including endothelial cells and have been shown to regulate heparin-binding
growth factor binding and activity in tissue culture [17, 16, 25, 53, 58, 92]. FGF-2 is
a heparin-binding molecule associated with a number of physiologic and pathologic
processes [23] and, therefore, the role of HSPG in regulating FGF-2 retention under
ﬂow was examined. Although the binding aﬃnity of FGF-2 for HSPG has been
shown to be lower than the aﬃnity for the FGF receptor, these HSPG sites can
provide up to a thousand fold more binding sites for FGF-2 [17, 16] signiﬁcantly
impacting the cell binding ”potential” for heparin-binding growth factors. Cartridges
were treated with heparinase, an enzyme speciﬁc for heparin and heparan sulfate, and
FGF-2 outﬂow quantiﬁed. After heparinase treatment, FGF (1 ng) was injected and
pumped through the cartridge. Almost 74% of the total FGF-2 added to the system
was recovered in the outﬂow, compared to 46% of the total FGF-2 recovered from
the nonheparinase treated cartridge prior to subtraction of non-speciﬁc binding. The
amount of FGF-2 retained in the cartridge after heparinase treatment corresponded
to the measured level of nonspeciﬁc binding and thus indicated no speciﬁc binding
to cell-lined ﬁbers in the absence of HSPGs (Table 4.2). In contrast, 25% of the
FGF-2 pumped through untreated cartridges was retained after subtraction of non62

Table 4.2: Heparinase and chondroitinase but not keratanase impact FGF-2 output.
Treatment
control
heparinase
chondroitinase
keratanase

FGF-2
0.95 ±
0.92 ±
1.73 ±
0.95 ±

input(ng)
0.05
0.00
0.68
0.15

% FGF-2 retained
25 ± 1.7
0.0 ± 2.9∗
16 ± 4.1∗
20 ± 7.5

ﬂow
0.62
0.66
0.65
0.62

rate(mL/min)
± 0.02
± 0.02
± 0.03
± 0.08

Mean ± standard deviation of at least three experimental runs.
cantly (p,0.05) diﬀerent from control.

∗

indicates signiﬁ-

speciﬁc binding. Although FGF-2 can bind to its receptor in the absence of HSPG
stabilization, that binding, based on the apparent KD of the receptor for FGF-2 in the
absence of heparan sulfate, the lower level of FGFR generally found, and the ligandreceptor exposure time under ﬂow, would be expected to be at least ten-fold lower
than in the presence of HSPG [16] and the data certainly support this. To ensure
that the eﬀect with heparinase under ﬂow was due to the speciﬁc removal of heparan
sulfate and not a general eﬀect due to enzymatic treatment of the cartridge or the
enzyme incubation process, the cartridges were treated with keratanase, an enzyme
having no speciﬁc known target on these cells. Keratanase, as opposed to heparinase,
had no signiﬁcant eﬀect on FGF-2 retention (Table 4.2). Interestingly, there was
a small but reproducible reduction ( 9%) after chondroitinase treatment on FGF-2
retention compared to control. Chondroitin sulfate proteoglycans are typically found
on vascular surfaces but FGF-2 has not been shown to bind directly to chondroitin
sulfate [52, 88]. It is not known at this time what the cause for the reduced binding
is, although it has been reported that both chondroitin sulfate and dermatan sulfate
under certain circumstances are able to inﬂuence FGF binding [2, 75, 82].
4.4.4

VEGF but not EGF is Impacted by Heparinase Treatment

VEGF, a heparin binding protein, and EGF, which does not bind heparin, were next
tested in this system. Both the initial appearance time and outﬂow volume for the
protein as well as the general shape of the outﬂow peak for both VEGF and EGF were
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Table 4.3: VEGF but not EGF retention is impacted by heparinase (experimental).
Treatment
EGF
+Enzymes
VEGF
+Heparinase

Growth Factor input(ng)
1.4 ± 0.15
1.6 ± 0.170
1.2 ± 0.19
1.0 ± 0.26

% Growth Factor Retained
19 ± 8.1
20 ± 7.2
16 ± 5.8
-2.5 ± 6.1∗

Mean ± standard deviation of at least three experimental runs.
cantly (p,0.05) diﬀerent from non-enzyme treated case.

ﬂow
0.61
0.62
0.66
0.66
∗

rate(mL/min)
± 0.01
± 0.01
± 0.00
± 0.02

indicates signiﬁ-

similar to FGF-2 (Fig. 4.3). To ensure that the measured eﬀects seen with heparinasetreatment on FGF-2 retention were due to speciﬁc responses of the growth factor to
the removal of heparan sulfate and not a general response by all proteins, ﬂow studies
were done with VEGF and EGF following enzymatic treatment. EGF retention and
outﬂow were unaﬀected by treatment with a cocktail of heparinase, chondroitinase,
and keratanase (Table 4.3). Treatment with heparinase without chondroitinase or
keratanase also had no eﬀect on EGF retention or outﬂow. In contrast, VEGF showed
a signiﬁcant decrease in speciﬁc retention between control and heparinase treated
cartridges (16±5.8% versus 22.5±6.1% VEGF retained) indicating the critical role
HSPG can have in heparin-binding growth factor capture under ﬂow. The lack of a
change in EGF binding or outﬂow proﬁle under heparinase treatment is supportive
that there are no gross changes in the cell glycocalyx that might impact the shear
stress in the system.
4.4.5

Simulations Capture Critical Properties of Process

Capture of FGF-2 by endothelial cells within the vasculature is a critical step in
growth factor activity and the bioreactor is an excellent tool for investigating the
capture process. However, it has limitations with regard to quantiﬁcation of cellular binding behavior. The cartridges are expensive for short-term experiments and
culture time and preparation can be relatively lengthy. Visualization of individual
cell behavior within the culture is not feasible. In addition, the ability to predict the
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capture of molecules by cells under ﬂow has value across a wide range of areas and
the development of a ﬂow-based tool for the design and testing of mechanisms related
to retention is desirable. The computer model of this research was designed based on
medium ﬂow equations and mass transport equations [12] with cell surface reaction
equations to reﬂect the cell growth factor interactions (see Materials and MethodsModel development). To validate the model, simulations were performed using the
variables (i.e., FGF input concentration and ﬂow rate) speciﬁc for an experimental
series and a comparison was made. Experimental trials were run in which FGF-2
(0.92 ng) was added to the reservoir, pumped through the cartridge, and outﬂow
collected and analyzed for FGF-2. FGF-2 in the outﬂow showed a characteristic peak
outﬂow approximately 100s after ﬂow was initiated at 0.63 mL/min (1.26 mm/sec)
and 17±6.3% of the input FGF-2 was retained within the cartridge after non-speciﬁc
binding was subtracted (Fig. 4.4). Simulations performed using the same input FGF2 value and ﬂow rate were run and comparison was made between the simulations and
experimental outﬂow from control (Fig. 4.4(A)) or heparinase-treated (Fig. 4.4(B))
cartridges. Good agreement was deﬁned based on two criteria; the amount of FGF-2
recovered and the curve similarity. Criteria one requires the relative diﬀerence in
FGF-2 outlow from the experimental and simulation studies to be less than 1% while
the second criteria compares the actual amounts of FGF-2 exiting from the experimental and the simulation system (see Materials and Methods). The research did
note that FGF-2 retention with the simulations was very dependent on the level of
HSPGs with higher densities resulting in too much retention via HSPG-FGF-2 binding and subsequent FGFR coupling while lower HSPG densities resulted in too little
retention. Comparison of simulation results with the heparinase-treated data showed
ﬁne agreement with regard to the criteria when non-speciﬁc loss in the reservoir was
subtracted.
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4.4.6

Pulsatile and Steady Flow Results Are Similar at Low Flow Rates

Capillary ﬂow is generally steady, and gradually becomes pulsatile at higher ﬂow
rates. The simulations and in vitro experiments are conducted to compare steady
and pulsatile ﬂow at a low ﬂow rate (0.6 mL/min, 1.2 mm/sec) to determine whether
the model would predict diﬀerences between FGF-2 interactions using steady and
pulsatile ﬂow. Simulations predicted no diﬀerence in FGF-2 binding at low ﬂow
using pulsatile ﬂow conditions versus steady ﬂow in either the FGF-2 binding down
the cell-lined hollow ﬁber (Fig. 4.5(A)) or in the proﬁle of the outﬂow (Fig. 4.5(B)).
In vitro experiments were performed using a syringe pump for steady ﬂow and the
bioreactor’s pulsatile ﬂow pump (Fig. 4.5(C)). FGF-2 outﬂow measurements indicated
no overall change at 0.6 mL/min (1.2 mm/sec) suggesting that, at low rates typical
of capillary ﬂow, no signiﬁcant change in FGF-2 interactions takes place.
4.4.7

Simulations Predict Peak FGF-2 Binding at Entrance to the Celllined Hollow Fibers

The experimental system does not allow easy separation between internalized FGF-2
and that bound to the cell surface or visualization of FGF-2 distribution within the
cell-lined hollow ﬁber. The simulations were used to examine how FGF-2 would be
distributed with respect to time after ﬂow was initiated (Fig. 4.6). At a relatively low
ﬂow rate (0.63 mL/min, 1.26 mm/ sec), the FGF-2 in the reservoir had essentially
all entered the hollow ﬁbers by 150s and the peak outﬂow of FGF-2 was evident
∼200s after ﬂow was initiated corresponding to the time when the bulk FGF-2 had
exited the hollow ﬁbers. Later times showed cellbound FGF-2 either internalized or
dissociated from the cell surface with little chance to reassociate. The vast majority
of binding is predicted to occur near the entrance to the cell-lined hollow ﬁbers as
opposed to the middle or end of the ﬁbers (Fig. 4.6(B)). The impact of time was more
pronounced in the front section also as ﬂuid entering the hollow ﬁber after ∼150s was
devoid of FGF-2 (< 0.1% of initial FGF-2). Increasing the diﬀusion rate for FGF-2 in
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solution by increasing the diﬀusion coeﬃcient by an order of magnitude is predicted to
have a negligible impact on FGF-2 capture in the front of the capillary but increased
signiﬁcantly the FGF-2 bound down the length of the cell-lined hollow ﬁber. This
was due to changes in the depletion zone near the cell-lined walls (Fig. 4.7). After
44 seconds, an FGF-2 depletion zone near the surface was evident which was reduced
when the diﬀusive transport of FGF-2 was increased. The replenishment of FGF-2
near the wall promoted greater FGF-2 binding as complex formation is a second-order
process and illustrates the importance of surface depletion in growth factor capture.
4.4.8

Flow Rate Impacts FGF-2 Binding

The simulations indicate that depletion near the cell surface impacts binding and
suggests that residence time in the vicinity of the cell surface is important. Therefore,
how ﬂow impacted cell binding of FGF-2 was studied. Simulations predict that cell
binding is signiﬁcantly diminished with increased ﬂow rate (Fig. 4.8(A)) although the
basic result of high binding at the entrance and reduced binding down the cell-lined
hollow ﬁber was consistent across ﬂow rates examined. This diﬀerence was evident
regardless of the concentration of FGF-2 introduced to the system with the diﬀerence
being more pronounced at higher ﬂow rates (Fig. 4.8(B)). Reduction in binding due
to the loss of HSPG is less evident at higher ﬂow rates where the speciﬁc binding was
already greatly reduced. This inverse relationship between ﬂow and cell binding is
potentially important especially at these relatively low ﬂow rates. The highest rate
used in the simulations (∼3 mL/min,∼6 mm/sec) is considerably lower than average
arterial ﬂow rates (100-400 mm/sec) in larger vessels of the circulatory system [83]
suggesting that, with a short half-life, retention may be relevant only in small vessels
with lower velocities. Note that simulations were run to a constant time rather than
volume to reduce small ﬂuctuations in retained FGF-2 due to dissociation eﬀects.
Experimentally, the results were consistent but not quantitatively exact with this
model prediction (Table 4.4). FGF-2 retention in the hollow ﬁbers was virtually
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Table 4.4: Increased ﬂow rate eliminates FGF-2 binding (experimental).
Treatment
Control
+Heparinase
Control
+Heparinase

FGF-2 input(ng)
1.1 ± 0.11
1.1 ± 0.02
0.91 ± 0.17
0.95 ± 0.25

% FGF-2 Retained
6.7 ± 4.6
6.7 ± 1.2
0.5 ± 9.1
0.5 ± 10

Flow rate(mL/min)
1.7 ± 0.10
1.8 ± 0.05
2.9 ± 0.13
3.0 ± 0.03

Mean ± standard deviation of at least two experimental runs.
eliminated under medium (∼1.7 mL/min, 3.4 mm/sec) and higher ﬂow rates (3.0
mL/min, 6 mm/sec), a signiﬁcant reduction compared to binding at 0.62 mL/min
(1.24 mm/sec) (Table 4.2- control group). The simulations, in contrast, did show
some level of binding even at the highest level but this likely reﬂects the idealized
conditions used for the model system (i.e., uniform receptor and HPSG densities, free
access to coupling between FGF-2 bound molecules). Heparinase treatment showed
no signiﬁcant further reduction in retention at the higher ﬂow rates in agreement with
the simulation results.
Simulations indicated no diﬀerence in FGF-2 binding under the pulsatile ﬂow conditions versus steady ﬂow. Additional experiments were performed using a syringe
pump with steady ﬂow rather than pulsatile ﬂow. FGF-2 outﬂow measurements indicated no overall change at 0.62 mL/min (1.2 mm/sec). Qualitatively the experimental
results agreed with the simulation predictions for the overall eﬀect of ﬂow rate on retention although the model suggested higher retention levels for the control case and
closer agreement between control and heparinase at both higher ﬂow rates.
4.4.9

Changes in FGF-2 Aﬃnity for HSPG Are Predicted to Have a
Larger Impact on Retention Than Similar Changes in Aﬃnity for
FGFR at Physiological Cell Densities

FGF-2 binding aﬃnity and concentration, along with binding partner density, regulates the capture process for FGF-2 from the ﬂuid phase. Therefore, the simulations
were used to examine how varying the aﬃnity of FGF-2 for either HSPG (Fig. 4.9(A))
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or FGFR (Fig. 4.9(B)) while holding all other parameters at their baseline value
would impact retention. Decreasing the aﬃnity (i.e., increasing KD ) for HSPG had
a dramatic eﬀect on retention, reducing it to 40% of baseline capture at the lowest
value examined. The association rate constant had a greater impact than the dissociation rate constant although both followed similar trends. Somewhat surprisingly,
increasing the aﬃnity of the interaction by reducing the value of the dissociation
rate constant of FGF-2 for HSPG did not alter FGF-2 binding likely due to the
strong coupling present between FGFR and HSPG in the presence of FGF-2, making
strict HSPG-dissociation somewhat irrelevant. For the same reason, FGF aﬃnity for
FGFR did not have a strong impact on FGF-2 capture since the vast majority of
FGF-2 interacting with FGFR was via FGF-2-HSPG coupling.
4.4.10

Simulations Predict Binding Site Density is Critical for FGF-2
Retention

Cells typically express signiﬁcantly more HSPG than FGFR and the research next
asked how varying the cell surface densities of these binding sites would impact FGF-2
capture. In the absence of FGFR, a typical density of HSPG in the cartridge (2.5 ×
105 #/cell) resulted in signiﬁcant binding of FGF-2 in the absence of FGFR that is
essentially doubled when FGFR density is 1×106 #/cell, a two-fold increase in binding
sites (Fig. 4.10(A)). FGFR typically are expressed at densities of approximately 1 ×
104 #/cell thereby keeping the primary signaling receptor at a controlled level. This
is predicted to result in an order of magnitude less overall FGF-2 binding than that
found at typical HSPG levels but which is increased in a similar way when HSPG
are present. The combination of the two surface binding sites (FGFR and HSPG)
is critical. For example, when 1.0 × 104 FGFR are present, the retained FGF-2 is
increased to ∼0.25ng from a value of ∼0.14ng without the FGFR. Looking at cell
binding at the entrance of the cell-lined hollow ﬁber as a function of time after FGF2 has been introduced with constant FGFR (1 × 104 #/cell) and variable HSPG, this
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research found that there was a signiﬁcant increase in bound FGF-2 at the higher
HSPG (1×105 #/cell) when compared to the lower values and that the FGFR binding
was essentially all coupled to HSPG (Fig. 4.10(B)). When there are fewer HSPG, there
is a lower percentage of coupled binding at least at earlier times as well as lower overall
FGFR complexes.
4.4.11

Simulations Predict Coupling is Key to Eﬀective Capture of FGF2

The results with the FGF-2-HSPG aﬃnity simulations and the density studies indicated the importance of coupling in facilitating eﬀective FGF-2-FGFR interactions.
Next, the research looked at how varying the coupling rate constant impacted binding and internalization using simulations (Fig. 4.11). In the absence of HSPG-FGFR
coupling (kc = 0), there is a reduction in peak binding of FGF-2 and the majority
of FGF-2 bound is not internalized but dissociates and exits from the system in the
outﬂow. Even with a low level of coupling, the FGF-2 binding and internalization
is dramatically increased until a peak eﬀect is seen with kc = 0.01(#/cell)−1 min−1 .
Looking at later times in the simulation (Fig. 4.11(B)), it would be found that a
large fraction of the FGF-2 injected is bound during the initial pass and that this
bound FGF-2 is largely internalized with little exiting the system. If coupling between HSPG and FGFR is eliminated (Fig. 4.11(C)), this is not the case. In this
scenario, the cells bind a smaller but still signiﬁcant level of FGF-2 during the initial
pass but this FGF-2 is not retained and nearly all of the FGF-2 captured ultimately
exits the system in the outﬂow.
To further illustrate the importance of the coupling process, simulations were
performed with cell-lined hollow ﬁbers having only HSPG (2.5 × 105 #/cell) in the
front 25% of the tube and both FGFR (1 × 104 #/cell) and HSPG (2.5 × 105 #/cell)
in the back 75% of the ﬁber (Fig. 4.12). The entrance area (front 25%) did not
include internalization of FGF-2 by HSPG modeling an ECM-like section, however,
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the overall outcomes are not signiﬁcantly changed when internalization is included.
HSPGs in this front section were able to capture FGF-2 but there is a signiﬁcant
rise in retention in the back section where both HSPG and FGFR are present. This
is not simply due to the increase in binding sites due to the addition of FGFR as
increasing HSPG by an equivalent level to that of the HSPG plus FGFR did not lead
to the same increase in retention. Moreover, this increase in retention is lost when
the dissociation rate for FGF-2-FGFR-HSPG is reduced to that of FGF-2-HSPG and
only nominally increased when the coupling rate is eliminated, reﬂecting the increased
aﬃnity of FGFR compared to HSPG for FGF-2. The eﬀect is evident at both low
and high ﬂow rates.
Finally, The simulations were used to ask whether dissociation from HSPG in an
ECM-like section could lead to increased binding downstream due to slow dissociation
of the growth factor and prolonged availability of the growth factor for downstream
binding. When the HSPG density in the front 25% zone was increased to 5 × 106
HSPG/cell, a large increase in overall retention of FGF-2 in the front section was
evident, resulting in a decrease in FGF binding in the HSPG-FGFR section (back
75%) due to a depletion of FGF-2 in the ﬂuid zone near the cells. This was evident at
both 5 (Table 4.5) and 10 min. In contrast, a low level of HSPG (5×104 or less) in the
entrance section did not lead to signiﬁcant binding in this zone and results in increased
binding of FGF-2 in the ﬁnal 75% section. FGF-2 in the ﬂuid phase was at a higher
concentration at later times after FGF-2 injection when there were more HSPG in
the front section due to dissociation from the HSPGs; however, under ﬂow conditions,
this dissociated FGF-2 is not predicted to grow to a high enough concentration to
meaningfully impact downstream receptor binding. This is an important diﬀerence
between ﬂow and static culture studies.
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Table 4.5: Simulations predict eﬀect of entrance HSPG zone on FGF-2 capture at 5
min.
HSPG Density in front 25% of Cell-lined
5 × 106
Total FGF-2 Retained(ng)
0.39
FGF-2 Bound(ng) (Front 25%)
0.16
FGF-2 Bound(ng) (Back 75%)
0.17
FGF-2 Internalized(ng) (Back 75%) 0.013
FGF-2 in Fluid Phase(ng)
0.029

4.5

Hollow Fiber
5 × 105 5 × 104
0.34
0.31
0.063
0.0022
0.24
0.28
0.017
0.022
0.022
0.008

Discussion

Circulation is an obligatory process for the maintenance of human life. The proper
balance of solid and ﬂuid components, ﬂow and pressure, and chemical content are
all tightly regulated to maintain homeostasis. Within these limits, however, wide
ﬂuctuations can occur. The eﬀects of the regulatory processes that are in place
to deal with these ﬂuctuations are not well characterized. Often the overall eﬀects
can be easily measured but not the changes in the microenvironment that come
together to drive these eﬀects. Although traditional tissue culture studies have added
a wealth of knowledge in such areas, they often lack the capability to emulate the
in vivo environment. In the study of the eﬀect of ﬂow in regulating vessel wall
interactions, for example, three-dimensional studies can provide valuable information.
Three-dimensional studies have been used previously to measure the eﬀects of ﬂow on
cell populations [7, 54, 79, 34, 59]. Such an approach has been chosen in this study
to measure the eﬀect of ﬂow on heparin binding protein delivery. By employing a
single pass method to focus on the initial growth factor-vessel wall interaction, it was
able to more directly measure the eﬀect of ﬂow on the bioavailability of these growth
factors. Substantial binding of all growth factors (FGF-2, VEGF, and EGF) were
measured at the lowest ﬂow rate tested (0.61-0.66 mL/min, 1.22-1.32 mm/sec). Had a
traditional two-dimensional approach been used instead, these factors would have had
few limitations on their rebinding potential since in a closed system they would not
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be subject to the ﬂow that would remove them from the vessel as is typical of normal
circulation. In the case of the heparin binding proteins (FGF-2 and VEGF), removal
of heparan sulfate sites via enzyme digestion resulted in a signiﬁcant increase in
growth factor outﬂow (i.e., non-retention within the vessel), suggesting an important
regulatory role for these proteoglycans in ligand capture. This is not necessarily
surprising given the large number of binding sites these proteoglycans provide on
normal cell surfaces. Certainly, it has been shown by many researchers that HSPGs
are important regulators of FGF-2 binding to FGF receptors in tissue culture [92],
although not essential for the interaction [17, 16, 58]. Their importance with regard
to capture under ﬂow has, however, not been shown previously and suggests a critical
role in the circulation.
An equally signiﬁcant inﬂuence on FGF-2, VEGF, or EGF binding, regardless of
heparin binding characteristics however, was the ﬂow rate. By increasing the ﬂow
rate by less than a factor of three (∼1.8 mL/min, 3.6 mm/sec) a signiﬁcant increase
was seen in growth factor outﬂow, reﬂecting the absence of speciﬁc binding taking
place on vessel surfaces. A higher ﬂow rate (∼3.0 mL/min, 6 mm/sec) showed no
further increase in FGF-2 outﬂow above that observed at the medium ﬂow rate with
both showing retention levels equivalent to that evident in the absence of heparan
sulfate. This correlation of ﬂow rate and outﬂow of growth factors suggests a strong
regulatory eﬀect and an environment in the bloodstream that reduces the probability
of capture signiﬁcantly at ﬂow rates typically measured in arteries [83]. Although
pulsatile ﬂow is undoubtedly important in increasingly larger vessels and higher ﬂow
rates, both simulations and experiments showed that at the low ﬂow rate typical of
capillaries it had no signiﬁcant eﬀect on FGF-2 interactions when compared to steady
ﬂow.
The removal of chondroitin sulfate created a small but signiﬁcant increase in FGF2 outﬂow. This is interesting since a number of published ﬁndings found no signiﬁcant
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aﬃnity between FGF-2 and chondroitin sulfate [52, 88]. It is possible that under ﬂow
conditions subtle changes in chondroitin sulfate modiﬁcations allow for some weak
interaction. Others have reported the ability of FGF-2 to bind chondroitin sulfate
under certain circumstances [2, 75, 82]. EGF binding was, however, unaﬀected by
treatment with a heparinase, chondroitinase and keratanase cocktail suggesting the
chondroitinase eﬀect was not universal. How this eﬀect is manifest is currently under
further study.
The minimum size of capillaries has been shown to be relatively ﬁxed across species
regardless of size [69] and is a basic assumption in the general model of allometric
scaling laws proposed by West et al. [90]. This suggests an optimum environment
for the exchange of gases, nutrients, and the removal of waste products that is likely
rooted in fundamental physical laws. In order to best make use of these environmental conditions blood ﬂow must also be optimal. The data demonstrate an inverse
correlation between ﬂow rate and probability of capture. Although the presence of
heparan sulfate is crucial to FGF-2 capture at low ﬂow rates, at higher ﬂow rates the
overriding regulator seems to be the ﬂow rate itself which, based on the results, would
all but preclude eﬃcient FGF-2 binding to vessel walls in a single pass under all but
the slowest ﬂow conditions. The expectation of lower binding at increasingly higher
ﬂow rates might be somewhat expected but the relatively small increase in ﬂow rate
required to ablate binding was surprising.
Other inﬂuences, such as viscosity, and the presence of competing molecules were
not addressed in this work. These are ongoing studies as the research begins to
add complexity to the system so as to form even more accurate models of circulation. The advantage of this method is that the conditions can be monitored and
controlled much as two dimensional culture systems can be but include the three
dimensional architecture and ﬂow characteristics that are part of normal blood ﬂow.
This approach has obvious potential in the testing of both endogenous molecules and
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pharmaceuticals in order to provide a better perspective of molecular interactions in
the microenvironment of blood vessels.
The importance of HSPGs in FGF-2 binding and signaling has been shown in many
systems [17, 20, 27, 38, 48, 55], and is a generally accepted feature for heparin-binding
growth factors. The research work builds upon those studies and shows the critical
importance of HSPGs in FGF- 2 capture under ﬂow (Fig. 4.2). In this chapter, the
impact of this critical component is explored in detail using the computational model
and show the parameters that regulate this process. In particular the study shows
that the two-step coupling process and the accompanying decrease in dissociation are
essential for eﬀective retention of FGF-2 in a ﬂow situation.
HSPG can mediate both the heparin-binding growth factor-receptor interaction
at the cell surface and the accumulation and storage of these growth factors in the
extracellular matrix [63, 84]. Removal of HSPG from the cell surface by enzymatic
digestion greatly impairs FGF-2 activity in vitro and inhibits neo-vascularization in
vivo [58, 92, 67]. HSPG interacts with FGFR directly [41, 68] and FGF-2 binding to
cell surface HSPG can facilitate FGF-2 binding to FGFR, which in turn can result
in activation of intracellular signaling cascades. Using the simple model under ﬂow,
the study shows in several ways that the coupling step is critical for FGF-2 retention.
Elimination of coupling or decreasing the rate constant describing that interaction
has a dramatic eﬀect on both FGF-2 bound and internalized with essentially no internalization or eﬀective binding when coupling is eliminated (Fig. 4.11). Reducing
the density of HSPG (Fig. 4.10) or the aﬃnity of FGF-2 for HSPG (Fig. 4.8) signiﬁcantly reduces the amount of FGF-2 bound to both the cell surface and to FGFR. In
addition, simulations with only low levels of HSPG (Fig. 4.10, 4.11 - entrance zone)
or FGFR do not exhibit high retention but, when both HSPG and FGFR are present
(Fig. 4.12), the combination of both increases retention. This is evident independent
of ﬂow rate. The ability of ﬂow to regulate the level of binding suggests how crucial
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the presence of HSPG is on the vessel wall, in order to increase the probability of capture of heparinbinding molecules especially given the short half-lives of some growth
factors in circulation.
Under the ﬂow condition, simulations predict that the majority of FGF-2 binding
occurs at the entrance to the cell-lined hollow ﬁber (Fig. 4.6). In the simulations set
up to match the experimental conditions, FGF-2 enters at its highest concentration
and thus is most likely to bind under those conditions. Once binding occurs, there is a
depletion of FGF-2 in the ﬂuid phase near the cell surface (Fig. 4.7). Under ﬂow, this
zone can be replenished via diﬀusion as increasing the diﬀusion coeﬃcient increases
the concentration in this zone (Fig. 4.7) and ultimately leads to higher binding down
the cell-lined hollow ﬁber. The research had postulated that FGF-2 bound in the
entrance zone of the cell-lined hollow ﬁber would eventually dissociate and rebind
further down the tube but this does not appear to be the case. Even when binding
is extremely high at the entrance, FGF-2 that dissociated from the entrance was
not in high enough concentration to impact downstream binding and was eventually
washed out of the system. In a non-ﬂow system this would likely not be the case and
exempliﬁes the importance of including ﬂow in studies.
In conclusion, a simulation program for the speciﬁc cell investigations of FGF-2
binding under ﬂow [71, 96] performed well when compared to the experimental endothelial cell-lined bioreactor. The simulations suggest that:
(1) The amount of FGF-2 bound to FGFR is dominated by HSPG and the coupling
rate constant, and this triad (FGFR-HSPG-FGF-2) is the key to FGF-2 capture;
(2) The amount of FGF-2 bound is proportional to the diﬀusivity of the growth factor
in solution and inversely proportional to the ﬂow rate;
(3) Flow rate and diﬀusivity will aﬀect the FGF-2 outﬂow proﬁle and the distribution
of FGF-2 bound along the cell-lined hollow ﬁber wall;
(4) The majority of FGF-2 binding occurs in the entrance zone of the cell-lined hollow
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ﬁber;
(5) Most FGF-2 eﬀectively bound by FGFR and HSPG will be internalized rather
than dissociated.
The simulation environment can provide additional information and insight into capture of FGF-2 that is not easily accessible from experimental work. The model is
applied to in vitro bioreactor system but it has potential to be used for other growth
factors as well as other cell systems where ﬂow and capture are pivotal such as in
drug and biologicals delivery testing.
4.6

Summary

Circulation is an important delivery method for both natural and synthetic molecules,
but microenvironment interactions, regulated by endothelial cells and critical to the
molecule’s fate, are diﬃcult to interpret using traditional approaches. This research
analyzed and predicted growth factor capture under ﬂow using computer modeling
and a three-dimensional experimental approach that includes pertinent circulation
characteristics such as pulsatile ﬂow, competing binding interactions, and limited
bioavailability. An understanding of the controlling features of this process was desired. The experimental module consisted of a bioreactor with synthetic endotheliallined hollow ﬁbers under ﬂow. The physical design of the system was incorporated
into the model parameters. The heparin-binding growth factor ﬁbroblast growth
factor-2 (FGF-2) was used for both the experiments and simulations. The computational model was composed of three parts: (1) medium ﬂow equations, (2) mass
transport equations and (3) cell surface reaction equations. The model is based on
the ﬂow and reactions within a single hollow ﬁber and was scaled linearly by the total
number of ﬁbers for comparison with experimental results. The model predicted, and
experiments conﬁrmed, that removal of heparan sulfate (HS) from the system would
result in a dramatic loss of binding by heparin-binding proteins, but not by proteins
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that do not bind heparin. The model further predicted a signiﬁcant loss of bound
protein at ﬂow rates only slightly higher than average capillary ﬂow rates, corroborated experimentally, suggesting that the probability of capture in a single pass at
high ﬂow rates is extremely low. Several other key parameters were investigated with
the coupling between receptors and proteoglycans shown to have a critical impact on
successful capture. The combined system oﬀers opportunities to examine circulation
capture in a straightforward quantitative manner that should prove advantageous for
biologicals or drug delivery investigations.

c Changjiang Zhang 2011
Copyright ⃝
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Figure 4.2: Signiﬁcant retention of FGF-2 occurs under ﬂow). (A) FGF-2 (5.0±0.4
ng) was injected into the inlet reservoir, pumped through the cartridge at 0.65±0.01
mL/min (1.3 mm/sec), and measured in the output stream samples from three independent runs on three separate cartridges. The average retention of FGF-2 within
the cell-lined cartridge was 40±0.5of the three runs shown) with a speciﬁc binding
of 9±2.5% (B) FGF-2 ((•) 0.92 ng , (◦) 6.9 ng, (×) 12 ng, and () 18 ng FGF-2)
was injected into the initial reservoir, run through the system at 0.64 mL/min, and
the FGF-2 in the output stream measured using ELISA. Results are from individual
runs with 9 independent cartridges. (C) FGF-2 (ng) retained within the cell-lined
cartridge versus the FGF-2 (ng) injected into the system is shown. The ﬂow rate for
this study varied between 0.60 and 0.67 mL/min (1.2 and 1.34 mm/sec respectively).

79

Figure 4.3: EGF and VEGF are retained under ﬂow. (A) EGF (1.49 ng) was injected
into the input reservoir, pumped through the system at 0.61 mL/min (1.22 mm/sec),
and EGF quantiﬁed in the output ﬂow by ELISA. Data shown are from the same
cartridge either untreated (◦) or enzyme-treated (•). FGF-2 (1.01ng - ×) is shown
for comparison. (B) VEGF was injected into the input reservoir of untreated (0.95ng
- ◦) or heparinase-treated (0.98ng - •) cartridges, run through the system at 0.66
mL/min (1.32 mm/sec), and VEGF quantiﬁed in the output ﬂow by ELISA. Data
are representative of at least three runs quantiﬁed in Table 4.3
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Figure 4.4: Simulations agree well with FGF-2 outﬂow measurements. (A) FGF2(0.92 ng) was injected into the cartridge reservoir and then ﬂowed through the
cell-lined hollow ﬁbers at 0.63 mL/min (1.26 mm/sec), pulsatile ﬂow. FGF-2 collected from the exit ﬂuid (•) is shown. Simulation results based on cells expressing
1 × 104 FGFR/cell and 2.5 × 105 HSPG/cell with 32% loss in the entrance reservoir
having the same FGF-2 amount injected at the same ﬂow rate (◦) are also shown.
(B) Similar outﬂow FGF-2 measurements are shown following FGF-2 (0.92 ng) addition for heparinase-treated (experimental - •) and simulation results with out HSPG
(simulations - ◦). Simulations were run with cells expressing 1 × 104 FGFR/cell and
30% loss in the entrance reservoir.
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Figure 4.5: Simulation and experimental comparison between pulsatile and steady
ﬂow. (A) Simulation results of FGF-2 in the outﬂow as a function of time for pulsatile
(◦) or steady (•) ﬂow, (B) Simulation results of FGF-2 bound along the endotheliallined hollow ﬁber as a function of distance at 44 sec (pulsatile (◦), steady (pink circle)
ﬂow) and at 88 seconds (pulsatile (2), steady (green square) ﬂow) as a function of
time, (C) Experimental comparison of FGF-2 in outﬂow using pulsatile (◦) and steady
(•) ﬂow. Simulations and experiments used 1 ng of FGF-2 at a ﬂow rate of 0.6 mL/min
(1.2 mm/ sec) and pulsatile ﬂow was set at ∼36 strokes/min.

82

Figure 4.6: Simulations show FGF-2 binding and internalization under ﬂow. For the
simulations, FGF-2 (1 ng) was introduced into the reservoir (30% nonspeciﬁc loss)
and sent into the cell-lined hollow ﬁbers under pulsatile ﬂow (0.63 mL/min, 1.26
mm/sec). (A) The sum of all cell surface bound FGF-2 (•) and FGF-2 internalized
(◦) within the celllined hollow ﬁber are shown. (B) and (C) Plot of % FGFR bound
to FGF-2 versus time at the entrance (•), middle (N) and at the exit () cell when
the diﬀusion coeﬃcient is 1.67 × 10−10 (B) or 1.67 × 10−9 m2/s (C). The ﬂuid entering
the system is essentially free of FGF-2 by 150s after ﬂow is initiated.
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Figure 4.7: Simulations predict FGF-2 concentration proﬁle in the cell-lined hollow
ﬁber is impacted by diﬀusion. Grayscale images of FGF-2 concentration within the
cell-lined hollow ﬁber (1 × 104 FGFR/cell and 2.5 × 105 HSPG/cell) at 44s after FGF2 (1 ng) addition from the reservoir (30% nonspeciﬁc loss) at 0.63 mL/min (1.26
mm/sec) with FGF-2 having a diﬀusion coeﬃcient of 1.67 × 10−10 (A) or 1.67 × 10−9
m2/s (B). The scale and numbers on the plots indicates the concentration of FGF-2
in ng/mL.
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Figure 4.8: Simulations show reduced binding with increased ﬂow rate. (A) Simulations for control (•), and HSPG-deﬁcient cells (◦), were run modeling injection
of FGF-2 (1 ng) into the system and run at varied ﬂow rate. 30% non-speciﬁc loss
of FGF-2 in the reservoir was incorporated. (B) Cell-bound+internalized FGF-2 as
a function of injection concentration at 5 min as a function of ﬂow rate is shown.
Simulations performed at 0.63 (•), 1.8 (◦), and 3.0 () mL/min pulsatile ﬂow(1.26,
3.6, and 6 mm/sec, respectively). Each cell on the cell-lined hollow ﬁber expressed
1 × 104 FGFR/cell and 2.5 × 105 HSPG/cell.
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Figure 4.9: Simulations predict binding aﬃnity of FGF-2 for HSPG impacts FGF2 capture more than aﬃnity for FGFR. (A) The aﬃnity of FGF-2 for HSPG was
varied in simulations by changing the association rate constant (•) or the dissociation
rate constant (◦). (B) The aﬃnity of FGF-2 for FGFR was varied by changing
the association rate constant (•) or the dissociation rate constant (◦). The FGF-2
captured within the celllined hollow ﬁber (bound or internalized) at the given KD
value after 5 min. was scaled by that same value from simulations using the base case
KD value (Table 4.1). Arrow indicates base case KD .
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Figure 4.10: Simulations predict cell surface density impacts FGF-2 retention. Simulations were run for FGF-2 (1ng) added to the system (30% non-speciﬁc loss) at 0.63
mL/min pulsatile ﬂow (1.26 mm/sec) for 5 min. (A) Cells expressed either 1 × 104
FGFR/cell and variable densities of HSPG (◦) or 2.5 × 105 HSPG/cell and variable
densities of FGFR (•) on the cell-lined hollow ﬁbers. The amount retained within the
system (bound, internalized, and ﬂuid phase FGF-2) is shown. (B) Cells expressed
1 × 104 FGFR/cell and 2 × 103 (•, ◦), 2 × 104 (, 2), or 2 × 105 (N, △) HSPG/cell on
the cell-lined hollow ﬁbers and simulation results correspond to entrance cell value
at a given time. Filled symbols correspond to % of FGF-2 bound to FGFR which
are simultaneously bound to HSPG and open symbols correspond to the #/cell of
FGF-2 bound to FGFR and HSPG.
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Figure 4.11: Simulations indicate coupling is critical for FGF-2 retention. (A) FGF-2
bound on cell surfaces plus internalized FGF-2 as a function of time for kc values of
0 (◦), 0.0001(•), 0.001(2), and 0.1()(#/cell)−1 min−1 ; (B) and (C) FGF-2 bound
(), internalized (•), bound plus internalized (◦) and exited (2) under ﬂow with
kc = 0.0024 (B) or 0 (C) (#/cell)−1 min−1 following addition of FGF-2 (1ng) at
0.63 mL/min (1.26 mm/sec) pulsatile ﬂow(30% non-speciﬁc loss). Capillaries were
simulated to include 1 × 104 FGFR/cell and 2.5 × 105 HSPG/cell on the cell-lined
hollow ﬁbers. 300s corresponds to the time when essentially all of the FGF-2 has
entered the hollow ﬁber from the reservoir.
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Figure 4.12: Simulations predict both FGFR and HSPG contribute to retention
through FGF-2-mediated coupling. In these simulations, HSPG (2.5×105 #/cell) were
expressed on the cell-lined ﬁbers along the entire chamber while FGFR (1×104 #/cell)
were expressed only in the cells found in the ﬁnal 75% of the hollow ﬁber. FGF-2 (1ng)
was added at time 0 (30% loss in the reservoir) at 0.65 (•), 1.3 (◦), and 2.6 () mL/min
pulsatile ﬂow (1.3, 2.6, and 5.2 mm/sec respectively). Cell-bound+internalized FGF2 after 5 min of simulation time is shown.
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5 Parallel Simulation of Multiple Proteins Through a Bioreactor
Coupled with Biochemical Reactions
5.1

Introduction

This chapter presents a parallel system to handle complex models, in which more
complexities are added into the binding model to mimic complicated binding mechanisms in human blood vessels or capillaries, as presented in Forsten-Williams recent
models [28].
Instead of only one growth factor in the ﬂuid, FGF-2, more growth factors are
allowed to investigate cross regulation of diﬀerent growth factors, such as heparinbinding EGF-like growth factor (HB-EGF), heparin and FGF-2, etc. Instead of occurring on cell surfaces only, competitive bindings now occur in the ﬂuid as well,
adding more complexity for calculating the mass transport equations. Also, the concentrations of diﬀerent growth factors or proteins at the inlet reservoir (see Fig. 3.1)
are complicated due to binding among diﬀerent growth factors compared with only
one growth factor in the basic model (see Chapters 3 and 4). Parallel methods are
appropriate to solve the whole coupled nonlinear system eﬀectively.
5.2

Modeling Process

Fig. 3.1 is the diagram of the hollow ﬁber cartridge system used in the experiments.
Diﬀerent growth factors or ligands are injected into the left sampling port or the inlet
reservoir. The ﬂuid is then pumped into the cartridge and proteins enter into the
20 hollow-ﬁber capillaries, which are coated with endothelial cells on the wall. Fluid
from the capillaries is pooled in the right reservoir or the outlet reservoir and collected
manually in tubes [71, 96, 99].
The geometric model is based on the experimental one (shown in Fig. 3.1) and
illustrated in Fig. 5.1. The ﬂow is pulsatile. To simplify modeling, the following
assumptions are made:
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Figure 5.1: Diagram of single pass simulation geometric modeling.

(1) All of the 20 hollow-ﬁber capillaries have the same dimensions, ﬂow, cell densities, and the endothelial cells are distributed evenly on the wall of the ﬁber capillaries
and tightly packed;
(2) The ﬂuid is incompressible, Newtonian, viscous and isothermal;
(3) The ﬂow is steady, axis-symmetric and laminar and entrance eﬀects are ignored
[35];
(4) The walls of the hollow-ﬁber capillaries are rigid and nonporous.
Supposing the mass transports of diﬀerent growth factors or complexes created to
have the same ﬂow. In other words, they have the same medium ﬂow equations. The
model consists of three coupled parts:
(1) the medium ﬂow equations;
(2) the convection-diﬀusion mass transport equations of growth factors and their
complexes;
(3) the competitive binding kinetics equations on cell surfaces and in the ﬂuid [27,
71, 96].
The modeling is illustrated in Fig. 5.2.
5.2.1

Medium Flow Equations

Since all the proteins (growth factors plus all the intermediate complexes created in
the ﬂuid) are assumed to have the same ﬂow, as investigated in Chapter 3, Eq. 3.12
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Figure 5.2: The modeling diagram of extended binding system.

is still valid and used for calculating the velocity u in the axial direction.
5.2.2

Mass Transport Equations

Due to the same ﬂow, for each protein in the ﬂow, the mass transport equation is the
same as described in Eq. 3.16. Assuming there are m diﬀerent kinds of growth factors
and k diﬀerent kinds of complexes formed among them, the total number of mass
transport equations is S (S = m + k). The mass transport equations are described
as:
1 ∂
∂ϕk
∂
∂ϕk
∂ϕk ∂(uϕk )
+
=
(rKd
)+
(Kd
) + F (ϕk , t, x) (k ∈ 1 ∼ S)
∂t
∂x
r ∂r
∂x
∂x
∂x

(5.1)

The boundary conditions of each protein in the ﬂuid are the same, that is:
(1)

∂ϕk
∂r

= 0 at r = 0, reﬂecting symmetry of the ﬂow along the ﬁber centerline.

(2)

∂ϕk
∂r

= F (ϕk , t, x) at r = R, reﬂecting binding rate of the kth protein on cell

surfaces on the wall of the ﬁber.
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(3) ϕk (t) = ϕk,ent (t) at x = 0, assuming well mixed entrance ﬂow, with uniform
concentration along the ﬁber radius.
The numerical solution of Eq. 5.1 will be performed by the ﬁnite volume method
described in section 3.3.2. Since all proteins in the ﬂuid are assumed to have the same
ﬂow properties, the concentration of each protein can be expressed as the following
set of algebraic equations, that is, each protein has the same scalar coeﬃcients in its
mass transport equations:
AW ϕk,W + AS ϕk,S + AP ϕk,P + AE ϕk,E + AN ϕk,N = bk (k ∈ 1 ∼ S)

(5.2)

The coeﬃcients in Eq. 5.2 consist of a pentadiagonal matrix [19, 71, 96] and can be
expressed as (refer to section 3.3.2):
δxi rn
rN − rP
δxi rs
AS = −D
rP − rS
AN = −D

δrj rP
xE − xP
δrj rP
AW = − max((ρu)w δrj , 0) − D
xP − xW
3ρrP δxi δrj
AP =
− (AW + AS + AE + AN )
2δt
AE = min((ρu)e δrj , 0) − D

bk = ((Sk,c + Sk,P )rP δxi δrj + (

2ρϕnk,P ρϕn−1
k,P
c
u
c
u
−
)rP δxi δrj ) − λ(Fk,e
− Fk,e
− Fk,w
+ Fk,w
)
δt
2δt

Considering a rectangular 2D space (see Fig. 5.1) with I and J grid points in the
axial and the radius directions, respectively, Eq. (5.2) can also be expressed as:
AW ϕk,i,j−J + AS ϕk,i,j−1 + AP ϕk,i,j + AN ϕk,i,j+1 + AE ϕk,i,j+J = bk (k ∈ 1 ∼ S) (5.3)
where, k is the kth protein in the ﬂow, j := 1, 2, ..., IJ, and IJ := I × J = 1500 × 24,
AW , AS , AP , AN , AE , bk are scalars. It can be expressed in a matrix form and shown
in Fig. 5.3, where ϕk is represented by xk .
For the solution of this nonsymmetric sparse matrix linear system, the commonly
used methods are: relaxation methods, Alternating Direction Implicit (ADI) methods,
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Figure 5.3: Matrix system to be solved for mass transport equations.

BiConjugate Gradient Stabilized (BiCGStab) methods, and Stone’s SIP methods, etc.
Compared to the above-mentioned methods, the advantages of SIP methods are: (1)
fewer number of iterations for required accuracy; and (2) lower computational cost for
each time step. The SIP’s higher convergence rate is attributed to its more strongly
implicit nature against ADI methods [80], which in turn are more strongly implicit
methods than the SOR method and the point-Jacobi method. Therefore, the SIP
methods are used extensively in computational ﬂuid dynamics.
The coeﬃcients of the matrix are time dependent, and thus the corresponding
linear system must be solved separately for each time step. It is time consuming
so that parallel methods are of great importance, especially when more proteins are
involved. In order to solve those equations eﬃciently, a high performance parallel
algorithm has been designed and implemented, including parallel discretization and
a parallel SIP solver [19, 60, 80].
5.2.3

Binding Kinetics Equations

Similar to the basic model described in the previous chapters (Chapters 3 and 4),
the complex model also involves a series of molecular activities, including proteins
binding to their receptors to form some intermediate complexes and dimers on cell
surfaces, and competitive binding among proteins to form some complexes in the
ﬂuid as well. Forsten-Williams 2008 models (the non-receptor coupling model and
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Table 5.1: Model reactions on cell surfaces.
HB-EGF
H
SR
→ RH
SPH → PH
SPC → P C
RH + H ↔ CH
PH + H ↔ GH
CH + CH ↔ C2H
C2H + PH ↔ XH
RH + GH ↔ TH
RH + PH ↔ TH
TH + TH ↔ T2H
XH + PH ↔ T2H
P C + H ↔ GC
H
C
PH
+ H ↔ GC
H
C
C
+ CH ↔ TH
PH
C
C
GH + RH ↔ TH
C
C
C2H + PH ↔ XH
C
C
C
TH + TH ↔ T2H
C
C
TH
+ TH ↔ THH
C
C
C
XH + PH ↔ T2H
C
C
XH + PH ↔ THH

FGF-2
F
SR
→ RF
SPF → PF
same common sites HSPG
RF + F ↔ CF
PF + F ↔ GF
CF + CF ↔ C2F
C2F + PF ↔ XF
RF + GF ↔ TF
RF + PF ↔ TF
TF + TF ↔ T2F
XF + PF ↔ T2F
P C + F ↔ GC
F
PFC + F ↔ GC
F
PFC + CF ↔ TFC
C
GC
F + RF ↔ TF
C
C2F + PF ↔ XFC
C
TFC + TFC ↔ T2F
C
C
TF + TF ↔ TF F
C
TFC + PFC ↔ T2F
C
C
TF + PF ↔ TF F

EGF
RH + E ↔ CE
CE + CE ↔ C2E
No HSPG binding

The ﬁrst part is the non-receptor-coupling model. Adding second part to the
ﬁrst one becomes the receptor-coupling model. h=heparin, F =FGF-2, H=HBEGF, E=EGF, S=synthesis, R=receptors, C=ligand-receptor complexes, P =HSPG,
T =ligand-receptor-HSPG complexes, C2 =dimers of C, X = C2 bound to P , T2 =
dimers of T . Unique receptors, proteoglycans and their ligand complexes are distinguished with a subscript H or F . The common site HSPG and their resulting
complexes are designated with a subscript C.
the receptor coupling model) [28] were adopted as the simulation target, in which
at most four proteins, such as FGF-2, HB-EGF, EGF, and heparin, can be injected
into the system or any combination of them can be injected at the inlet reservoir
simultaneously.
The model reactions on cell surfaces are listed in Table 5.1, and the model reactions
in the ﬂuid are listed in Table 5.2.
There are at most ﬁve equations in the ﬂuid listed in Table 5.3. The non-receptor
coupling model involves twenty four equations on cell surfaces listed in Table 5.4, and
the receptor-coupling model involves thirty-two equations on cell surfaces listed in
Table 5.5. The parameters used in simulation are listed in Table 5.6.
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Table 5.2: Model reactions in the ﬂuid.
HB-EGF
h + H ↔ ChH

FGF-2
h + F ↔ ChF

heparin
h + F ↔ ChF
h + H ↔ ChH

EGF
E
no binding

h=heparin, F =FGF-2, H=HB-EGF, E=EGF
Table 5.3: Binding equations in the ﬂuid.
1
2
3
4
5

dF
hF
hF
dt = −ka hF + kd ChF
dh
hF
hF
dt = −ka hF + kd ChF −
dChF
hF
hF
dt = ka hF − kd ChF
dH
hH
hH
dt = −ka hH + kd ChH
dChH
hH
= ka hH − kdhH ChH
dt

kahH hH + kdhH ChH

Table 5.4: Binding equations on cell surfaces in the non-receptor-coupling model.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24

dRF
F
F RF
F RF + kdF RF CF − kc GF RF + kuc TF − kint RF
dt = SR − ka
dCF
F RF
F RF − kdF RF CF − kc (CF CF + PF CF ) + kuc (2C2H + TF ) − kint CF
dt = ka
dC2F
dt = kc (0.5CF CF − C2F PF ) + kuc (XF − C2F ) − kintD C2F
dTF
dt = kc (RF GF + PF CF − TF TF ) + 2kuc (T2F − TF ) − kintD TF
dT2F
dt = kc (0.5TF TF + XF PF ) − 2kuc T2F − kintD T2F
dPF
F
F PF
F PF + kdF PF GF − kc (CF PF + C2F PF + XF PF )
dt = SP − ka
+kuc (TF + XF + T2F ) − kint PF
dGF
=
kaF PF F PF − kdF PF GF − kc RF GF + kuc TF − kint GF
dt
dXF
dt = kc (C2F PF − PF XF ) + kuc (T2F − XF ) − kintD XF
C
C
dF
F RF
F RF + kdF RF CF − kaF PF F PF + kdF PF GF − kaF P F P C + kdF P GC
F )/(Na V )
dt = (−ka
dP C
C
FPC
C
FPC C
HP C
C
HP C C
=
S
−
k
F
P
+
k
G
−
k
HP
+
k
G
a
a
P
F
H
d
d
dt
dGC
FPC
C
FPC C
F
=
k
F
P
−
k
G
a
F
d
dt
dE
ERH
ERH + kdERH CE )/(Na V )
dt = (−ka
dRH
H
HRH
HRH + kdHRH CH − kaERH ERH + kdERH CE − kc GH RH + kuc TH − kint RH
dt = SR − ka
dCE
ERH
ERH − kdERH CE − kc CE CE + 2kuc C2E − kint CE
dt = ka
dC2E
dt = 0.5kc CE CE − kuc C2E − kintD C2E
C
C
dH
HRH
HRH + kdHRH CH − kaHPH HPH + kdHPH GH − kaHP HP C + kdHP GC
H )/(Na V )
dt = (−ka
HRH
dCH
HRH
=
k
HR
−
k
C
−
k
(C
C
+
C
P
)
+
k
(2C
+
T
)
−
k
C
H
H
c
H
H
H
H
uc
2H
H
int
H
a
d
dt
dC2H
dt = kc (0.5CH CH − C2H PH ) + kuc (XH − C2H ) − kintD C2H
dGH
HPH
HPH − kdHPH GH − kc RH GH + kuc TH − kint GH
dt = ka
dTH
dt = kc (RH GH + PH CH − TH TH ) + 2kuc (T2h − TH ) − kintD TH
dT2H
dt = kc (0.5TH TH + PH XH ) − 2kuc T2H − kintD T2H
dXH
dt = kc (C2H PH − PH XH ) + kuc (T2H − XH ) − kintD XH
C
dGC
HP C
H
HP C − kdHP GC
H
dt = ka
dPH
H
HPH
HPH + kdHPH GH − kc (CH PH + C2H PH + XH PH )
dt = SP − ka

+kuc (TH + XH + T2H ) − kint PH
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Table 5.5: Binding equations on cell surfaces in the receptor-coupling model.
1
2
3
4
5
6
7
8
9
10

11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32

dRF
F
F RF
C
F RF + kdF RF CF − kc (GF RF + GC
F RF ) + kuc (TF + TF ) − kint RF
dt = SR − ka
F
R
dCF
F RF
F RF − kd F CF − kc (CF CF + PF CF + CF P C ) + kuc (2C2H + TF + TFC ) − kint CF
dt = ka
dC2F
C
C
dt = kc (0.5CF CF − C2F PF − C2F P ) + kuc (XF − C2F + XF ) − kintD C2F
dTF
C
C
dt = kc (RF GF + PF CF − TF TF − TF TF ) + 2kuc (T2F − TF + TF F ) − kintD TF
dT2F
dt = kc (0.5TF TF + XF PF ) − 2kuc T2F − kintD T2F
dPF
F
F PF
F PF + kdF PF GF − kc (CF PF + C2F PF + XF PF + XFC PF )
dt = SP − ka
+kuc (TF + XF + T2F + TFCF ) − kint PF
dGF
F PF
F PF − kdF PF GF − kc RF GF + kuc TF − kint GF
dt = ka
dXF
C
C
dt = kc (C2F PF − PF XF − P XF ) + kuc (T2F − XF + TF F ) − kintD XF
C
F
R
F
P
dF
F RF
F RF + kd F CF − kaF PF F PF + kd F GF − kaF PC F P C + kdF P GC
F )/(Na V )
dt = (−ka
C
C
C
C
C
dP
C
FP
C
FP
C
HP
C
HP
C
F P + kd GF − ka
HP + kd
GH
dt = SP − ka
C C
−kc (CF P C + C2F P C + XF P C + XFC P C + CH P C + C2H P C + XH P C + XH
P )
C
C
C
C
C
C
C
C
C
kuc (TF + T2F + TF F + XF + TH + T2H + THH + XH ) − kint P
C
dGC
C
C
C
FPC
F
F P C − kdF P GC
F − kc GF RF + kuc TF − kint GF
dt = ka
ERH
dE
ERH
ERH + kd
CE )/(Na V )
dt = (−ka
HRH
dRH
H
HRH
=
S
−
k
HR
+
k
CH − kaERH ERH + kdERH CE
H
a
R
d
dt
C
−kc (GH RH + GC
H RH ) + kuc (TH + TH ) − kint RH
ERH
dCE
ERH
ERH − kd
CE − kc CE CE + 2kuc C2E − kint CE
dt = ka
dC2E
=
0.5k
C
C
−
k
C
c
E
E
uc
2E − kintD C2E
dt
C
C
HRH
dH
HRH
=
(−k
HR
+
k
CH − kaHPH HPH + kdHPH GH − kaHP HP C + kdHP GC
H
a
H )/(Na V )
d
dt
HRH
dCH
C
HRH
HRH − kd
CH − kc (CH CH + CH PH + CH P )
dt = ka
C
+kuc (2C2H + TH + TH
) − kint CH
dC2H
C
C
=
k
(0.5C
C
−
C
P
c
H
H
2H
H − C2H P ) + kuc (XH − C2H + XH ) − kintD C2H
dt
HPH
dGH
HPH
HPH − kd
GH − kc RH GH + kuc TH − kint GH
dt = ka
dTH
C
C
dt = kc (RH GH + PH CH − TH TH − TH TH ) + 2kuc (T2h − TH + THH ) − kintD TH
dT2H
dt = kc (0.5TH TH + PH XH ) − 2kuc T2H − kintD T2H
dXH
C
C
dt = kc (C2H PH − PH XH − P XH ) + kuc (T2H − XH + THH ) − kintD XH
C
C
C
dGH
HP
C
C
C
HP C − kdHP GC
H − kc GH RH + kuc TH − kint GH
dt = ka
HPH
dPH
H
HPH
C
HPH + kd
GH − kc (CH PH + C2H PH + XH PH + XH
PH )
dt = SP − ka
C
+kuc (TH + XH + T2H + THH ) − kint PH
C
dTH
C
C
C C
C
C
C
C
C
dt = kc (GH RH + P CH − TH TH − TH TH ) + kuc (2T2H + THH − 2TH ) − kint TH
C
T2H
C C
C C
C
C
dt = kc (0.5TH TH + XH P ) − 2kuc T2H − kintD T2H
C
THH
C
C
C
C
C
dt = kc (TH TH + XH PH + XH P ) − 3kuc THH − kintD THH
C
XH
C
C
C C
C
C
C
C
dt = kc (C2H P − XH PH − XH P ) + kuc (THH + T2H − XH ) − kintD XH
dTFC
C
C
C C
C
C
C
C
C
dt = kc (GF RF + P CF − TF TF − TF TF ) + kuc (2T2F + TF F − 2TF ) − kint TF
C
T2F
C C
C C
C
C
dt = kc (0.5TF TF + XF P ) − 2kuc T2F − kintD T2F
TFCF
C
C
C
C
C
dt = kc (TF TF + XF PF + XF P ) − 3kuc TF F − kintD TF F
C
XF
C
C
C C
C
C
C
C
dt = kc (C2F P − XF PF − XF P ) + kuc (TF F + T2F − XF ) − kintD XF
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Table 5.6: Parameter values used in simulation.
Para.
kaF RF
kdF RF
kaF PF
kdF PF
C
kaF P
C
kdF P
kc
kuc
kint
kintD
kaHRH
kdHRH
kaHPH
kdHPH
C
kaHP
C
kdHP
ERH
ka
kdERH
kahF
kdhF
kahH
kdhH
RF 0
RH0
PF 0
PH0
P0C
Kd
µ
ρ

Value
3.24 × 108 M −1 /min
0.281min−1
1.19 × 108 M −1 /min
0.556min−1
7.35 × 106 M −1 /min
0.398min−1
0.0024(#/cell)−1 /min
0.6min−1
0.005min−1
0.078min−1
9.7 × 107 M −1 /min
0.6887min−1
1.45 × 107 M −1 /min
0.398min−1
2.01 × 106 M −1 /min
0.398min−1
9.7 × 107 M −1 /min
0.24min−1
4.2 × 105 M −1 /min
0.01min−1
4.2 × 105 M −1 /min
0.01min−1
104 #/cell
104 #/cell
17600#/cell
4200#/cell
232400#/cell
1.67 × 10−10 m2 /s
0.00094P a · s
1000kg/m3

Meaning
ARC for F & RF
DRC for F & RF
ARC for F & PF
DRC for F & PF
ARC for F & P C
DRC for F & P C
coupling rate const
uncoupling rate const
IRC for complexes
IRC for dimers
ARC for H & RH
DRC for H & RH
ARC for H & PH
DRC for H & PH
ARC for H & P C
DRC for H & P C
ARC for E & RH
DRC for E & RH
ARC for h & F
DRC for h & F
ARC for h & H
DRC for h & H
initial RF density
initial RH density
initial PF density
initial PH density
initial P C density
F diﬀusivity at 25◦ C
viscosity of ﬂuid
density of ﬂuid

ARC = association rate constant, DRC = dissociation rate constant, IRC = internalization rate constant, h = heparin, F = FGF-2, H = HB-EGF, E = EGF, RF
= FGFR, RH = EGFR, PF = unique FGF-2 binding HSPG, PH = unique HB-EGF
binding HSPG, P C = common HB-EGF and FGF-2 binding HSPG, rate constants
are scaled to 25◦ C.
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Figure 5.4: Column-wise stripping for processors domain partition. (◦) and (•) points
are boundary points between processors. P0 has no (•) points and PN −1 has no (◦)
points.

5.3

Parallel Design and Implementation

5.3.1

Parallel Discretization

After discretization, a set of algebraic equations are obtained, as shown in Eq. 5.3.
In the whole domain (see Fig. 5.1), the coeﬃcients of Eq. 5.3 should be recalculated
or updated at each time step.
This research takes the advantage of the mesh shape (1500 × 24), that is, the
number of rows is much less than that of columns, to allocate the processors using
column-wise stripping as shown in Fig. 5.4 to keep the total communication costs
low and the load balanced among processors compared to other domain decomposition techniques, such as block checker-board processor partitions, where both row
and column boundary data need to be exchanged between processors and also some
processors do not have cell surfaces binding due to its position only on the north
boundary or the wall of ﬁbers.
In the above partition, each processor has no boundary rows and just has two
boundary columns, the ﬁrst and the last columns, except the left most and the right
most processors P0 and PN −1 (assuming N processors). Thus, each processor needs
two boundary columns of data from the left and the right neighboring processors,
except P0 and PN −1 .
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AN , AS , and AE are not related to the grids on neighboring processors, and can
be computed concurrently among processors.
c
u
c
u
AW , AP and the second part of source term bk or bk (2) = λ(Fk,e
−Fk,e
−Fk,w
+Fk,w
)

are related to boundary points and need special treatments. First, AW and bk (2) are
computed in each processor concurrently, then, AW at (◦) points of Pi are replaced
with the AW values of Pi−1 , and bk (2) at (◦) points in Pi−1 are added to that of Pi .
Once AW and bk (2) are obtained by each processor, AP and source term bk can be
computed in each processor simultaneously. The parallel algorithm is shown in the
following algorithm.
Algorithm 9 Parallel discretization of mass transport equations
Compute AN and AS in each processor in its subdomain simultaneously.
Compute AE , AW and bk (2) in each processor in its subdomain concurrently.
Exchange boundary data as follows:
Pi−1 sends AW at (◦) points to Pi as the new AW values.
Pi−1 sends bk (2) at(◦)points to Pi ,adding to Pi values.
Compute AP and bk in each processor in its subdomain concurrently.

5.3.2

Parallel SIP solver

Stone’s strongly implicit procedure (SIP) algorithm has three parts: (a) LU factorization; (b) forward substitution; (c) backward substitution. The sequential SIP
algorithm (refer to 6.2) is illustrated as follows.
For a sparse matrix linear system Ax = b with a pentadiagonal nonzero coeﬃcient
matrix A, shown in Fig. 5.3, Stone proposed an incomplete LU factorization method
[80], that is A + E = LU . E is an error matrix. L and U are lower and upper triangle
matrix, respectively, as shown in Fig. 5.5.
The coeﬃcient matrix A is augmented by an error matrix E, which has two
diagonals lying inside and adjacent to the outer diagonals of A (see Fig. 5.5). Stone’s
SIP algorithm is designed so that terms in Ex are very small [80]. An iteration
parameter α (0 ≤ α < 1) is used to calculate L and U . The parameter α may be a
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Figure 5.5: LU factorization of A+E.

function of the mesh. For simplicity, α is treated as a constant parameter, i.e., users
can set its value before simulation. In Algorithm 10, ϵ is the convergence criteria, r is
Algorithm 10 Stone’s SIP(A, L, U , b, ϵ, maxloop)
1: LU factorization:
for i=1 to I, j=1 to J, do
LW [i, j] = AW [i, j]/(1 + αUN [i, j − J])
LS [i, j] = AS [i, j]/(1 + αUE [i, j − 1])
P 1 = αLW [i, j]UN [i, j − J]
P 2 = αLS [i, j]UE [i, j − 1]
LP [i, j] = AP [i, j] + P 1 + P 2 − LW [i, j]UE [i, j − J] − LS [i, j]UN [i, j − 1]
UN [i, j] = (AN [i, j] − P 1)/LP [i, j]
UE [i, j] = (AE [i, j] − P 2)/LP [i, j]
2: initialization: k = 1
3: while ∥r∥2 > ϵ∥InitialResidual∥2 and k < maxloop do
4:
forward substitution:
for i=1 to I, j=1 to J, do
r[i, j] = b[i, j] − (AS [i, j]x[i, j − 1] + AW [i, j]x[i, j − J] + AP [i, j]x[i, j] +
AE [i, j]x[i, j + J] + AN [i, j]x[i, j + 1])
Y [i, j] = (r[i, j] − LS [i, j]Y [i, j − 1] − LW [i, j]Y [i, j − J])/LP [i, j]
5:
backward substitution:
for i=I to 1, j=J to 1, do
δ[i, j] = Y [i, j] − UN [i, j]δ[i, j + 1] − UE [i, j]δ[i, j + J]
6:
update solution:
x[i, j] = x[i, j] + δ[i, j]
7:
k =k+1
8: end while
the residual, maxloop is the maximum number of iterations, and δ is the correction.
The same array is used for r, Y and δ to save memory cost.
Based on the domain partition scheme (refer to Fig. 5.4), there is a boundary dependency between processors in LU factorization and forward substitution, as shown
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Figure 5.6: Boundary dependency between processors in factorization and forward
substitution.

in Fig. 5.6. Only after the left processor ﬁnishes calculating the boundary points and
sends them to the right processor, the right one can start to compute. This process
continues up to the last processor [60, 80]. Backward substitution has similar fashion
but in the reverse order. Basically, by using the pipeline technique, it is trivial to
implement a naive parallel Stone’s SIP solver. Reeve et al. proposed a parallel SIP
algorithm, in which a red-black approach for forward and backward substitutions is
presented [60]. This study proposed an overlapped Jacobi iteration method. Instead
of using the red-black approach for forward and backward substitutions, let each processor do forward and backward substitutions concurrently in each iteration and use
previous boundary values of neighboring processors. After each iteration, boundary
data are exchanged among processors. In forward substitution, only (◦) points of
Y(i,j) are transferred, while in backward substitution, only (•) points of Y(i,j) are
transferred (see Fig. 5.4 and Algorithm 10). The Y (i, j) can also be used for δ(i, j)
to save memory cost.
After forward and backward substitutions, the boundary points of current solution
should be exchanged among processors. If the relative error is still larger than the preset stopping criteria in the inner loop, it will loop until reaching the preset maximum
number of loops or the relative error is less than the preset stopping criteria.
The overall speedup is measured for forward and backward substitutions using
two techniques, respectively. The results are shown in Fig. 5.7. It is found that the
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Figure 5.7: Speedup factors using the overlapped Jacobi iteration and pipeline techniques. The results are based on simulation of FGF-2 alone moving through the
bioreactor for 300 seconds in single pass simulation, non-receptor-coupling model,
and the software is running on the DLX high performance cluster at the University
of Kentucky.

overlapped Jacobi iteration method has better speedup than the pipeline technique.
The overlapped Jacobi iteration may need more iterations than the pipeline does,
but actually is much faster due to simultaneous computation among processors. The
overlapped Jacobi iteration method could be applied to speed up similar pipeline
methods and save computational costs signiﬁcantly (refer to Chapter 6 for details).
The computational cost depends mainly on the number of growth factors involved
and the expected temporal goal to be simulated. It also depends on the time step
used for simulation. If more growth factors are involved in the ﬂuid, and the binding
is studied for several hours, this parallel algorithm can be used to shorten the overall
simulation time by more than sixty percent if four processors are used. Due to heavy
boundary data exchanges among processors in each time step, simulations with more
than eight processors do not yield better performance in the current DLX cluster
settings at the University of Kentucky, as shown in Fig. 5.8.
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Figure 5.8: Speedup factors comparison between the overlapped Jacobi iteration and
pipeline techniques, and ideal linear. The results are based on the same simulation
settings shown in Figure 5.7.

5.3.3

Parallel Algorithm

Since the whole system is composed of a series of coupled nonlinear PDEs and ODEs,
the order of calculation of those equations is important. First, ODEs in the ﬂuid
(equations shown in Table 5.3) are calculated by the CVODE to update the concentrations in each grid. Second, binding ODEs on cell surfaces (equations shown in
Table 5.4 or Table 5.5) are calculated , and the solution in each grid on north boundary is used as the boundary condition for mass transport equations of each protein
in the ﬂuid. At this point, mass transport equations of each protein in the ﬂuid are
calculated to get the new concentration of each protein in each grid. A sequential
CVODE solver combined with a parallel scheme obtains an eﬃcient solution for mass
transport equations in the whole domain. The parallel algorithm for the whole system
is illustrated in Algorithm 11.
In the while loop, the ﬂow velocity equations are calculated ﬁrst, then the binding
ODEs in the ﬂuid are calculated followed by the calculation of binding ODEs on cell
surfaces. Actually, the sequence of calculation of the above three kinds of equations
is not critical, and they can be calculated in any order without noticeable diﬀerences.
After the solutions of the above equations are obtained, the mass transport equations
of diﬀerent proteins in the ﬂuid are solved iteratively in parallel. A for loop is used
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Algorithm 11 Parallel algorithm of the simulation system
1: Initialization
2: t = 0
3: while t < tend do
4:
Each processor computes velocity u in its subdomain
Each processor solves binding ODEs in ﬂuid in its subdomain
5:
6:
Each procesor solves binding ODEs on cell surfaces in its subdomain
7:
for (i = 1 to W)
8:
Solve Mi (mass transport PDEs) for each protein in parallel
Perform parallel discretization of mass transport PDEs
9:
10:
Update boundary conditions in subdomain concurrently
11:
Call parallel Stone’s SIP solver
12:
Exchange boundary mass transport data among processors
13:
Each processor does calculations for outputting binding information in its subdomain if user needs
14:
All reduce those binding information to P0 for output
15:
P0 saves those output data for analysis and visualization
16:
P0 recalculates the concentration of each protein at entrance
17:
t = t + ∆t
18: end while
to calculate mass transport equations of each protein in the ﬂuid one after another.
For each one, ﬁrst perform discretization of mass transport equations; second, update boundary conditions; third, call parallel Stone’s SIP solver; and last, exchange
boundary data among processors. All these four steps are performed in subdomain
by each processor in parallel. Once the mass transport equations of all proteins in the
ﬂuid are solved, each processor only has solutions in its subdomain. At this point, if
needed, the binding information can be calculated by each processor and all reduced
to P0 , and P0 saves the data for analysis and visualization. Then, P0 recalculates the
concentration of each protein at the inlet reservoir. In the end, it moves forward one
time step and loops again until reaching the target simulation time.
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5.3.4

Time Analysis

If a sequential algorithm is used, the total simulation time can be expressed in the
following formula:
∑
∑
T1 = Tinit1 +
(Tv + Tb + Tm + To1 + To2 ) ≈
(Tv + Tb + Tm + To1 + To2 ) (5.4)
For the parallel algorithm, the total simulation time can be expressed as following:
∑
∑
Tp = Tinit2 + (Tv +(Tb +Tm +To1 )/p+To2 +Tc ) ≈
(Tv +(Tb +Tm +To1 )/p+To2 +Tc )
(5.5)
where, Tinit1 and Tinit2 are the initialization time for sequential and parallel algorithms, respectively, Tv is the time for calculating velocities of the ﬂuid, Tb is the time
for solving binding ODEs on cell surfaces and in the ﬂuid, Tm is the time for solving
mass transport PDEs in the ﬂuid, To1 is the time for calculating output data by each
processors, To2 is the time for saving output data for analysis and visualization by
P0 , Tc is the time for inter communications between processors, and p is the number
of processors used.
Therefore, the speedup of parallel algorithm is expressed as:
∑
∑
Sp = T1 /Tp ≈
(Tv +Tb +Tm +To1 +To2 )/
(Tv +(Tb +Tm +To1 )/p+To2 +Tc ) (5.6)
Normally, the simulation time is in minutes or hours, therefore, Tv ,To1 ,and To2 are
very small compared to Tb and Tm . Speedup can be further simpliﬁed as:
∑
∑
Sp ≈
(Tb + Tm )/
((Tb + Tm )/p + Tc )

(5.7)

Tc is a dominant factor for the optimization of speedup.
5.4
5.4.1

Some Implementation Details
The Concentration of Proteins at Entrance

Supposing that diﬀerent proteins are injected into the inlet reservoir at the same time
and bioreactions are known among these proteins, the concentrations of proteins in
the ﬂuid can be calculated in two steps as follows:
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Calculate Concentrations of Proteins by Solving Binding Kinetics ODEs
Method: suppose two proteins p1 and p2 are injected into the inlet reservoir at the
same time with the amount of m1 and m2 , respectively. p1 and p2 will form complex
p3 with association rate constant ka . Meanwhile, p3 will dissociate into p1 and p2
with dissociation rate constant kd . Let ϕ1 (t), ϕ2 (t), ϕ3 (t) be the concentration of p1 ,
p2 , and p3 in the reservoir at time t, respectively. They can be calculated by the
following ODEs:
dϕ1 (t)
= −ka ϕ1 (t)ϕ2 (t) + kd ϕ3 (t)
dt

(5.8)

dϕ2 (t)
= −ka ϕ1 (t)ϕ2 (t) + kd ϕ3 (t)
dt

(5.9)

dϕ3 (t)
= ka ϕ1 (t)ϕ2 (t) − kd ϕ3 (t)
dt

(5.10)

with the initial values of ϕ1 (0) = m1 /v, ϕ2 (0) = m2 /v, ϕ3 (0) = 0, and v is the
volume of the inlet reservoir.
If more than two proteins are injected with diﬀerent binding kinetics, the method
is similar. The diﬀerence is the above ODEs.
Adjust the Concentration of Each Protein
The concentration of each protein needs to be adjusted due to the ﬂuid ﬂowing in
and out of the inlet reservoir at each time step. The following formula is used:
ϕi (n) = ϕi (n − 1) ×

v − ∆vn
v

(5.11)

where, v is the volume of the inlet reservoir, ∆vn is the volume of the ﬂuid ﬂowing
into the ﬁbers at the nth time step, ϕi (n − 1) is the previous concentration, and ϕi (n)
is the current concentration of the ith protein (growth factor or complex) in the inlet
reservoir.
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5.4.2

The Mass of Proteins Bound

Protein (growth factor or complex) binding could occur on cell surfaces or in the ﬂuid.
Thus the amount of the ith protein bound in the nth time step Mi (n) includes three
parts: (1) bound on cell surfaces; (2) bound in the ﬂuid; (3) internalized, as shown
in the following formula:
Mi (n) = Mif luid (n) + Misurf ace (n) + Miint (n)

(5.12)

Based on a deterministic approach and the uniform mesh, the number of molecules
of the ith protein bound in the nth time step Fi (n) could be determined by the
formulas, accordingly:
Fi (n) = Fiint (n) + Fisurf ace (n) + Fif luid (n)
Fif luid (n)

= Nf Kgf

M
N ∑
∑

(5.13)

Ci,j (k, l, n)

(5.14)

k=1 l=1

Fisurf ace (n)

N ∑
∑
∑
(
Ci,j (k, M, n) + 2
Gi,j (k, M, n))
= Nf Kgf

(5.15)

k=1

Fiint (n) = Fiint (n − 1) + Nf Kgf dt

N
∑

(kint

∑

Ci,j (k, M, n) + 2kintD

∑

Gi,j (k, M, n))

k=1

(5.16)
where, Ci,j (k, M, n) is the number of complexes of the ith growth factor binding to
the jth receptor in the (k, M )th grid (on cell surfaces), at the nth time step, if the
binding exists, and Gi,j (k, M, n) is the number of dimer of the ith protein binding
to the jth receptor in the (k, M )th grid (on cell surfaces), at the nth time step.
Ci,j (k, l, n) is the number of complexes of the ith protein binding to the jth protein
in the (k, l)th grid (in the ﬂuid), at the nth time step, if the binding exists, M and
N are the number of grids in the radius and the axial directions, respectively, kint
is the internalization rate constant of complexes and kintD is the internalization rate
constant of dimers, Nf is the number of ﬁbers in the cartridge, dt is the time step,
and Kgf is the grid factor.
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Figure 5.9: Plot with varied heparin impact on FGF-2 cell surface capture. (1ng
FGF-2, at 600 seconds, 30% loss at inlet, non-receptor-coupling and receptor-coupling
models [28]).

The mass of the ith proteins bound can be calculated by multiplying a constant
Ki if its molecular weight is known [96], that is:
Mi (n) = Ki × Fi (n)
5.5

(5.17)

Simulations

The purpose of these simulations is to predict whether competitors for proteoglycans
impact FGF-2 binding in a solution based on both models (non-receptor-coupling
and receptor-coupling models) (see section 5.2.3). The study will look at: (1) soluble
traps, such as heparin; (2) surface competitors, such as HB-EGF; (3) multi-pass
simulations. The conclusions are drawn from the simulation results, which need
further experimental veriﬁcations.
5.5.1

Eﬀect of Heparin on FGF-2 Capture

Heparin will bind to FGF-2 directly in the ﬂuid, limiting the available amount of FGF2 binding to its receptors on cell surfaces. Fig. 5.9 shows heparin impact on FGF-2
capture under diﬀerent amounts of heparin. Fig. 5.10 shows FGF-2 captured along
the endothelial-lined hollow ﬁber as a function of distance under diﬀerent amounts of
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Figure 5.10: Simulation results of FGF-2 captured along the endothelial-lined hollow
ﬁber as a function of distance under diﬀerent amount of heparin. (1ng FGF-2, at 600
seconds, 30% loss at inlet, non-receptor-coupling model [28]).

heparin at 600 seconds. In Fig. 5.9 and Fig. 5.10, it has been found that heparin (or
possibly other solution binding agents) can prevent FGF-2 capture under ﬂow, but it
occurs only at high concentrations (> 100ug).
5.5.2

Eﬀect of HB-EGF on FGF-2 Capture

FGF-2 and HB-EGF can cross regulate receptor binding of the other despite having
unique receptors [28]. Is this conclusion still correct in the ﬂow condition? Also,
the research wants to ﬁnd out how large the impact would be? In Fig. 5.11, the
amount of FGF-2 are captured under diﬀerent amounts of HB-EGF, supposing FGF2 and HB-EGF are injected simultaneously. Fig.5.12 shows FGF-2 captured along
the endothelial-lined hollow ﬁber as a function of distance under diﬀerent amounts of
HB-EGF at 600 seconds. It is shown that the addition of HB-EGF has only a slight
eﬀect on FGF-2 capture and it occurs when HB-EGF is at high concentrations.
5.5.3

HB-EGF Has Only a Minor Impact on Heparin Regulation of FGF2 Binding

Fig. 5.13 shows that the addition of HB-EGF has only a minor impact on heparin
regulation of FGF-2 binding.
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Figure 5.11: Plot with varied HB-EGF impact on FGF-2 cell surface capture. (1ng
FGF-2, at 600 seconds, 30% loss at inlet, non-receptor-coupling and receptor-coupling
models [28]).

The research concludes that HB-EGF or other proteoglycan-competitors has very
little eﬀect on FGF-2 capture under a single pass ﬂow.
5.5.4

Multi-pass Simulation

The human blood system is constantly in circulation, which means that when injecting
some drugs into human blood vessels, some of them may bind somewhere in each
circulation, leaving the remaining part to circulate. It is very hard to do experiments
to study a mechanism of this kind. However, by using computer simulation, it is fairly
easy to implement diﬀerent strategies to simulate this situation, called a multi-pass
simulation.
The multi-pass simulation is designed as follows:
Step 1: In the ﬁrst few minutes, before all the injected growth factor enters the
entrance port of ﬁbers, the single pass simulation is used, but the growth factor
moving out of the ﬁbers at the outlet is saved in a FIFO queue in each time step.
Step 2: Once all the growth factor has entered the ﬁbers, lets say after 10 minutes,
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Figure 5.12: Simulation results of FGF-2 captured along the endothelial-lined hollow
ﬁber as a function of distance under diﬀerent amount of HB-EGF. (1ng FGF-2, at
600 seconds, 30% loss at inlet, non-receptor-coupling model [28]).

the growth factor will be dequeued and enters into the ﬁbers again in each time step.
There is no mixing. In the meantime, the growth factor moving out of the ﬁbers at
the outlet is queued.
The process is illustrated in Fig. 5.14.
The concentration of a growth factor at the inlet reservoir after switching to queue
is:
qinlet (t + i) = qi

(5.18)

where, t is the time when all the initial injected growth factor has entered the ﬁbers
and it is a parameter for user to set up before simulation, and i is the ith time step
after t.
This is one strategy for some special purposes. Generally, some actions on the
growth factor can be applied in the queue, for example, the growth factor in the queue
could be mixed or some kinds of attenuation could be applied to simulate functions
of kidneys or liver if their mechanisms were known, etc. Then, the concentration of
the growth factor at the inlet reservoir after switching to queue becomes:
qinlet (t + i) = f (qi , t)

(5.19)

where f is a function applying on the concentration of the growth factor in the queue,
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Figure 5.13: Plot with varied HB-EGF impact on heparin regulation of FGF-2 cell
surface capture. (1ng FGF-2, 20 ug heparin, at 600 seconds, 30% loss at inlet, nonreceptor-coupling and receptor-coupling models [28]).

and it is time dependent.
5.5.5

Eﬀect of Time on FGF-2 Capture Under Multi-pass

Some multi-pass simulations were conducted based on strategy illustrated in Fig. 5.14
to study the eﬀect of time on FGF-2 capture. Both non-receptor-coupling model and
receptor-coupling model are used. The results are shown in Fig. 5.15. The results
show that the FGF-2 captures are increased with the time in both models and there
is a tendency that most of the FGF-2 will be captured eventually if no attenuation
exists.
5.5.6

Eﬀect of Diﬀerent Radiuses of Fibers on FGF-2 Capture

The human blood vessels or capillaries are in diﬀerent sizes of radius, which may have
some critical eﬀects on the growth factor capture. Some simulations were conducted
in diﬀerent radiuses with the same cell density on the wall of ﬁbers. Some additional
simulation values are listed in Table 5.7 and other parameters are the same as listed in
Table 5.6. Fig. 5.16 shows the simulation results in diﬀerent radiuses of ﬁbers under
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Figure 5.14: The diagram of a multi-pass simulation design. The average concentration of the growth factor at outlet is saved in a FIFO queue along with the delta
volume of ﬂuid in each time step. Once the original growth factor at inlet is depleted,
switching to the queue, forming a simulation loop, but without mixing the growth
factor in the queue.

Table 5.7: Some values used in simulations of diﬀerent radiuses.
radius
(um)
2.5
5.0
10
25
50
100
200
350

two models.

Cell/ﬁber
(#)
5000
10000
20000
50000
100000
200000
400000
700000

Ave. ﬂow rate
(ml/min)
0.0000235
0.000094
0.000376
0.00235
0.0094
0.0376
0.1504
0.4606

Ave. ﬂow velocity
(mm/s)
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0

The simulation results reveal that when average velocity is 1 mm/s,

similar to blood ﬂow in human capillaries, almost all FGF-2 entered are captured
when the radius is small, such as 2.5, 5 or 10 um. The relative capture (captured
/entered) decreases as the radius increases.
It is worth mentioning that in the simulation, the viscosity is treated as a constant,
but in human capillaries, the viscosity of blood ﬂow depends on the radius of the
capillary it ﬂows through. The Poiseuille’s relationship for viscosity doesn’t hold for
blood ﬂow in capillaries, at least in a range of capillary radiuses (15 µm < r < 150
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Figure 5.15: The eﬀect of time on FGF-2 capture under multi-pass simulation. 1ng
FGF-2 injected at t=0 and 30% loss at inlet as non-speciﬁc binding. After 600
seconds almost all FGF-2 entered the ﬁber(0.7ng), and the FGF-2 at inlet uses the
saved values at queue.

µm). This is called the Fahraeus-Lindqvist eﬀect [15]. This eﬀect would be considered
in the future when conducting in vitro human blood simulations.
5.6

Summary

Since all proteins are assumed to have the same ﬂow, the multi-physics of ﬂuid ﬂow
is modeled by the same incompressible Navier-Stokes equations. The kinetics of biochemical reactions occurs in the ﬂuid and on cell surfaces as well, so they are modeled
by two separate sets of coupled nonlinear ordinary diﬀerential equations (ODEs). The
mass transport of diﬀerent proteins in the ﬂuid is modeled by a distinctive set of coupled nonlinear partial diﬀerential equations (PDEs) for each of them.
To solve this computationally intensive system eﬃciently, a novel parallel algorithm is devised, in which all the numerical computations are solved in parallel,
including parallel discretization of those mass transport equations PDEs and a parallel linear system solver. A novel parallel SIP solver is designed. For solving binding
equations ODEs in the whole domain eﬃciently, a parallel scheme combined with a
sequential CVODE solver is used for the purposes of high performance and simplicity
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Figure 5.16: The eﬀect of diﬀerent radiuses of ﬁbers on FGF-2 capture under two
models. simulation were run with 1ng FGF-2 injected at t=0, 30% loss at inlet,an
average ﬂow velocity = 1mm/s for all radiuses.

[98].
Some predictions have been obtained based on the parallel system. The research
has found that: (1) heparin or possibly other solution binding agents can eﬀectively
prevent FGF-2 capture under the ﬂow, but it occurs only at high concentrations
(≥ 100µm); and (2) FGF-2 cross regulating receptor binding agents, such as HBEGF or possibly other proteoglycan-competitors, have little eﬀect on FGF-2 capture
in single pass ﬂow even at high concentrations. The experiments also conﬁrmed this
conclusion. Further experiments need to be conducted to verify the predictions of
the parallel simulation system. This parallel modeling system can be used to analyze
any other biochemical reactions in a similar ﬂow environment with trivial eﬀort.
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6
6.1

Parallel Stone’s Strongly Implicit Procedure Solver
Introduction

The modeling of mass transport equations in the ﬂow condition is very important in
binding kinetics analysis. Normally, the ﬁnite volume method is appropriate for discretization of those PDEs. The corresponding system of linear algebraic equations is
represented by a pentadiagonal nonsymmetric matrix. The coeﬃcients of the matrix
are time dependent, and thus the corresponding linear system must be solved separately for each time step. It is time consuming so that parallel methods are of great
importance, especially considering that more species are involved. For the solution
of the nonsymmetric sparse matrix linear system in computational ﬂuid dynamics,
SIP methods are used extensively due to their fewer number of iterations for required
accuracy and lower computational costs for each time step (see Chapter 2). There are
several parallel SIP methods proposed [32, 60]. For example, Ladislav, et al. proposed
a parallel algorithm for calculating a 3D diﬀusion process of the underground water,
including a speciﬁc parallel SIP for their problems. Reeve, et al. also proposed a parallel SIP method for solving sparse linear equations arising from the ﬁnite diﬀerence
approximation to partial diﬀerential equations. They investigated the sequential SIP
method, and proposed wavefront and red-black MPI-based algorithms; and they concluded that their red-black MPI-based algorithm is more eﬃcient due to half values
updated simultaneously in each pass before exchanging edge values [60]. This study
proposed an overlapped Jacobi iteration algorithm, where, instead of waiting for new
edge values to proceed, the previous edge values are used and all the other values
in its subdomain are updated by each processor simultaneously. Compared to the
pipeline method, the overlapped Jacobi iteration method has higher speedup with
the same accuracy. The study did not compare the red-black algorithm proposed by
Reeve, et al. Based on the overlapped Jacobi iteration method, a general parallel SIP
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solver is built.
6.2

Analysis of Sequential Strongly Implicit Procedure

Stone’s SIP method solves a set of linear equations obtained from the discretization
of some arbitrary elliptic problems using a ﬁve point stencil. The matrix system
obtained is shown in Fig. 5.3, and Eq. 6.1.
Ax = b

(6.1)

Stone’s SIP method uses the implicit iteration procedure:
(A + E)xn = (A + E)xn+1 − (Axn − b)

(6.2)

where A + E = LU has a sparse LU factorization. E is an error matrix, which has
two diagonals lying inside and adjacent to the outer diagonals of A (see Fig. 5.5).
Stone’s algorithm is designed so that terms in Ex are very small [80]. An iteration
parameter α (0 ≤ α < 1) is used to calculate L and U. α may be a function of mesh.
Stone’s SIP algorithm consists of the following steps:
step 1. Initial factorization of matrix A into lower and upper triangular matrices L
and U;
step 2. Forward substitution;
step 3. Backward substitution and correction;
step 4. Maximum relative error check.

Steps 2, 3, and 4 are repeated until the maximum relative error diﬀerence between
the old and the new solution is within the deﬁned tolerance or the maximum number
of iterations has been reached [60].
6.2.1

LU Factorization

Considering a rectangular 2D space with I, J grid points in the axial and the radius
directions, the code of LU factorization can be expressed as:
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LW (i, j) = AW (i, j)/(1 + αUN (i, j − J))
LS (i, j) = AS (i, j)/(1 + αUE (i, j − 1))
t1 = αLW (i, j)UN (i, j − J)
t2 = αLS (i, j)UE (i, j − 1)
LP (i, j) = AP (i, j) + t1 + t2 − LW (i, j)UE (i, j − J) − LS (i, j)UN (i, j − 1)
UN (i, j) = (AN (i, j) − t1)/LP (i, j)
UE (i, j) = (AE (i, j) − t2)/LP (i, j)
The calculation of LW , LS , LP , UN , and UE depends on its left neighboring point of
UN and/or north neighboring point of UE .
6.2.2

Forward Substitution

Similarly, the code of forward substitution can be expressed as:
r(i, j) = b(i, j)−(AS (i, j)x(i, i−1)+AW (i, j)x(i, j−J)+AP (i, j)x(i, j)+AE (i, j)x(i, j+
J) + AN (i, j)x(i, j + 1))
Y (i, j) = (r(i, j) − LS (i, j)Y (i, j − 1) − LW (i, j)Y (i, j − J))/LP (i, j)
The calculation of r depends on its left, right, upper and lower neighboring points of
x. Thus, x needs to be updated in each iteration. The calculation of Y depends on
its left and upper neighboring points of Y . The pipeline technique is appropriate.
6.2.3

Backward Substitution and Correction

The code of backward substitution and correction can be expressed as:
δ(i, j) = Y (i, j) − (UN (i, j)Y (i, j + 1) + UE (i, j)Y (i, j + J))
x(i, j) = x(i, j) + δ(i, j)
The calculation of δ depends on its right and upper neighboring points of Y . Again,
the pipeline technique is appropriate.
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6.3

Parallel SIP Algorithms

Based on the analysis of the sequential code in the previous section and the domain
partition scheme used (refer to Fig. 5.4), a parallel algorithm can be designed as
follows: For LU factorization, the pipeline technique is used in order to get the exact
solution as the sequential algorithm for L and U .
For forward and backward substitutions, two algorithms are designed: one algorithm uses a pipeline method, the other one uses an overlapped Jacobi iteration
method.
6.3.1

Pipeline Algorithm

For forward substitution, each processor has to wait for its left side processor to ﬁnish
doing the calculation in order to obtain the new values of Y in left neighboring points
to start the calculation. Pi has to send the boundary values of Y to Pi+1 , and only
after Pi+1 receives the data, it can start calculation. A blocking send or receive is
used.
The solution values of x in boundary points are updated in each iteration, so the
calculation of r is the same as the sequential algorithm. Maximum relative error is
calculated by each processor and then the algorithm does a reduction to obtain the
ﬁnal value.
Similarly, for backward substitution, each processor has to wait for its right side
processor to ﬁnish doing the calculation in order to obtain the new values of Y in right
neighboring points to start the calculation. Pi+1 has to send the boundary values of
Y to Pi , and only after Pi received the data from Pi+1 , it can start the calculation.
A blocking send or receive is used.
The algorithm is shown below.
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Algorithm 12 Parallel SIP algorithm using pipeline techniques
1: LU factorization by using pipeline technique
2: (Pi starts LU calculation after Pi−1 ﬁnishes and Pi receives the left boundary
data sent by Pi−1 )
3: while ||Rn+1 ||2 /||xn+1 ||2 > ε do
Forward substitution by using pipeline technique
4:
5:
(Pi starts calculation after Pi−1 ﬁnishes and Pi receives the left boundary data
sent by Pi−1 )
6:
Backward Substitution by using pipeline technique
7:
(Pi−1 starts calculation after Pi ﬁnishes and Pi−1 receives the right boundary
data sent by Pi )
8:
Update residual Rn+1 = Rn + A∆xn
9:
Update solution xn+1 = xn + ∆xn
10: end while
6.3.2

Overlapped Jacobi Iteration Algorithm

For forward substitution, each processor uses the previous values of Y in left neighboring points to calculate Y instead of waiting for its left side neighboring processor to
send those values, allowing each processor to process concurrently. When all processors ﬁnish the calculation, the boundary points of Y are updated among processors,
i.e., processor Pi sends the boundary values of Y to processor Pi+1 . Blocking send
and receive are used.
The solution values of x in boundary points are updated in each iteration, so the
calculation of r is the same as the sequential algorithm. Maximum relative error is
calculated by each processor and then the algorithm does a reduction to obtain the
ﬁnal value.
For backward substitution, each processor also uses the previous values of Y in
right neighboring points to calculate δ instead of waiting for those neighboring points
to be sent by its right neighboring processor, allowing each processor to process
concurrently. The solution x is corrected based on the δ value. After all the processors
ﬁnish the calculation, the boundary points of Y are updated among processors, i.e.,
processor Pi+1 sends the boundary values of Y to processor Pi . Again, blocking send
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and receive are used.
In each iteration, the left and right boundary points of solution x are updated
among processors. That is, processor Pi+1 sends the boundary values of x to processor
Pi , and vice versa.
The algorithm is shown below:
Algorithm 13 Parallel SIP algorithm using overlapped Jacobi iteration technique
1: LU factorization by using pipeline technique
2: (Pi starts LU calculation after Pi−1 ﬁnishes and Pi receives the left boundary
data sent by Pi−1 )
3: while ||Rn+1 ||2 /||xn+1 ||2 > ε do
4:
Forward substitution by using overlapped Jacobi iteration technique
5:
(All processors start calculation at the same time, the left boundary data use
the previous values)
6:
Exchange left boundary data between processors
7:
Backward Substitution by using overlapped Jacobi iteration technique
(All processors start calculation at the same time, the right boundary data
8:
use the previous values)
9:
Update residual Rn+1 = Rn + A∆xn
10:
Update solution xn+1 = xn + ∆xn
Exchange right boundary data between processors
11:
12:
Exchange solution boundary data among processors
13: end while

6.4

Results

Diﬀerent runs were conducted up to eight nodes on the same supercomputer using
the above two algorithms. Problem size is ﬁxed to be 1500 × 24. The results are
shown in Fig. 5.7. It shows that the overlapped Jacobi iteration method has better
speedup than the pipeline does. The overlapped Jacobi iteration method may need
more iterations than the pipeline, but it is much faster.
6.5

Summary

A novel parallel SIP solver is designed and two techniques (pipeline and overlapped
Jacobi iteration) are implemented. The simulation results show that the overlapped
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Jacobi iteration method has better speedup. This method could be used to replace
the pipeline technique in similar situations to obtain a better performance.
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7
7.1

Conclusion, Contribution and Future Work
Conclusion

This dissertation presents the research work in computer modeling and simulation
of biochemical reactions in a ﬂow environment using the deterministic method. The
whole simulation procedure includes: the mathematical modeling, the discretization
of partial diﬀerential equations, the solutions of linear and nonlinear systems, and
the scientiﬁc visualization. Several typical simulation models are discussed, such
as a basic binding model and a complex binding model. The dissertation work is
summarized as follows.
• First, it introduces a basic novel convection-diﬀusion-reaction model to simulate ﬁbroblast growth factor (FGF-2) binding to cell surface molecules of its
receptor and heparan sulfate proteoglycan (HSPG) and MAP kinase signaling
under ﬂow condition. This model includes three parts: the ﬂow of medium
using incompressible Navier-Stokes equations, the mass transport of FGF-2 using convection-diﬀusion transport equations, and the binding and signaling of
growth factors-receptors using chemical kinetic equations. The whole model
consists of a set of coupled nonlinear partial diﬀerential equations (PDEs) for
ﬂow and mass transport, and a set of coupled nonlinear ordinary diﬀerential
equations (ODEs) for binding kinetics. In order to obtain a reasonable accuracy of the binding and dissociation from cells, a uniform mesh is used. To
handle pulsatile ﬂow, several assumptions are made including neglecting any
entrance eﬀects and an analytical solution for axial velocity within the ﬁbers is
obtained. To solve the time-dependent mass transport PDEs, a second order
implicit Euler method is used by ﬁnite volume discretization. The ODE system is stiﬀ and solved by an ODE solver CVODE using backward diﬀerencing
formulation (BDF). The spatial distribution of FGF-2, FGFR, HSPG and their
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binding complexes are obtained and presented.
• After the basic simulation system is built, the growth factor (FGF-2) capture
under ﬂow is analyzed and predicted using this computer modeling and experimental approach that includes pertinent circulation characteristics such as
pulsatile ﬂow, competing binding interactions, and limited bioavailability. The
experimental module consisted of a bioreactor with synthetic endothelial-lined
hollow ﬁbers under ﬂow. The physical design of the system was incorporated
into the model parameters. The heparin-binding growth factor FGF-2 was used
for both the experiments and simulations. The model is based on the ﬂow and
reactions within a single hollow ﬁber and was scaled linearly by the total number
of ﬁbers for comparison with experimental results. The model predicted, and
experiments conﬁrmed, that removal of heparan sulfate (HS) from the system
would result in a dramatic loss of binding by heparin-binding proteins, but not
by proteins that do not bind heparin. The model further predicted a signiﬁcant
loss of bound protein at ﬂow rates only slightly higher than average capillary
ﬂow rates, corroborated experimentally, suggesting that the probability of capture in a single pass at high ﬂow rates is extremely low. Several other key
parameters were investigated with the coupling between receptors and proteoglycans shown to have a critical impact on successful capture. The combined
system oﬀers opportunities to examine circulation capture in a straightforward
quantitative manner that should prove advantageous for biologicals or drug delivery investigations.
• The biochemical mechanism in human blood vessels and capillaries is very complicated, where diﬀerent kinds of growth factors, receptors and diﬀerent cells
are involved. A complex model system is proposed to handle such cases, in
which more growth factors, receptors and even diﬀerent cells are allowed. The
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binding kinetics are not only allowed to occur on cell surfaces, but in the ﬂuid
as well. The complex model also includes three major parts similar to the basic
model, but mass transport equations and chemical kinetics are diﬀerent. First,
the complex model has more types of proteins in the ﬂuid, and thus, more sets
of mass transport equations are included. Next, the binding kinetics occurs in
the ﬂuid as well as on cell surfaces. Therefore, two diﬀerent sets of ODEs are
needed to handle this situation. In order to solve this coupled nonlinear system
to obtain simulation results within a reasonable waiting period, a special parallel simulation program is created based on message passing interface(MPI),
in which a parallel discretization and a parallel linear solver are designed. For
simplicity, a parallel scheme combined with a sequential ODE solver CVODE
is used to solve binding kinetics in the ﬂuid and on cell surfaces. Overall, the
parallel system is stable and some simulation results are obtained. This research
has found that: (1)heparin (or possibly other solution binding agents) can prevent FGF-2 capture under ﬂow, but only at high concentrations (> 100ug); (2)
HB-EGF or other proteoglycan-competitors can have an eﬀect on FGF-2 capture but it is small under single pass. In the future, more experiments need to be
conducted to verify the correctness and eﬀectiveness of the parallel simulation
system.
7.2

Contribution

The contribution of the author can be summarized in the following:
(1) designed an interactive multi-threading software package running on Windows
operating systems to simulate growth factor-receptor binding and dissociation processes in a bioreactor ﬂow environment, in which several issues are solved, such as:
a) deduced an approximate analytical solution for pulsatile ﬂow; b) provided a general quantitative formula to calculate growth factor binding and internalization on
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cell surfaces within a ﬁber based on a uniform mesh and the deterministic method;
c) provided a reasonable formula to calculate the concentration of growth factors at
inlet reservoir; d) solved the nonspeciﬁc binding issue based on experimental measurements.
(2) conducted massive simulations based on experimental results and provided two
criteria: the amount criterion and the curve-matching criterion, to determine a correlation between the simulation and experimental results. Based on the two criteria,
the simulation and experimental results have good agreements, indicating the software package is trustworthy.
(3) designed a parallel distributed software package with MPI technique running on
cluster machines to simulate multiple growth factors-receptors competitive binding
and dissociation processes in a bioreactor ﬂow environment, in which competitive
bindings can occur on cell surfaces and in the ﬂuid as well, and all the calculations
are parallelized including the parallel discretization and a parallel linear solver. This
parallel software package can be used for any complex binding system in a similar
ﬂow environment. The idea has hints for simulation of binding processes in human
blood vessels or capillaries with multiple proteins and irregular geometry.
(4) parallelized Stone’s SIP solver in two methods: the pipeline and the overlapped
Jacobi iteration method, and found that the latter method has better speedup. This
parallel SIP solver can be used for solving the linear system of sparse matrix with
similar structures.
7.3

Future Work

Some fundamental work has been done that relates to the simulation and modeling
of biological processes in a ﬂow environment. In-depth research needs to be done
to make the simulation as close to human blood vessels or capillaries as possible.
Possible future research directions in protein transport are listed below.
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• Develop a multiphysics mathematical model for simulating ligand-receptor binding, dissociation and transport in blood circulation using a group of nonlinear
diﬀerential equations. In the one phase model of ligand transport presented
in the dissertation, the blood stream is considered as a single phase, and the
proteins are transported passively and their eﬀect to blood ﬂow is neglected.
In the multiphase model, the blood stream may be considered a mixture of
several phases, in which plasma is considered the continuous phase, while protein
molecules are regarded as dispersed phases. The multiphase model allows people
to take a closer look at the motion of protein molecules in the blood stream and
its inﬂuence on the ﬂuid dynamic behavior of the mixture of blood and proteins.
The dynamic system can be modeled by a set of partial diﬀerential equations,
where each phase has its own continuity and momentum equations.
• The mathematical models and corresponding software packages for proteins
transport prediction in circulation are developed for 2D applications in axisymmetric coordinates. This 2D system may be extended to 3D applications
involved in some complex 3D geometries, such as human blood vessels or capillaries, to simulate blood ﬂows in heart and lung, etc. It will be closer to in vivo
simulations but the computational cost could be very high. Eﬃcient parallel
algorithms are still one of the major design goals in those 3D systems. Some
high performance parallel techniques, such as multilevel multigrid acceleration
and eﬃcient preconditioning may be used to achieve the goal of high order accuracy and low computing cost. To be speciﬁc, adaptive multilevel multigrid
method can achieve high order accuracy by mesh reﬁnement in large gradient
region and low computing cost by mesh coarsening in small gradient region.
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Appendix
7.4

A

The basic model [27] studied in Chapter 3 and 4 consists of the following 9 equations,
which describe the rate of components change with respect to time.

dR
= −konF R F R + kof f F R C + kof f F HR T − kc RG − kint R + kint R0
dt
dC
= konF R F R − kof f F R C − kc CH − kc C 2 + 2kuc C2 − kint C
dt
dC2
kc
= C 2 − kuc C2 − kintD C2
dt
2
dT
= kc RG + kc CH − kof f F HR T − kc T 2 + 2kuc T2 − kint T
dt
dT2
kc
= T 2 − kuc T2 − kintD T2
dt
2
dH
= −konF H F H + kof f F H G + kof f F HR T − kc CH − kint H + kint H0
dt
dG
= konF H F H − kof f F H G − kc RG − kc G2 + 2kuc G2 − kint G
dt
dG2
kc
= G2 − kuc G2 − kintD G2 ,
dt
2
dF
V
= −konF R F R + kof f F R C + kof f F HR T − konF H F H − kof f F H G
dt

(7.1)
(7.2)
(7.3)
(7.4)
(7.5)
(7.6)
(7.7)
(7.8)
(7.9)

where F is FGF-2, R is FGFR, C is FGF-2-FGFR complex, H is HSPG, G is FGF2-HSPG complex, T is FGF-2-FGFR-HSPG complex, C2 is FGF-2-FGFR dimer, G2
is FGF-2-HSPG dimer, and T2 is FGF-2-FGFR-HSPG dimer.
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